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2. Abbreviations 
AIRE autoimmune regulator  mRNA messenger RNA 
APC antigen-presenting cell  mTec medullary thymic epithelial cell 
BCR B cell receptor  NK cell natural killer cell 
cTec cortical thymic epithelial cell  NKT cell natural killer T cell 
CTLA-4 cytotoxic T lymphocyte associated 
antigen 4 
 PLZF promyelocytic leukemia zinc 
finger protein 
DC dendritic cell  pTreg  peripherally-derived regulatory 
T  
DN double negative  RAG recombinase activating gene 
DNA deoxyribonucleic acid  RNA ribonucleic acid 
ER endoplasmic reticulum  RSS recombination signal sequence 
FADD Fas-associated via death domain  SP single-positive 
FoxP3 forkhead box P3  TC cell cytotoxic T cell 
HLA human leukocyte antigen  TCR T cell receptor 
HSC hematopoietic stem cell  Tdt terminal deoxynucleotidyl 
transferase 
ICOS T cell inducible co-stimulator  Tet ten-eleven-translocation 
IFN-γ interferon-γ  TH cell helper T cell 
Ii invariant chain  TNF tumor necrosis factor 
IL interleukin  TRAIL TNF-related apoptosis-inducing 
ligand 
IPEX immune dysregulation, poly-
endocrinopathy, enteropathy, X-
linked 
 Treg regulatory T cell 
LAG-3 lymphocyte activation gene 3  TSA tissue-specific antigen 
LPS lipopolysaccharide  tTreg  thymus-derived regulatory T  
MHC major histocompatibility complex    
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3. Summary 
B cells and T cells, which compose the cells of the adaptive immune system, express highly 
variable B cell receptors (BCRs) or T cell receptors (TCRs) on their surface. The generation 
of these receptors through the almost random rearrangement of gene segments during B and 
T cell development is a tightly controlled process to prevent the occurrence of self-reactive 
cells that could cause autoimmune diseases. Nevertheless, some T cell subsets, most 
prominently natural killer T (NKT) cells and regulatory T (Treg) cells, are selected for the 
expression of autoreactive TCRs that enable them to recognize self-ligands during 
development. However, to what extent TCR-mediated signals are required to maintain the 
identity and functional capabilities of mature NKT cells and Treg cells remained incompletely 
understood. 
In Paper I, we analyzed the importance and consequences of TCR signals for mature 
NKT cells by TCR ablation and TCR switch experiments. The vast majority of NKT cells 
express a semi-invariant TCR, which is composed of the same Vα14i-TCRα-chain for all of 
these cells, together with a limited set of TCRβ-chains. As expected, we found that transgenic 
expression of the Vα14i-TCR at the physiological time point during thymic T cell 
development resulted in the generation of large numbers of bona fide NKT cells. 
Subsequently, we could show by employing a TCR switch approach that replacing the 
endogenous TCR repertoire with a Vα14i-TCR on conventional T cells in the immunological 
periphery is not sufficient to reprogram these cells towards the NKT cell lineage. However, 
the Vα14i-TCR-expressing formerly conventional T cells were significantly activated, 
indicating that NKT cells constantly receive autoreactive TCR signals at these locations. 
Finally, to examine whether these autoreactive TCR signals are important for NKT cell 
homeostasis and effector function, we ablated TCR expression on a fraction of NKT cells and 
followed their fate over time. Since NKT cell lineage identity, homeostasis and their innate 
rapid cytokine secretion abilities were virtually unchanged upon TCR ablation, our results 
indicate that peripheral NKT cells become unresponsive to and thus are independent of their 
continuously autoreactive TCR. 
Treg cells are indispensable to prevent the development of autoimmune diseases. Similar 
to NKT cells, Treg cells are selected upon auto-antigen recognition during thymic 
development, although not much is known about the nature of the selecting ligands. 
Furthermore, accumulating evidence suggests that Treg cells still receive stronger TCR signals 
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than conventional CD4 T cells upon emigration to the periphery. In order to examine the 
impact of these signals, we inducibly ablated the TCR from Treg cells and monitored the 
homeostasis, gene expression and suppressive function of TCR-deficient Treg cells (Paper II). 
Interestingly, Treg cell biology is strongly changed upon the loss of TCR expression. The 
TCR-deficient Treg cells decayed quickly, lost a substantial proportion of their typical gene 
expression pattern, and furthermore lost the expression of several key suppressor proteins. 
Therefore, we could show that in striking contrast to NKT cells, Treg cells rely on tonic signals 
received through their autoreactive TCR to maintain their cellular identity and functionality. 
In addition to TCR signals, T cell behavior can also be heavily influenced through 
immunomodulatory cytokines. The deletion of the ubiquitin-editing enzyme A20, a negative 
regulator of the NF-κB signaling cascade, specifically in B cells led to cellular expansion and 
activation of T cells as well as myeloid cells (Paper III). We present evidence that this 
expansion was most likely caused by the spontaneous release of pro-inflammatory cytokines, 
prominently IL-6, through A20-deficient B cells. Interestingly, under these conditions 
Treg cells were also expanded, and might keep the sterile inflammation initially at bay.  
In summary, we could demonstrate that for two inherently autoreactive T cell subsets, 
NKT cells and Treg cells, the dependence on autoreactive signals for homeostasis, gene 
expression and function is fundamentally different. On the one hand, NKT cells become 
completely independent from their autoreactive TCR during their development, similar to 
receptors of cells of the innate immune system. In contrast, Treg cells that do not receive 
continuous TCR signals quickly lose their suppressive potential as well as a large part of their 
signature gene expression, and they also rapidly decay. 
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4. Introduction 
The human body is under constant attack from various pathogens, disease-causing agents, 
such as bacteria, viruses, fungi, protozoa and parasites. During evolution, an immune system 
has developed that is able to efficiently protect us. Broadly, it can be separated into two parts: 
the innate and the adaptive immune system [1,2]. The innate immune system is composed of 
cells that recognize pathogen-associated foreign structures with germline-encoded receptors. 
B cells and T cells constitute the adaptive arm of the immune system. In contrast to receptors 
of the innate immune system, each of these latter cells assembles a unique receptor from 
many gene segments in a randomized process during their development – the B cell receptor 
(BCR) or T cell receptor (TCR) [3,4]. This resulting huge repertoire of receptor specificity 
guarantees that at least in principle, an adaptive immune response against every pathogen can 
be generated. Upon activation by their cognate antigen, individual B and T cells enormously 
expand in order to effectively combat pathogenic invaders. 
4.1.  T cell biology 
T cells are named after the thymus, a primary lymphoid organ in which most steps of T cell 
development take place. The structure and function of the thymus are conserved in animals 
harboring an adaptive immune system [5].  
T cells recognize antigen through their heterodimeric 
T cell receptor (TCR), which is expressed on the cell 
surface [6,7]. It consists of TCRα and TCRβ polypeptide 
chains in more than 85 % of all T cells, which are linked 
through a disulfide bond (Figure 1). This subset is called 
α/β T cells [8]. Few T cells express TCRγ/TCRδ chains 
and will not be discussed here in more detail [8-10]. 
TCRα-/TCRβ-chains have short cytoplasmic tails, 
consisting of around 5-12 amino acids, which cannot 
transduce signals to the cytosol [6,10]. Instead, they are 
associated with the non-polymorphic CD3 complex, 
composed of CD3γ, CD3δ, CD3ε and CD3ζ, which 
induces intracellular signaling pathways upon TCR 
receptor binding [11-15]. 
Figure 1 α/β T cells recognize antigen 
through their heterodimeric T cell 
receptor. Upon T cell receptor 
crosslinking, CD3 molecules mediate 
intracellular signaling. Figure is adapted 
from [1]. 
 
Introduction 6 
4.1.1. Antigen presentation to T cells 
The vast majority of T cells recognize peptide antigens, presented through major 
histocompatibility complex (MHC) proteins. In the human, the system is called human 
leukocyte antigen (HLA), and constitutes the most polymorphic region of the whole genome, 
with over 7000 allelic variants over the population [16]. In both man and mice, two classes of 
MHC molecules can be found, termed MHCI and MHCII, which vary in their function, 
loading and cellular expression [10,16].  
The main role of MHCI is to present intracellular peptides. Thereby, virus- or bacteria-
infected cells, or cells that are oncogenic, can be recognized and destroyed by the immune 
system. MHCI is composed of the MHCI α-chain and β2-microglobulin [10]. It is expressed 
on the surface of all nucleated cells. Nuclear or cytoplasmic proteins are constantly being 
degraded through proteasomes, the resulting fragments are shuttled to the endoplasmic 
reticulum (ER) and loaded onto MHCI [10]. Usually, these peptides are rather short, with 
around 8-14 amino acids [16]. Only upon successful loading of a peptide, the peptide-MHCI 
complex is presented on the cell surface.  
In contrast to MHCI, MHCII mainly presents peptides derived from endocytic pathways. 
Thereby, immune responses against extracellular pathogens can be mounted [10,17]. 
Importantly, MHCII is almost exclusively expressed on the surface of antigen-presenting cells 
(APCs), such as dendritic cells (DCs), B cells and macrophages, as well as on thymic 
epithelial cells [10,17]. Still, in some conditions, such as inflammation, MHCII expression 
can be also induced in other cells [10]. Peptide fragments presented by MHCII are at least 13 
amino acids long, but they can also be much longer [10]. MHCII is composed of an MHCIIα 
and MHCIIβ chain. In the ER, these molecules form a complex together with a third protein, 
the invariant chain (Ii). The Ii stabilizes the MHCII dimer and inhibits loading of other 
peptides [10]. Furthermore, the invariant chain is thought to play a role in targeting MHCII to 
late endosomes, where it finally dissociates from MHCII to allow loading of exogenous 
peptides [10]. 
However, exceptions to this strict separation have been demonstrated. In some conditions 
like viral infections, dendritic cells (DCs) are able to engulf infected cells and present 
processed peptides of these cells over MHCI, a process which is called cross-presentation 
[9,10]. Furthermore, endogenous peptides derived from autophagy may also be presented via 
MHCII [10,18]. 
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4.1.2. T cell co-receptors 
CD4 and CD8 are both designated as co-receptors, as 
they were shown to bind together with the TCR to 
peptide-MHCII or peptide-MHCI complexes, 
respectively [12,19]. The simultaneous binding to the 
same peptide-MHC molecule has been shown to strongly 
increase the signaling intensity in comparison to TCR 
binding alone [12]. CD4 is a single-chain protein, 
consisting of four immunoglobulin-like domains 
(Figure 2). CD8 is usually a heterodimer of the 
CD8α/CD8β-chain, which each contain one 
immunoglobulin-like domain. Few T cells also express 
CD8α-homodimers. 
 
4.1.3. T cell receptor rearrangements 
T cell development is a stepwise process. Hematopoietic stem cells (HSCs) in the bone 
marrow constantly generate T cell progenitors, which leave the bone marrow and enter the 
thymus [17,20]. There, developing T cells can be distinguished by their distinct expression 
pattern. Early T cell-precursors do not express CD4 or CD8 on their surface; this is called the 
double-negative (DN) stage [8,17]. These cells can further be distinguished by surface 
expression of the proteins CD25, the α-chain of the high affinity receptor for the cytokine IL-
2, and the adhesion molecule CD44, into DN1 (CD44+ CD25-), DN2 (CD44+ CD25+), DN3 
(CD44- CD25+) and DN4 (CD44- CD25-) [8,17].  
A crucial process during thymic T cell development is the generation of a functional and 
diverse TCR repertoire. This is accomplished through V(D)J recombination, sometimes also 
called somatic recombination. In this process, each one of the various variable (V), joining (J) 
and in the case of the TCRβ-chain also diversity (D) gene segments are joined together and 
put in close proximity of the constant (C) exons of these genes [21]. The parts of the TCR 
encoded by V, D and J segments contact the antigen/MHC complex, whereas the constant 
region encodes the part that anchors the polypeptide in the cell membrane (Figure 3). 
 
Figure 2 The CD4 and CD8 co-
receptors are composed of Ig 
domains. Figure is adapted from [1]. 
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In the human, the TCRβ locus consists of around 47 V, 13 J, 2 D and 2 C genes, whereas 
the TCRα locus consists of 70 V genes, 61 J genes and one C gene [13]. The main enzymes 
involved in V(D)J recombination are two recombinases, called recombination activating 
gene-1 (RAG-1) and RAG-2. These enzymes recognize recombination signal sequences 
(RSS) flanking the V(D)J gene segments [4]. During recombination, RAG molecules 
introduce DNA double-strand breaks, which are reassembled together by non-homologous 
end joining [3,4]. 
It has been shown that both enzymes are expressed in two waves in developing T cells 
[22,23]. First, RAG-1 and RAG-2 are expressed at the DN2 (CD44+ CD25+) stage, when 
rearrangements of the TCRβ-chain take place. If the rearrangement of the TCRβ-chain was 
successful, meaning that no stop codon was introduced during recombination and a full-length 
protein can be generated, the TCRβ-chain is expressed on the cell surface together with a 
germline-encoded pre-Tα chain [17]. Once the cell receives signals through this pre-TCR, 
expression of both recombinases is stopped and the cells undergo 6-8 divisions [17,23]. 
Subsequently, the cells upregulate CD4 and CD8 to become double-positive (DP) 
thymocytes, and re-express RAG-1 and RAG-2 to rearrange the TCRα chain in a similar 
manner [17,23]. However, in contrast to the generation of the TCRβ-chain, T cells can 
Figure 3 During V(D)J recombination, the germline V, (D in the case of the TCRβ chain) 
and J segments are joined together in an almost random process. Expression of these 
variable TCR chains yields a highly diverse TCR repertoire. Figure is adapted from [1]. 
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undergo several rounds of rearrangements, termed secondary rearrangements, of the TCRα 
chain locus on one chromosome [24] (Figure 4). Primary rearrangements were shown to start 
at the 3’ Vα segments and 5’ Jα segments of the TCR. If these do not lead to positive 
selection of the developing T cell, secondary rearrangements of flanking 5’ Vα segments and 
3’ Jα take place, thereby optimizing the generation of mature T cells by allowing them to test 
several possible TCRα chains during thymic selection [24]. 
 
Theoretically, T cells are capable to express one out of more than 1015 different receptors 
[16,25], although the actual repertoire found in the periphery of mice (~ 2 x 106) and humans 
(~ 2.5 x 108) is much smaller [25,26]. One factor how this high TCR diversity is 
accomplished is the random selection of different segments during V(D)J recombination. 
Moreover, the diversity is further increased through imprecise joining of the segments at the 
junctions, and also through the random removal or addition of nucleotides through the 
enzyme terminal deoxynucleotidyl transferase (TdT) [25,27]. 
4.1.4. T cell selection 
During T cell development, it is on the one hand of importance that the newly generated TCR 
is able to recognize MHC-presented peptides [16]. On the other hand, the development of 
self-reactive T cells that could cause pathology has to be strictly prevented [28]. To meet both 
requirements, T cells undergo strict selection processes in the thymus before they are released 
in the periphery [17-19,28]. These processes mostly take place at two different anatomical 
locations in the thymus, an outer part called cortex, and an inner part called medulla 
[17,18,28]. 
Figure 4 The structure of the TCRα-locus allows several sequential rounds of V(D)J recombination, 
termed secondary rearrangements.  
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T cell progenitors enter the thymus and undergo V(D)J recombination in the cortex [8,17] 
(Figure 5). Upon TCR surface expression, DP T cells are tested for their ability to recognize 
self-peptides presented by MHCI and MHCII on cortical thymic epithelial cells (cTECs) 
[18,28]. In this interaction, the vast majority of T cells does not receive a sufficient stimulus 
through their newly developed TCR to survive, causing “death through neglect” [17,18,28]. 
Only those T cells expressing a potentially useful TCR with sufficient affinity for self-
antigen-MHC complexes are positively selected and allowed to survive [19]. Depending on 
whether the recognized antigen is presented via MHCI or MHCII, T cell commitment towards 
the CD8- or CD4-lineage takes place at this developmental stage, and the cells downregulate 
expression of either CD4 or CD8 to become single-positive (SP) T cells [19,29,30].  
Figure 5 Overview of thymic T cell development. T cell progenitors migrate from the bone 
marrow into the thymus. There, they start to rearrange their T cell receptor. Upon surface 
expression, these cells undergo positive and negative selection mechanisms before they finally 
leave the thymus as naïve mature T cells. Figure is adapted from [17]. 
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The final steps of thymic T cell development take place in the thymic medulla. Here, 
autoreactive T cells recognizing self-peptides are deleted from the repertoire. It has been 
shown that medullary thymic epithelial cells (mTECs) are able to present tissue-specific 
antigens (TSA) due to the actions of a protein called autoimmune regulator (AIRE) [31]. 
Furthermore, additional self-peptides, and also antigens derived from the commensal gut flora 
and the food, are presented by immigrant dendritic cells [32]. T cells that can be activated 
upon recognition of these peptides could be harmful for the host if they were released into the 
periphery. Therefore, these cells quickly undergo apoptosis upon strong activation, a process 
called negative selection [18,28]. Only those cells with weak affinity for self-peptide/MHC 
complexes are finally allowed to leave the thymus.  
Collectively, the mechanism that prevent autoimmune T cell activation during early T cell 
development before the mature T cell leaves the thymus are called central tolerance [18,28]. 
Still, the elimination of autoreactive cells through central tolerance mechanisms is 
incomplete, amongst other things because not all possible self-antigens are presented by 
mTECs and DCs in the thymus. To control autoreactive T cells in the immunological 
periphery, several peripheral tolerance mechanisms have evolved. These include protection 
through regulatory T cells that are able to directly suppress autoreactive T cells in trans, but 
also cell-intrinsic pathways such as anergy, a hypo-responsive state that is induced through 
chronic self-antigen recognition [18,28]. 
4.1.5. Naïve, effector and memory T cells 
After their selection, T cells leave the thymus as mature naïve, antigen-inexperienced cells. 
These cells express specific homing receptors, most importantly CD62L, and chemokine 
receptors such as CCR7, which allow them to migrate through the bloodstream to the 
secondary lymphoid organs, spleen and lymph nodes, where they eventually encounter their 
antigen [33,34]. Naïve T cells are not able to immediately react upon primary activation 
through antigen encounter. Instead, antigen encounter rapidly induces a developmental 
program towards the so-called effector T cells [33,35,36]. These effector cells express homing 
and chemokine receptors that allow them to migrate to the sites of infection [36]. 
Furthermore, they start to produce specific effector molecules, e.g. immuno-modulatory 
cytokines, chemokines and cytotoxic substances, which allow them to fight the infection once 
they encounter their antigen for the second time [33]. Due to the huge amount and variability 
of possible antigens that have to be recognized, only few T cells are able to recognize a 
specific antigen. Therefore, this population has to vigorously expand upon antigen encounter 
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to mount an effective immune response [35]. It was shown that during an immune response, 
more than 10 000 effector T cells can be generated from one mother cell [35]. At the end of 
the immune response, 90-95 % of these effector cells die in the so-called contraction phase 
[35,36]. Nevertheless, a pool of long-lived memory cells remains that is able to quickly 
protect the body in case of another infection with the same pathogen, which is the hallmark of 
adaptive immunity [33-36]. 
4.1.6. Conventional T cell subsets 
As previously noted, the presentation of intracellular and extracellular pathogen-derived 
antigens is predominantly separated on two different MHC molecule classes. This separation 
is essential to allow the immune system to mount pathogen-specific responses. In this line, 
functionally different T cell subsets specific for MHCI and MHCII have evolved. Broadly, 
these can be separated in CD4+ helper T (TH) cells and CD8+ cytotoxic T (TC) cells [12,37].  
Cells that harbor intracellular bacteria or that are infected with a virus need to be 
destroyed in order to eradicate the infection and to prevent further spreading of the disease. 
As previously noted, these cells will eventually present peptides derived from their 
intracellular pathogen via MHCI to CD8+ cytotoxic T cells [10]. Activated cytotoxic T cells 
are able to directly kill infected cells through two distinct mechanisms. First, CD8+ T cells 
start to produce and store various cytotoxic and pro-apoptotic molecules in secretory vesicles 
upon their activation, which they directly release on their target cells through exocytosis [38]. 
Among these secreted molecules, the two most prominent members are perforins and 
granzymes. Perforins are pore-forming, membranolytic proteins that directly integrate in the 
target cell plasma membrane [38,39]. Thereby, perforin facilitates the entry of granzymes, 
which are serine proteases that induce programmed cell death into the target cell [39]. 
The second pathway to trigger the direct destruction of infected cells is called FADD 
(Fas-associated via death domain) [7,38]. Activated cytotoxic CD8+ T cells upregulate the 
expression of the ligands for the FAS, TNF (tumor necrosis factor) and TRAIL (TNF-related 
apoptosis inducing ligand) receptors on their surface. Once these ligands bind to their 
respective receptors on their target cells, an intracellular signaling cascade is induced that 
ultimately triggers caspase activation and apoptosis [7,38]. 
The main role of CD4+ helper T cells in immune responses is not to kill other cells, but to 
modulate and control the function of various other cells of the immune system. Naïve CD4+ 
T cells may differentiate into one of several helper T cell subsets. Initially, these were 
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separated into TH1 T cells that elicit cell-mediated, pro-inflammatory immune responses, and 
TH2 T cells that control antibody-mediated humoral immunity [40].  
However, the TH1/TH2 model eventually turned out to be an oversimplification [41,42]. 
Through IFN-γ production, TH1 T cells also effect humoral immune responses by inducing B 
cells to switch their antibody isotypes towards those that help with the phagocytosis of 
microbes [43]. Furthermore, several additional CD4+ T cell subsets have been discovered 
over the last years. At the moment, it is believed that a naïve CD4+ T cell can differentiate 
into one of at least five different subsets: TH1, TH2, TH17, peripherally-derived regulatory 
T (pTreg) or follicular helper T (TFH) cells [44]. 
TH1 T cells produce several chemokines and cytokines, most importantly interferon-γ 
(IFN-γ), upon activation. Thereby, they recruit macrophages to sites of inflammation and 
activate these cells [45]. Activated macrophages consequently engulf and destroy microbes 
[45]. Thus, TH1 T cells play a main role in the defense against intracellular pathogens [46].  
TH2 T cells are crucial in immune responses against extracellular parasites, and also to 
help B cells to produce antibodies. They influence the production of specific antibody classes 
by B cells, mostly through release of the cytokines interleukin-4 (IL-4) and IL-5 [45]. IL-4 
elicits an isotype switch towards IgE antibodies, which are important in mast cell- and 
basophil-mediated responses against extracellular parasites and toxins. Furthermore, they are 
able to control the generation, recruitment and activation of eosinophils by producing the 
cytokine IL-5 [47]. 
A third subset was found to produce the cytokines IL-17A and IL-17F during immune 
responses and consequently called TH17 T cells [48,49]. In addition, they also produce IL-22 
[46]. These cytokines have a broad effect on various different cells types, but the main role of 
TH17 T cells seems to lie in the defense against fungi and some bacteria strains [46,50]. 
Follicular helper T (TFH) cells are the newest addition to the growing list of helper T cells 
subsets. They can be found in germinal centers, where they aid B cells undergoing class-
switch recombination and somatic hypermutation reactions [51]. The existence of further 
helper T cell subsets, including TH9 and TH22 T cells, was proposed, but it is not clear at the 
moment whether these cells represent separate lineages [51]. 
Two additional CD4+ T cell subsets that are essential to maintain immune homeostasis, 
natural killer T (NKT) cells and regulatory T (Treg) cells, do not develop from conventional 
CD4+ naïve T cells, but instead are generated as separate lineages during thymic T cell 
development [52]. Both of these cells were the main topic of my PhD thesis research and are 
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discussed below in more detail. However, it was found that peripheral naïve CD4+ T cells 
have the ability to differentiate into cells with a similar function and gene expression as 
thymus-derived regulatory T cells. To distinguish both lineages, a new nomenclature was 
recently proposed [53]. Thymus-derived Treg cells should be called thymic Treg cells (tTreg), 
whereas those that differentiate from naïve T cells in the periphery should be called 
peripherally-derived Treg (pTreg) cells. 
The differentiation of naïve CD4+ T cells into one of the different effector lineages 
depends on the strength of TCR signaling, as well as the presence of distinct cytokines, during 
activation. In a recent paper, it was demonstrated that although a single T cell clone gives rise 
to various effector T cells during an immune response, the fate of these cells seems to be 
predominantly determined through their TCR [54]. Nevertheless, at least in vitro, the addition 
of cytokines during T cell activation also significantly influences their effector fate. IL-12 and 
IFN-γ induce development towards the TH1 lineage, whereas IL-4 directs T cells towards the 
TH1 effector T cells [51]. Similarly, TGF-β together with IL-6 or IL-21 induces differentiation 
towards TH17 cells, whereas pTreg cells can be induced through IL-2 and TGF-β [51].   
4.2.  Natural killer T cells 
Over 20 years ago, a subset of T cells in mice expressing the natural killer (NK) cell surface 
marker NK1.1 was first described [55]. Shortly afterwards, a similar T cell population was 
also identified in the human [56,57]. In addition to NK1.1, these T cells can express several 
other receptors typically associated with NK cells [58-60]. Although a variety of different 
names have been proposed over the last years, most commonly these cells are called natural 
killer T (NKT) cells [61]. Nevertheless, it is important to mention that not all NKT cells 
express NK1.1 or other NK cell markers, and some CD8+ conventional T cells also express 
NK1.1 upon activation [61-63].  
In mice, NKT cells represent about 2.5 % of T cells in the spleen, 0.5 % in the blood and 
peripheral lymph nodes, and up to 30 % of T cells in the liver [64]. They appear about 10 fold 
less frequent in the human, but their numbers are very variable between individuals [64]. In 
contrast to peptide-recognizing conventional T cells, NKT cells recognize glycolipids, 
presented by the MHCI-like molecule CD1d [65]. The vast majority, called type-I-NKT cells, 
express a peculiar T cell receptor [64], which is composed of the invariant Vα14–Jα18 
(Vα14i) rearrangement of the TCRα-chain in mice [66]. Importantly, the Vα14i protein 
derived from this rearrangement is the same for all NKT cells [63]. This Vα14i-TCRα-chain 
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is expressed together with a limited set of TCRβ-chains that predominantly contain Vβ8, Vβ7 
or Vβ2 [66,67]. In man, a similar group of NKT cells expresses the homologous Vα24-Jα18 
rearrangement, together with a Vβ11-containing TCRβ-chain [58,66]. Interestingly, the 
interaction of NKT cell TCRs and glycolipids presented by CD1d is strongly conserved 
among different species, with mice NKT cells recognizing glycolipids presented by human 
CD1d and vice versa [68]. Type-II-NKT cells, which do not express the Vα14i-TCR, but also 
recognize glycolipids presented by CD1d, are very rare [69]. These cells are much less 
understood, and will not be discussed here in further detail. 
4.2.1. CD1d mediates antigen presentation to NKT cells 
Early on, it was discovered that CD1d plays a critical role in the selection and function of 
NKT cells [67,70]. Hence, NKT cells do not develop in mice deficient for CD1d [71]. In the 
human, the CD1 family consists of five members, CD1a, CD1b, CD1c, CD1d and CD1e, 
which all present glycolipids to different T cell subsets with the exception of CD1e [72]. In 
rodents, only CD1d is expressed due to the deletion of the other genes during evolution 
[72,73]. The most efficient loading of glycolipids on CD1d molecules takes place in 
lysosomes and late endosomes [73,74]. Still, CD1d can also be loaded directly at the cell 
surface [73]. In contrast to MHCI, which is expressed on the surface of all nucleated cells, 
CD1d is only expressed on antigen-presenting cells (DCs, B cells and macrophages), cortical 
thymocytes and activated hepatocytes [64].  
In mice, most NKT cells express CD4 and few are DN (CD4- CD8-), whereas in the 
human, also some CD8+ NKT cells are present [75,76]. However, CD4 and CD8 do not 
directly bind to CD1d and do not act as co-receptors on NKT cells as opposed to their role in 
the interactions of conventional T cells with MHC molecules [75,76]. Thus, the functional 
role of CD4 and CD8 on NKT cells is still unclear. 
4.2.2. Thymic NKT cell development 
Currently, it is believed that NKT cells diverge from conventional T cells at the DP stage in 
the thymus [59,77]. The assembly of a Vα14i-TCR through V(D)J recombination is a 
stochastic event in T cell development, with an estimated incidence of about 1 in 106 cells 
[78]. In mice, NKT cells first appear around day 5 after birth [79], whereas conventional α/β 
T cells are already present at birth [11]. The delayed emergence is due to the fact the Vα14-
Jα18 rearrangement is always a secondary rearrangement, because Jα18 is a rather distal gene 
segment close to the 3’ end of the Jα locus, and rearrangements generally progress from the 
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5’ end to the 3’ end at the Jα locus [76]. In line with this, gene mutations that shorten the life 
span of T cells undergoing rearrangements of the TCRα-chain, and thereby impair secondary 
rearrangements, show strongly decreased numbers of developing NKT cells [77,80]. In 
contrast, transgenic mice expressing a rearranged Vα14i-TCRα-chain contain significantly 
increased NKT cell numbers [81-84]. 
The thymic selection process of NKT cells differs in several aspects from that of 
conventional T cells. First, Vα14i-TCR-expressing DP T cells are not positively selected by 
thymic epithelial cells (TECs), but instead by other DP thymocytes that express CD1d on 
their surface [85,86]. Restricting CD1d expression to DP thymocytes was sufficient to allow 
NKT cell development [85,86]. A possible reason why thymic epithelial cells fail to select 
NKT cells is that homotypic interactions of members of the SLAM family (SLAMf) of 
surface receptors, which are not present on thymic epithelial cells, are obligatory during 
NKT cell selection [83]. However, CD1d is expressed on TECs as well as on thymic DCs, 
and these cells were suggested to play a role in negative selection of NKT cells [75].  
An additional major difference between conventional T cells and NKT cells is the TCR 
signal strength during thymic development. As discussed in the previous section, autoreactive 
T cells could be harmful for the host and are therefore deleted from the repertoire through 
negative selection. Still, some T cell subsets, including NKT cells and regulatory T cells, are 
instead selected for their ability to recognize specific self-antigens, which is known as agonist 
selection [52,87] (Figure 6). This recognition triggers a comparably strong TCR downstream 
signal, as it was recently demonstrated by using reporter mice for TCR signaling strength 
[88]. How TCR- and also SLAMf-generated signals are merged to direct these cells towards 
the NKT cell lineage is just beginning to be understood. Recently, it was observed that Egr1 
and Egr2, two transcription factors induced by TCR signaling, are significantly higher 
expressed at early NKT cell development stages in comparison to conventional T cells [89]. 
Furthermore, it was shown that Egr2 is directly able to bind to the promoter and to induce the 
expression of the transcription factor promyelocytic leukemia zinc finger protein (PLZF) [89]. 
PLZF itself controls the maturation and effector differentiation of NKT cells and is 
considered to be a key lineage-defining transcription factor [90,91]. 
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4.2.3. NKT cell maturation 
After selection by auto-antigenic activation, thymic NKT cells undergo a series of maturation 
steps. The first stage that can be identified by flow cytometry is called stage 0. These cells are 
characterized by the expression of CD24, a marker of immature T cells [92], and express 
neither CD44 nor NK1.1 [78]. Stage 1 NKT cells have downregulated CD24 and do 
proliferate vigorously, thereby increasing the pool of NKT cells after positive selection. 
Progression from stage 1 to stage 2 is characterized by increased CD44 expression, and these 
cells are still actively cycling [93]. The majority of stage 2 NKT cells exit the thymus to 
undergo their final maturation step, the upregulation of NK1.1 and other NK cell markers to 
become stage 3 NKT cells, in the periphery [79,93]. However, few long-lived NKT cells can 
also fully mature in the thymus [79]. Furthermore, NKT cells acquire a surface marker 
phenotype reminiscent of activated/memory T cells with low expression of CD62L, and high 
expression CD44, CD69, CD122 and ICOS, during their maturation [67,90,94]. 
4.2.1. Antigen recognition and activation of NKT cells 
The first antigen that was described to activate NKT cells and still the most potent one up to 
date is the glycolipid α-galactosyl-ceramide (αGalCer), which was discovered in a screen for 
novel compounds with anti-tumor activity [65,95]. Originally, αGalCer was isolated from a 
sample of the marine sponge Agelas mauritianus [95], but it is now believed that it was 
Figure 6 During T cell development, differences in TCR signal strength can lead to fundamental 
different developmental fates.  Conventional T cells are positively selected through rather weak 
signals. In contrast, NKT cells and regulatory T cells are selected for their ability to recognize self-
antigen, which induces strong TCR signals. Figure is adapted from [52]. 
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derived from bacteria colonizing the sponge [64]. NKT cell reactivity towards bacterial 
glycolipids has been demonstrated for several strains such as Streptococcus pneumoniae [96], 
some Sphingomonas species [97,98] and Borrelia burgdorferi [99]. 
However, NKT cells were shown not only recognize pathogen-derived lipids, but also 
display reactivity towards self-antigens. It is believed that NKT cells are “autoreactive by 
design” [100], and this autoreactivity is fundamental during development, as NKT cells are 
selected upon self-antigen recognition in the thymus [74,101,102]. In mice containing a 
mutated CD1d not able to target endosomal/lysosomal compartments for endogenous lipid 
loading, the development of NKT cells was strongly impaired [74]. At the moment, although 
some plausible candidates have been put forward [101,102], the exact nature of the 
endogenous ligand(s) involved in thymic NKT cell selection is still unclear.  
Moreover, also mature peripheral NKT cells display autoreactivity. When NKT cells 
were co-cultured in vitro with antigen-presenting cells in the absence of additional stimulatory 
lipids, they were activated to some extent, which was abrogated through the addition of CD1d 
blocking antibodies [58,103]. This inherent autoreactivity of NKT cells was shown to be 
important for NKT cell activation in several diseases. Infection of mice with Salmonella 
typhimurium, a bacterium that does not contain NKT cell antigen, led to NKT cell activation 
that was partially blocked by antibodies against CD1d [103]. Similar observations of CD1d-
dependent presentation of self-lipids to NKT cells were described for mice infected with 
influenza A virus [104]. Lastly, CD1d-dependent NKT cell activation in the absence of 
foreign antigen was also reported to be crucial for cancer rejection [105].  
In these disease settings, altered lipid metabolism in antigen-presenting cells was shown 
to induce the presentation of self-lipids with a stronger potential to activate NKT cells 
[106,107]. Using self-lipids as “danger signals” to activate NKT cells might be a useful 
mechanism for the immune system to elicit NKT cell responses in a broad range of immune 
responses [106,107]. 
For several microbial lipids [108], synthetic lipids [109] and self-lipids [110], the binding 
of the Vα14i-TCR to lipid-loaded CD1d has been analyzed so far. Despite the structural 
difference of these lipid antigens, the binding mode of the Vα14i-TCR was surprisingly 
similar for all complexes [111]. The only variable region of the Vα14i-TCR, a part of the 
TCRβ-chain, was never in direct contact with the lipid antigen, but just contacted CD1d 
[87,111]. Only the invariable Vα14i-TCRα-chain could ligate the presented lipid. This 
conserved binding mode of the Vα14i-TCR is very similar to pattern recognition receptors of 
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the innate immune system [87]. 
In addition to TCR-derived signals, also pro-inflammatory cytokines are able to induce 
NKT cell activation during immune responses (Figure 7). The best-described cytokine in this 
context is IL-12, and in contrast to naïve conventional T cells, NKT cells express high 
amounts of the IL-12 receptor in the steady state [103,112]. Likewise, IL-18 has been shown 
to directly induce NKT cell activation [113]. These cytokines are mainly produced by 
dendritic cells activated by innate immune pathways such as toll-like receptor signals 
[113,114]. In some extreme cases, cytokine-derived signals alone were proposed to be 
sufficient to fully activate NKT cells in the absence of additional TCR stimulation [112,113]. 
However, in most disease settings, TCR-dependent recognition of (self)antigen, together with 
cytokine signals, cooperatively mediate NKT cell activation [112,115]. 
4.2.2. NKT cell functions in disease 
Once activated, the most distinguishing feature of NKT cells is their rapid production and 
secretion of a large set of immuno-modulatory cytokines [94,116]. NKT cells comprise the 
only T cell subset that is able to simultaneously produce proinflammatory TH1 cytokines such 
as IFN-γ and TNF, as well as TH2 cytokines such as IL-4 and IL-13 [94,116]. Interestingly, 
the basis for their fast cytokine release during immune responses appears to be their ability to 
store large pools of untranslated cytokine mRNA, which can be quickly mobilized upon 
activation [117,118]. An additional important function of NKT cells is the release of 
Figure 7 Depending on the type of the pathogen, NKT cell activation is either dominated by TCR-
generated signals, or by cytokines released from antigen-presenting cells. Figure is adapted from [115]. 
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chemokines in order to recruit other immune cells to the sites of infection [119]. Similar to 
cytokine mRNA, NKT cells are also able to store mRNAs for several of these chemokines to 
allow an accelerated response [120]. Finally, NKT cells are able to employ cytotoxic 
mechanisms to directly kill other cells through perforin/granzyme-release as well as through 
the FADD pathway [120]. 
NKT cells are critical regulators of several immune responses, as it has been 
demonstrated through the analysis of diverse mouse models, but also the empirical 
investigations of human patients [64,121]. On the one hand, NKT cell have a protective role 
against microbial infection [97,99,122], autoimmune disease development [121] and cancer 
[105,121]. On the other hand, due to their potent immunoregulatory functions, inappropriate 
activation of NKT cells is implicated in the pathogenesis of atherosclerosis and allergies 
[64,121]. 
4.3.  Regulatory T cells 
The first indication for a suppressive T cells subset was found over 40 years ago. It was 
described that extraction of the thymus, a process called thymectomy, led to a destruction of 
ovaries when it was performed three days, but not seven days after birth in mice [123]. While 
this phenotype was primarily speculated to be due to the absence of hormones produced by 
the thymus, follow-up experiments showed that thymectomy triggers various autoimmune 
diseases in mice and in rats [124-127]. Furthermore, this pathology was caused by 
autoreactive T cells, as T cell transfer could transmit the disease to other animals [126,127]. 
Importantly, disease onset could be prevented upon transfer of either thymocytes or 
splenocytes from adult mice [128]. These findings indicated the existence of two distinct 
T cell populations in these animals: First, a subset of effector T cells that is causative for 
disease onset and also elicits the disease upon transfer into other animals. Secondly, a subset 
of suppressive T cells that is able to control autoimmunity, but is not generated until 3 days 
after birth [129]. 
Over the years, these suppressive cells were further characterized through experiments in 
which the transferred cells were depleted or enriched for cells expressing certain cell surface 
markers. In this way, it was shown that suppressive T cells predominantly expressed the cell 
surface markers CD4 [128], high levels of CD5 [130] and low amounts of CD45RB [131]. 
Furthermore, suppressive cells were found to express high amounts of CD25, the α-chain of 
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the high-affinity receptor for the cytokine IL-2 [132]. From thereon, these cells were called 
regulatory T (Treg) cells [132,133]. 
4.3.1. FoxP3 is the signature Treg cell transcription factor 
A major breakthrough in the understanding of Treg cells came in 2003, when several groups 
found that the forkhead box P3 (FoxP3) protein is specifically expressed by Treg cells [134-
136]. FoxP3 is a forkhead/winged-helix family transcription factor located on the X 
chromosome [137-139]. Mutations in the Foxp3 gene were initially found to be causative for 
the rare human autoimmune disease IPEX (immune dysregulation, polyendocrinopathy, 
enteropathy, X-linked), to which patients succumb during infancy [138,139]. A similar 
phenotype was observed in mice harboring the scurfy mutation, which is a loss of function 
mutation of the Foxp3 gene [137]. FoxP3 expression, which is confined to T cells, is crucial 
for Treg cell development, as these cells were shown to be absent in mice lacking FoxP3 [134], 
and T cell-specific FoxP3 inactivation reproduced the scurfy phenotype [140]. Importantly, 
ectopic expression of FoxP3 in activated CD4+ conventional T cells partially induced the 
Treg cell gene signature and also conferred suppressive abilities [134,135,141].  
Recently, it has been shown that FoxP3 can both induce and suppress target gene 
expression [141-143]. However, FoxP3 binds directly to less than 10 % of FoxP3-regulated 
genes [142]. Instead, FoxP3 was shown to control gene expression as part of large 
transcriptional complexes that can contain several hundred co-factors [144]. 
4.3.2. Regulatory T cell development 
Thymus-derived regulatory T (tTreg) cells are thought to branch off from the other T cell 
lineages at the DP stage in the thymus. However, in contrast to conventional T cells, which 
are present at birth [11], tTreg cell development is delayed during ontogeny [145]. Mature 
tTreg cells are rarely found in the thymus before day 3 after birth [145], explaining the 
previously observed differential outcomes of neonatal thymectomy on day 3 and day 7 [123]. 
The vast majority of tTreg cells express the co-receptor CD4 and accordingly recognize 
peptides presented by MHCII, and tTreg cells are not found in mice deficient for 
MHCI/MHCII [140]. Although the TCR repertoire of tTreg cells is partially shared with that of 
conventional CD4+ T cells, most TCRs are different [146,147]. Importantly, tTreg cells are 
thought to express autoreactive TCRs and are selected by agonist ligand, similar to NKT cells 
[52,146,147]. Still, agonists selecting tTreg cells have not been identified yet, but will probably 
include rare tissue-specific antigen [148].  
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The proposed autoreactive nature of tTreg cells is based on several experimental 
observations. First, the majority of tTreg cells have a surface phenotype that is reminiscent of 
recently activated T cells, with high expression of CD25, CD122, GITR, and Ox40 [142,149]. 
Second, in mice expressing a transgenic TCR, tTreg cells only developed once the cognate 
antigen was expressed as a second transgene [150]. Finally, in a mouse model that reports 
TCR signaling strength, tTreg cells consistently displayed higher signaling strength in 
comparison to conventional T cells in the thymus, and also in the periphery [88]. 
The thymic generation of tTreg cells is a multistep process. The observations that in 
addition to TCR signaling strength, interleukin-2 (IL-2) signaling is of critical importance for 
tTreg cell development [151,152], and that CD25high FoxP3– T cells are the direct precursors 
of FoxP3+ tTreg cells [152],  were recently combined in a two-step model for tTreg cell 
differentiation [152]. According to this model, strong TCR signals upon self-antigen 
recognition induce the surface expression of CD25 [152]. This is thought to increase the 
sensitivity for IL-2, which induces FoxP3 expression in a second (TCR-independent) stage 
[152]. 
However, despite its undeniable importance, FoxP3 expression alone is not sufficient to 
induce the characteristic Treg cell gene expression profile [141,153]. In mice in which GFP 
was inserted in an disrupted FoxP3 locus, the surface marker phenotype of GFP-expressing 
T cells resembled that of wild-type Treg cells despite the absence of FoxP3 [154]. An 
interesting explanation for this finding is the recent discovery that in addition to FoxP3 
expression, a second prerequisite for Treg cell development is the establishment of a specific 
DNA hypomethylation pattern (Treg-Me) [153]. Covalent methylation of cytosines, which is 
mainly found at clusters of CpG dinucleotides, is an epigenetic DNA modification that is 
connected to heterochromatin and transcriptional silencing [33]. In contrast, demethylation of 
CpG islands is connected to open chromatin structure and enhanced gene expression [33]. In 
Treg cells, the loci of five genes that are highly expressed in these cells, including FoxP3, were 
found to be significantly hypomethylated in comparison to conventional T cells [153]. 
Importantly, also Treg-Me induction is TCR signaling-dependent and progressively established 
through continuous TCR signaling over days [153]. This demethylation is an active process 
which acts independently of cell proliferation [155]. Altogether, the TCR-dependent induction 
of both FoxP3 expression as well as Treg-Me is a crucial process during thymic Treg cell 
commitment, since both play largely non-redundant roles in controlling Treg cell gene 
expression. 
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4.3.3. Regulatory T cell subsets 
Similar to the previously discussed conventional T cells, Treg cells can be broadly separated 
into naïve and effector subsets [156,157]. The majority of Treg cells in lymphoid organs 
usually express the surface markers CD62L and CCR7 resembling naïve T cells, which allow 
them efficient cycling between lymph nodes and spleen [156-158]. On the other hand, 
Treg cell migration into non-lymphoid tissues is usually accompanied with downregulation of 
both markers [156-158]. Instead, these Treg cells express receptors that can also be found on 
effector T cells, such as homing and chemokine receptors [157,158] as well as additional 
activation markers [156]. Interestingly, it was recently demonstrated that during immune 
responses, effector Treg cell subsets are generated that share the expression of specific 
transcription factors and surface receptors with the conventional helper T cells they suppress 
[159-161], which is crucial for optimal Treg cell function in distinct disease settings [162,163]. 
4.3.4. Regulatory T cell functions 
Throughout the lifetime of mice, Treg cells are needed to prevent aberrant 
autoimmune/inflammatory responses, as it was shown that deletion of these cells in mature 
animals led to death within 2-3 weeks [164]. Treg cells mainly act as suppressive cells, and are 
able to modulate the behavior of various other cell types, including T cells, B cells, DCs and 
NK cells. Due to the variety of immune responses and immune cells that have to be 
controlled, Treg cells possess several different suppressor mechanisms (Figure 8) [165,166].  
First, most Treg cells express high levels of CD25 on their surface, which is not only 
indispensable for their development [152] and their homeostasis [167], but also for the control 
of immune responses. High CD25 expression enables Treg cells to efficiently outcompete 
effector T cells for IL-2 [168]. It is believed that Treg cells can act as a “sink” for IL-2, causing 
effector T cell death due to withdrawal of IL-2 [168]. Furthermore, Treg cells are able to 
disrupt target cell metabolism through increasing the amount of extracellular adenosine, 
which inhibits T cell responses [169]. They do so through the surface coexpression of CD39 
and CD73, two ectoenzymes that in concert hydrolyze nucleotides to nucleosides [169].  
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A second suppressive mechanism of Treg cells is cytolysis. Similar to cytotoxic CD8+ 
T cells and NKT cells, Treg cells are able to directly induce target cell lysis through the release 
of granzymes and perforin [170,171]. To this date, Treg cell-mediated killing of effector T 
cells [170], B cells [171] as well as dendritic cells [172] has been demonstrated.  
A third important suppressive mechanism of Treg cells is the release of inhibitory 
cytokines. Early on, it was discovered that IL-10 is produced by Treg cells [173], which is able 
to dampen inflammatory cytokines production of innate immune cells during immune 
responses. Accordingly, in mice with Treg cell-specific deletion of the IL-10 gene, the control 
of immune responses at the colon and the lungs was impaired [174]. Recently, a novel 
cytokine, IL-35, has been found, which is mainly expressed by Treg cells and directly inhibits 
the proliferation of effector T cells [175].  
Finally, Treg cells are able to control immune response by interfering with the maturation 
and function of antigen-presenting DCs. Cytotoxic T lymphocyte associated antigen 4 
(CTLA-4) is constitutively expressed on the surface of Treg cells, and has been shown to block 
DC costimulation through removing costimulatory ligands from the surface of DCs by trans-
Figure 8 To control immune responses, Treg cells employ various suppressive mechanisms, including 
the release of cytokines or cytotoxic molecules, metabolic disruption as well as the modulation of 
dendritic cell function. Figure is adapted from [165]. 
 
Introduction 25 
endocytosis [176,177]. Furthermore, during direct interactions of Treg cells and DCs, binding 
of lymphocyte activation gene 3 (LAG-3) to MHCII on DCs blocks DC maturation [178]. 
Several Treg cell-specific knockout mice of putative suppressor molecules have been 
generated up to date, but none of these animals did develop systematic autoimmunity similar 
to that which is observed in Treg cell-ablated or FoxP3-deficient animals [129,179]. The most 
dramatic autoimmune symptoms were found in mice with CTLA-4 ablation in BALB/c 
Treg cells [176], but a less severe phenotype was observed when a similar analysis was 
performed in C57BL76 mice [129]. Therefore, it is believed that none of these suppressive 
mechanisms is indispensable for Treg cell function, and depending on the type of immune 
response, one or several act complementary in a non-redundant fashion [129,179]. 
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5. Aim of the thesis 
In addition to the innate immune system that operates with germline-encoded receptors, each 
cell of the adaptive immune system employs one of a large variety of different receptors for 
antigen recognition. This diversity is generated early in T cell or B cell development through 
the almost random rearrangement of certain gene segments, which together constitute the full-
length T cell receptor (TCR) or B cell receptor. Upon TCR surface expression, several 
mechanisms of tolerance take place to prevent the development of autoreactive cells that 
could induce immune responses against cells of the own body. In contrast, few T cell subsets, 
including natural killer T (NKT) and regulatory T (Treg) cells, are instead selected for their 
ability to recognize self-antigens during thymic development. However, the role of this 
inherent autoreactivity for mature NKT cells or Treg cell biology was not well understood. 
In the course of this thesis, we experimentally addressed the following important 
questions: 
1. Do mature peripheral NKT cells receive autoreactivity signals through their lipid-
recognizing Vα14i-TCR in the immunological periphery? If yes, to which degree does 
NKT cell gene signature, homeostasis and effector function rely on these signals? 
(Paper I) 
2. Are mature Treg cell homeostasis, gene expression and suppressive function affected if 
these cells lose persistent autoreactive TCR signals? (Paper II) 
3. How does the spontaneous secretion of inflammatory cytokines by A20-deficient 
B cells influence splenic T cell subsets? (Paper III) 
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6. Brief summaries of the publications 
Paper I: 
Vahl et al., 2013. NKT Cell-TCR Expression Activates Conventional T Cells in Vivo, but Is 
Largely Dispensable for Mature NKT Cell Biology. PLOS Biology 11(6): e1001589. 
The T cell receptor (TCR) is a heterodimer, and almost each conventional T cell 
expresses a different TCR. This diverse TCR repertoire is generated in a randomized process 
during T cell development. In contrast to peptide-recognizing conventional T cells, most 
natural killer T (NKT) cells express a semi-invariant, glycolipid-recognizing TCR that is 
called Vα14i. This receptor is composed of the same Vα14i TCRα-chain for all NKT cells, 
which is expressed together with a limited set of TCRβ-chains. During thymic T cell 
development, the rare cells that randomly express the Vα14i-TCR are selected to become 
NKT cells upon recognition of self-glycolipid antigens. 
In order to define the importance of the Vα14i-TCR and its inherent autoreactivity for 
NKT cell maintenance, cellular identity and function, we generated mice harboring a 
Vα14iStopF knock-in allele, which allows inducible expression of the invariant Vα14i-chain 
under endogenous control. In mice that expressed this knock-in transgene at the physiological 
expression time point during thymic T cell development, significantly higher numbers of 
NKT cells could be found in thymus, spleen and lymph nodes in comparison to littermate 
controls. These transgenic NKT cells showed, in comparison to wild-type NKT cells, similar 
expression patterns of important NKT cell markers and transcription factors, and furthermore 
a similar release of cytokines upon activation. 
To study the consequence of Vα14i-TCR expression and to examine its autoreactivity in 
the periphery, we developed a genetic switch system that enabled us to exchange the TCRα-
repertoire, present on naïve T cells, for a Vα14i-restricted TCR repertoire. We could show 
that Vα14i-TCR expression was not sufficient to convert naïve conventional T cells into 
NKT cells. However, the TCR-switched cells were significantly activated. Furthermore, we 
found evidence for ongoing sterile inflammation in these mice, altogether indicating that NKT 
cells receive autoreactive TCR signals not only in the thymus, but also in the periphery. 
Finally, to address the importance of this autoreactivity for NKT cells, we ablated the 
NKT cell-TCR from mature NKT cells in vivo and followed the fate of these cells over time. 
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We observed that homeostasis, gene expression and effector cytokine expression were 
unaltered in comparison to TCR-expressing NKT cells. 
In summary, we concluded that after thymic NKT cell selection by self-lipids, NKT cells 
become independent from constitutive signals received through their autoreactive TCR.  
In this study, I performed all experiments, except for the generation of the Vα14iStopF 
mouse, which was performed by Marc Schmidt-Supprian. I received experimental help from 
Klaus Heger and Nathalie Knies with the analysis of the switched animals and the cytokine 
secretion, respectively. Furthermore, I analyzed all data presented in this study together with 
Marc Schmidt-Supprian, and we received help from Marco Y. Hein with the generation of the 
heatmap shown in Figure 8. Louis Boon, Hideo Yagita and Bojan Polic provided blocking 
antibodies or mice. Moreover, I wrote the paper together with Marc Schmidt-Supprian. 
 
Paper II: 
Vahl et al., 2013. TCR ablation leads to loss of regulatory T cell identity. Manuscript in 
preparation. 
Regulatory T (Treg) are indispensable to protect humans and mice from the occurrence of 
spontaneous autoimmunity during their lifetime. At first glance, it seems rather astonishing 
that an intrinsic feature of Treg cells is their high reactivity towards self-antigens. During 
thymic T cell development, the vast majority of T cells whose newly generated T cell receptor 
(TCR) displays self-reactivity are deleted from the repertoire to avoid the onset of immune 
responses targeted at the own body. However, this is not the case for Treg cells, which are 
instead selected for their high self-reactivity. Additionally, Treg cells are believed to receive 
persistent autoreactive TCR signals in the periphery upon emigration from the thymus, but it 
remained unclear to which extent Treg cells rely on these signals. 
To study the role of autoreactive TCR signals for mature peripheral Treg cells, we 
conditionally ablated their TCR and monitored the behavior of these cells. Interestingly, TCR-
deficient Treg cell counts quickly decreased, which was due to impaired proliferation as well 
as impaired survival in absence of tonic TCR signals. Furthermore, we showed that the 
activated/effector phenotype of Treg cells, as well as a large part of their signature gene 
expression pattern, depends on continuous TCR signals. However, the recently discovered 
Treg cell-specific demethylation pattern of four important Treg cell markers was unaltered in 
TCR-deficient Treg cells, and fittingly the expression of these markers was only mildly 
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affected. Finally, we could demonstrate that TCR-deficient Treg cells lose a large proportion of 
their proteins implicated in their suppressive function. 
In summary, we showed that TCR signals are the basis for a stable Treg cell lineage, and 
in their absence, Treg cell homeostasis, signature gene expression and suppressive function are 
severly impaired. 
In this study, I performed and analyzed the majority of experiments. I received 
experimental help from Klaus Heger with the analysis of the cytokine secretion upon 
activation. The analysis of the methylation pattern was performed by Naganari Ohkura in the 
laboratory of Shimon Sakaguchi. Furthermore, the Affymetrix microarrays were run in the 
laboratory of Thorsten Buch, and we received help from Karsten Kretschmer and Olivia 
Prazeres da Costa with the analysis. Marco Y. Hein helped with the generation of the heatmap 
shown in the Supplementary Figure 2. Bojan Polic provided the CαF/F mice. Moreover, I 
wrote the paper together with Marc Schmidt-Supprian. 
 
Paper III: 
Chu et al., 2011. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired 
differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. 
Blood 117, 2227-2236. 
Various stimuli, most prominently B cell receptor (BCR) or T cell receptor (TCR) 
ligation, as well as toll-like receptor engagement, activate the nuclear factor-κB (NF-κB) 
signaling pathway in adaptive immune cells. One important regulator of this pathway is the 
ubiquitin-editing enzyme A20, which restricts NF-κB activation through a negative feedback 
loop. Polymorphisms and mutations of A20 have been found in patients suffering from 
autoimmune diseases connected to aberrant antibody secretion by B cells, including 
rheumatoid arthritis and system lupus erythematosus. Furthermore, A20 is frequently 
functionally inactivated in human B cell lymphoma. 
To study the role of A20 in B cell development and B cell-mediated autoimmunity, we 
ablated A20 specifically in B cells. Herein, we observed that A20 deficiency did not impair 
early B cell development. Yet, the mature recirculating B cell in the bone marrow as well as 
splenic B1 B cells subsets were reduced, whereas the numbers of marginal zone B cells and 
immature B cells were increased. Moreover, these mice showed an enlarged splenic 
cellularity, which was mostly due to significantly increased numbers of effector and 
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regulatory T cells, as well as of several myeloid cell subsets. This expansion could be 
attributed, amongst other possibilities, to the spontaneous release of pro-inflammatory 
cytokines, primarily IL-6, by A20-deficient B cells. Interestingly, the analysis of an aged 
cohort revealed even more pronounced effects of B cell-specific A20 deletion. These animals 
showed splenomegaly due to an even further increased expansion of T cells and myeloid 
cells. Moreover, we detected massive expansion of plasma cells, tissue-specific class-
switched autoantibodies in the serum, as well as IgG immune complex deposition in the 
kidney. 
In summary, we concluded that A20 is a critical regulator of B cell activation in mice. In 
its absence, spontaneous cytokine production of B cells leads to chronic inflammation, which 
exacerbates with age and finally ends in autoimmune disease states. 
My contribution to this study was the analysis of T cells and myeloid cells in both young 
and aged animals. 
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Natural killer T (NKT) cell development depends on recognition of self-glycolipids via their semi-invariant Va14i-TCR.
However, to what extent TCR-mediated signals determine identity and function of mature NKT cells remains incompletely
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endogenous Tcra locus. We demonstrate that naı¨ve T cells are activated upon replacement of their endogenous TCR
repertoire with Va14i-restricted TCRs, but they do not differentiate into NKT cells. On the other hand, induced TCR ablation
on mature NKT cells did not affect their lineage identity, homeostasis, or innate rapid cytokine secretion abilities. We
therefore propose that peripheral NKT cells become unresponsive to and thus are independent of their autoreactive TCR.
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Introduction
Natural Killer T (NKT) cells represent a subset of T cells in
mice and humans that express NK cell markers and recognize a
small class of glycolipid (auto-) antigens [1,2]. Most mouse NKT
cells express an invariant Va14-Ja18 (Va14i) TCRa rearrange-
ment (Va24-Ja18 in humans). In principle, all TCRb-chains are
able to pair with this Va14i-TCR chain [3]. However, the
selection of NKT cells by endogenous glycolipids presented by the
monomorphic MHC class I-like CD1d induces a strong bias
towards TCRs containing Vb8, Vb7, or Vb2 [1,3], which is
abrogated in the absence of selection [3,4]. Recently, crystallo-
graphic analysis demonstrated a conserved binding mode of the
NKT cell TCR to various glycolipids, where only germline-
encoded residues were in direct antigen contact, reminiscent of
innate pattern-recognition receptors [5]. Moreover, several
observations suggest that this receptor is inherently auto-reactive
[1,2] and thereby determines NKT cell identity and influences
their function. The expression of several inhibitory NK cell
receptors on NKT cells was suggested to control their self-
reactivity and avoid autoimmune activation [6,7].
During development in the thymus, the few T cells expressing a
Va14i-TCR are selected upon recognition of self-lipids on double-
positive thymocytes. Although several good candidates have been
put forward [8–10], the exact nature of the selecting glycolipids
remains controversial. Homotypic interactions involving the
SLAM family (SLAMf) receptors 1 and 6 are additionally required
for NKT cell differentiation [11]. Auto-reactive activation during
thymic selection is thought to induce a substantially stronger TCR
stimulus in comparison to that during the development of
conventional T cells [12,13]. As a consequence, expression of
the transcription factors Egr1 and Egr2 is strongly increased [13],
which in turn directly induce PLZF, the key transcription factor
controlling NKT cell differentiation, migration, and functions
[13].
Interestingly, the homeostatic proliferation of NKT cells after
adoptive transfer was similar in CD1d-deficient and wild-type
mice, indicating that this process is mostly cytokine-driven and
does not depend on continued TCR-mediated self-lipid-recogni-
tion [14,15]. However, as the transferred cells contained CD1d, a
role for antigen could not be completely excluded. In addition,
tonic antigen-independent TCR signals might contribute to NKT
cell maintenance and phenotype. During immune responses, NKT
cell activation depends mostly on two parameters: engagement of
the TCR and the presence of proinflammatory cytokines released
from antigen-presenting cells activated by innate immune path-
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ways such as toll-like receptor (TLR) signals. Lipids derived from
different bacteria [16–19] were shown to directly activate mouse
and human NKT cells in a TLR- and IL-12-independent manner,
and NKT cells are required for productive immune responses
against these pathogens. NKT cells can also be activated indirectly
through cytokines such as IL-12, IL-18, or type I interferons (IFNs)
[20]. However, it remains controversial whether, depending on the
strength of the cytokine signal, weak responses to self-antigens
presented by CD1d are an additional obligate requirement. In one
study, CD1d-dependent signals were found to be necessary for full
NKT cell activation in response to all tested pathogens [20]. In
contrast, others reported that IL-12-dependent NKT cell activa-
tion after LPS injection [21] or MCMV infection [22] is
independent of either foreign or self-glycolipid antigen presenta-
tion by CD1d.
Upon activation, the most distinguishing feature of NKT cells is
their ability to rapidly produce and secrete large amounts of
cytokines (Th1 and Th2 cytokines, among others). Their fast,
effector-like response could be based on steady-state expression of
cytokine mRNA in mice [23,24] that was suggested to be a
consequence of tonic self-reactive activation [2]. Recently, it was
reported that human NKT cells do not constitutively express
cytokine mRNAs. Instead, rapid cytokine-induced innate IFNc
production by NKT cells was suggested to rely on obligate
continuous recognition of self-lipids, which retains histone
acetylation patterns at the IFNG locus that favor transcription
[25]. Another characteristic feature of NKT cells, their surface
marker expression reminiscent of memory or recently activated T
cells, was also connected to their inherent autoreactivity [2].
To thoroughly address the open questions regarding the nature
and importance of TCR signaling for NKT cells, we generated a
novel mouse model that allowed us to study the extent of Va14i-
TCR-mediated auto-antigen recognition in the periphery and its
relevance for NKT cell identity. Furthermore, we monitored the
fate of NKT cells after TCR ablation. Our results prove the
inherent self-reactivity of the NKT cell TCR and demonstrate that
although essential for positive selection, tonic TCR signaling is not
required for NKT cell homeostasis, lineage identity, and rapid
cytokine secretion.
Results
Correct Timing and Endogenous Control of Va14i-TCR
Expression Produces Large Numbers of Bona Fide NKT
Cells
In order to produce large numbers of NKT cells in a
physiological manner and to manipulate the expression of the
semi-invariant Va14i-TCR in a conditional fashion, we generated
Va14iStopF knock-in mice. To this end we cloned a productive
Va14-Ja18 rearrangement, including the Va14 leader exon, intron
and 1.8 kb of upstream regulatory sequence, and 0.2 kb intronic
sequence downstream of Ja18. These elements were inserted by
homologous recombination 39 of Ja1 upstream of the Ca constant
region of the Tcra locus (Figure 1A). Expression of putative
upstream rearrangements is aborted by four SV40 polyA sites at
the 59 end of the construct, and expression of Va14i is rendered
conditional through a loxP-flanked STOP cassette. We obtained
over 80% (271 of 325) homologous recombinant ES cell clones
during gene targeting, indicating an unusually high targeting
efficiency of our construct (Figure S1A). The development of
conventional T and NKT cells, identified by staining with mouse
CD1d-PBS57-tetramers (tetramer+), occurs unperturbed in
Va14iStopF/wt heterozygous mice. In homozygous Va14iStopF/F
mice, T cell development is abolished due to transcriptional
termination of TCRa expression before the Ca exons (Figure 1B).
We bred Va14iStopF to CD4-Cre mice, in order to express the
inserted Va14i-chain in double-positive thymocytes, mimicking
the physiological timing of TCRa-chain rearrangement and
expression [26,27]. On average 23 times more thymic and 43
times more splenic NKT cells were generated in these, compared
to wild-type mice (Figures 1B and 2A–E). Around 9% of the
tetramer+ T cells in CD4-Cre Va14iStopF/wt mice expressed the
CD8 co-receptor (over 80% as CD8ab heterodimer; Figures 1C
and S1B,C), which is also expressed by some human NKT cells,
but normally not in mice [28]. The proportions of CD42 CD82
double negative (DN) and CD4+ cells were comparable between
transgenic (tg) and wild-type NKT cells (Figure 1C). Furthermore,
the tgNKT cells were largely comparable to wild-type NKT cells
with respect to Vb-chain bias (Figure 1D) and surface phenotype
(Figure 1E). Finally, we found that NKT cells from CD4-Cre
Va14iStopF/wt animals expressed the critical transcription factors
promyelocytic leukemia zinc finger (PLZF), GATA binding
protein 3 (GATA-3), and T-helper-inducing POZ/Kru¨ppel-like
factor (Th-POK) (Figure 1F) [28,29]. Interestingly, we also
detected a substantial proportion of the recently described
NKT17 subset in the transgenic animals. These DN NK1.12
NKT cells express the transcription factor ROR-ct and were
shown to produce the cytokine IL-17 upon activation (Figure 1F)
[29,30].
Timing of Transgenic Va14i-TCR Expression Is Critical for
Normal NKT Cell Development
Premature TCRa expression leads to aberrant T cell
development in transgenic mouse models [26,27]. To directly
compare the consequence of premature to CD4-Cre-mediated
timely Va14i-TCRa-chain expression in our knock-in approach,
we bred our mice to a germline Cre-deleter strain (Nestin-Cre) [31].
Compared to CD4-Cre-induced Va14i-TCRa-chain expression,
premature expression in Cre-deleter Va14iStopF/wt led to signifi-
cantly reduced numbers of NKT cells in thymus and spleen,
especially of CD4+ NKT cells (Figure 2A–C). In addition, we
Author Summary
Immune system natural killer T (NKT) cells help to protect
against certain strains of bacteria and viruses, and suppress
the development of autoimmune diseases and cancer.
However, NKT cells are also central mediators of allergic
responses. The recognition of one’s own glycolipid
antigens (self-glycolipids) in the thymus via the unique
Va14i T cell receptor, Va14i-TCR, triggers the NKT cell
developmental program, which differs considerably from
that of conventional T cells. We generated a mouse model
to investigate whether the Va14i-TCR on mature NKT cells
constantly recognizes self-glycolipids and to assess wheth-
er this TCR is required for survival and continued NKT cell
identity. Switching the peptide-recognizing TCR of a
mature conventional T cell to a glycolipid-recognizing
Va14i-TCR led to activation of the T cells, indicating that
this TCR is also autoreactive on peripheral T cells or can
signal autonomously. But TCR ablation did not affect the
half-life, characteristic gene expression or innate functions
of mature NKT cells. Therefore, the inherently autoreactive
Va14i-TCR is dispensable for the functions of mature
peripheral NKT cells after instructing thymic NKT cell
development. Thus the Va14i-TCR serves a similar function
to pattern-recognition receptors, in mediating immune
recognition of foreign invasion or diseased cells.
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found reduced thymocyte counts and a significant increase of
most likely lineage-‘‘confused’’ DN (CD42 CD82) tetramer-
negative T cells (Figure 2D,E). In fact Cre-deleter Va14iStopF/wt
mice strongly resemble the ‘‘first generation’’ Va11 promoter-
driven (Va11p) Va14i transgenic mice in these respects (Table S1)
[32]. Moreover, in Cre-deleter Va14iStopF/wt mice, we observed
increased proportions of Vb9-, Vb10-, and Vb14-containing
Va14i-TCRs, which can recognize a-GalCer-loaded tetramers,
but most likely not endogenous self-glycolipids [3,4], pointing to
perturbed positive selection (Figure 2F). CD4-Cre Va14iStopF/wt
mice produce more NKT cells than any of the previously
reported models, including mice with a Va14i allele derived from
a NKT cell nuclear transplantation experiment [11,32–35]. A
comparison of different Va14i-transgenic models demonstrates
that both the correct timing and endogenous control of TCR
expression control favor NKT cell development (Table S1). Our
analyses therefore showed that physiological timing of Va14i-
TCRa-expression at endogenous levels in CD4-Cre Va14iStopF/wt
Figure 1. The Va14i-TCR knock-in mouse produces large numbers of correctly selected, bona fide NKT cells. (A) Schematic
representation of the knock-in transgene. The Va14 promoter, loxP (triangle)-flanked STOP cassette, and pre-rearranged Va14i (Va14-Ja18, red square)
sequences were inserted 39 of Ja1 and 59 of the first Ca exon (coding exons are highlighted in blue); 4pA= 4 SV40 polyadenylation sites. AH, arms of
homology. Ea, enhancer (black oval). (B) Representative proportions of NKT cells and conventional T cells of total lymphocytes in thymus and spleen.
Numbers indicate mean percentages 6 SD of at least seven age-matched mice per genotype. (C) Representative proportions of splenic CD4+, CD8+,
and DN (CD42 CD82) NKT cells. Numbers indicate mean percentages6 SD of seven mice per genotype. (D) The Vb repertoires of splenic NKT cells of
the indicated genotypes. Bars indicate means and error bars SD of three independent experiments. (E) Representative flow cytometric analysis of the
indicated cell-surface proteins on conventional CD4+ T cells and NKT cells. (F) Intracellular flow cytometric staining of PLZF, GATA-3, ROR-ct, and Th-
POK in the depicted NKT cells. Numbers indicate means of the median fluorescence intensities (MFIs), normalized to CD4+ tetramer2 T cells of CTR
animals, or percentage of ROR-ct+ cells among DN NKT cells; calculated from three animals per genotype. Histograms are representative of three
independent experiments with eight mice in total. Throughout the figure, NKT cells were gated as tetramer+ TCRb+, conventional (conv) T cells as
tetramer2 TCRb+; CTR, CD4-Cre or Va14iStopF/wt.
doi:10.1371/journal.pbio.1001589.g001
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mice contributes to the production of large numbers of correctly
selected, bona fide NKT cells.
NKT Cell Maturation in CD4-Cre Va14iStopF/wt Animals
To test the functionality of our transgenic NKT cells, we
injected CD4-Cre Va14iStopF/wt mice with the NKT cell ligand a-
Galactosylceramide (a-GalCer) and determined their cytokine
production directly ex vivo. The transgenic NKT cells were able to
mount a rapid and robust cytokine response. Although a reduced
proportion of transgenic NKT cells responded, in absolute cell
numbers there was a 6–10-fold increase compared to wild-type
NKT cells (Figure 3A). We did not observe significant steady-state
cytokine production by transgenic or control NKT cells, and we
detected only minor increases in cytokine levels in the serum of
some of these mice (Figure S1D). Since cytokine production also
varies with NKT cell maturation, we analyzed NKT cell
development in CD4-Cre Va14iStopF/wt mice in more detail. This
revealed a strong bias toward immature fractions in the thymus,
due to the dramatic increase in NKT cell progenitors. In the
periphery, 20% of NKT cells fully matured, as judged by the
expression of NK1.1 and other NK cell markers (Figure 3B,C).
This view is further supported by the reduced proportion of CD69
and T-bet-expressing NKT cells in CD4-Cre Va14iStopF/wt com-
pared to wild-type mice (Figure 3D). The expression of both CD69
and T-bet strongly correlated with NK1.1 surface levels (Figure
S1E,F). This also explains the higher intracellular PLZF expression
in CD4+ and DN NKT cells of CD4-Cre Va14iStopF/wt animals in
comparison to control animals (Figure 1F), as it was shown that
PLZF expression is downregulated during NKT cell development
[36]. Reduced maturation seems to be a common feature in mice
with overabundance of NKT cells (Figure S1G and Table S1)
[33]. Indeed, a comparison of different Va14i-tg mice suggests
that independently of the total number of NKT cells generated,
the size of the homeostatic niche for mature NKT cells appears to
be around two million cells (Table S1).
IL-15 is critical for the final maturation of NKT cells [37] and
together with IL-7 required for their peripheral maintenance
[14,38]. NKT cells compete with NK cells for these resources [38].
The halved number of NK cells in CD4-Cre Va14iStopF/wt mice
(Figure 3E) suggests that the availability of these and maybe other
cytokines might be insufficient due to the dramatically increased
NKT cell numbers. The fact that a similar effect was observed in
Va11p-Va14itg mice (Figure 3E) underscores this notion. These
results let us conclude that while large amounts of NKT cells can
Figure 2. Premature Va14i-TCR expression impairs NKT and conventional T cell development. (A–E) Absolute cell numbers in thymus
and spleen of 7–13 mice of the indicated genotypes: NKT cells (A), CD4+ NKT cells (B), DN NKT cells (C), total cells (D), and DN tetramer2 T cells (E).
Bars indicate medians. *** p,0.001; ** p,0.01; * p,0.05; ns, not significant; one-way ANOVA. (A) Mean cell numbers are depicted below the scatter
blot. (F) The Vb repertoires of splenic NKT cells of the depicted animals. Data for CD4-Cre Va14iStopF/wt are the same as shown in Figure 1D. Bars
indicate means and error bars SD of 3–4 mice per genotype of 3–4 independent experiments. Throughout the figure, NKT cells were gated as
tetramer+ TCRb+, conventional (conv) T cells as tetramer2 TCRb+; CTR, CD4-Cre or Va14iStopF/wt.
doi:10.1371/journal.pbio.1001589.g002
Investigating NKT Cell-TCR Signals
PLOS Biology | www.plosbiology.org 4 June 2013 | Volume 11 | Issue 6 | e1001589
be produced in mice, depending on the mode of Va14i expression,
the number of fully mature NKT cells is restricted by homeostatic
constraints, some of which are shared with NK cells.
The Exchange of the Endogenous TCR Repertoire for a
Va14i-Restricted One on Mature Conventional T Cells
Leads to a Significant Population of Tetramer+ T Cells
The strong self-lipid-induced TCR stimulus that early NKT cell
progenitors receive in the thymus can be visualized through high
GFP expression under the control of the Nur77 gene locus,
reporting TCR signal strength [12]. However, the subsequent loss
of GFP in mature NKT cells suggests that these cells are either not
exposed to or not responsive to self-antigens. In order to answer
this question and to study NKT cell TCR-autoreactivity in the
periphery, we investigated the consequences of Va14i-TCR
signals for conventional naı¨ve T cells. We wondered whether
Va14i-TCR expression on naı¨ve T cells, lacking inhibitory
receptors and generally a NKT cell ‘‘identity’’, would lead to
activation upon (self-)lipid recognition and what cellular fate(s) are
elicited by such activation.
To this end, we generated mice enabling us to exchange the
endogenous TCR-repertoire present on naı¨ve peripheral T cells
for a Va14i-restricted TCR repertoire. The induction of Cre
expression in Mx-Cre CaF/Va14iStopF mice inactivates the CaF allele
and simultaneously turns on the Va14iStopF allele, leading to
substitution of endogenous TCRa-chains with the Va14i TCRa-
Figure 3. NKT cell overproduction affects their maturation and NK cell homeostasis. (A) Intracellular IL-4, IL-13, IFN-c, and TNF expression
of splenic CD4+ NKT cells isolated from the depicted animals 90 min after aGalCer injection. Cells were stained directly ex vivo without addition of
brefeldin or monensin. Black numbers indicate mean percentages 6 SD, and red numbers indicate mean total NKT cell counts expressing the
respective cytokine. Data are from three animals per genotype; FSC, forward scatter. (B) Representative proportions of stage 1 (CD44low NK1.1low),
stage 2 (CD44high NK1.1low), and stage 3 (CD44high NK1.1high) thymic and splenic NKT cells. Numbers indicate mean percentages 6 SD of 10 mice per
genotype. (C) Flow cytometric analysis of the depicted markers on thymic and splenic, transgenic, and control NKT cells. Bars indicate means and
error bars SD calculated from 4–7 mice. (D) Extracellular and intracellular flow cytometric stainings of CD69 and T-bet in the depicted NKT cell
subpopulations. Numbers in representative histogram indicate percentage of CD69high or T-bet+ cells among the indicated NKT cells calculated from
eight animals per genotype (CD69) or three animals per genotype (T-bet). Histograms are representative of at least three independent experiments
with each at least seven mice in total. (E) Absolute splenic NK cell numbers (NK1.1+ TCRb2 tetramer–) of age-matched 6–12-wk-old animals (7–16 per
genotype). Bars indicate medians. *** p,0.001; ns, not significant; one-way ANOVA. Throughout the figure, NKT cells were gated as tetramer+ TCRb+,
conventional (conv) T cells as tetramer2 TCRb+; CTR, CD4-Cre or Va14iStopF/wt.
doi:10.1371/journal.pbio.1001589.g003
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chain (Figure 4A). As mentioned above, the Va14i-chain can pair
with all TCRb-chains [3], although only Vb2-, Vb7-, and Vb8-
containing Va14i-TCRs can recognize endogenous lipids such as
iGb3 [3,4]. Since TCRs containing one of these Vb-chains
constitute approximately 30% of the CD4+ and CD8+ peripheral
T cell pool (Figure 1D and unpublished data), we predicted that
our genetic switch experiment should generate sufficient numbers
of T cells able to recognize self-lipids.
In Mx-Cre transgenic mice, Cre expression can be induced
through injection of dsRNA, such as poly(I:C) [39]. However, low-
level ‘‘leaky’’ recombination occurs also in absence of an inducer
[39,40], leading to increased numbers of tetramer+ T cells in naive
Mx-Cre CaF/Va14iStopF mice (Figure S2A). Therefore, splenocytes
were depleted of tetramer+ T cells by magnetic cell separation
(MACS, Figure S2A), and 206106 purified cells were injected
intravenously (i.v.) into recipient animals lacking conventional ab
T cells and NKT cells (Ca2/2 or Va14iStopF/F). After cells were
allowed to engraft for 2 wk, the TCR switch was induced by
poly(I:C) injection. Importantly, except for a short-term activation
of the immune system, poly(I:C) injection in Mx-Cre mice per se
has no significant long-lasting effect on peripheral conventional T
cells [40,41] or on the number and phenotype of NKT cells
(unpublished data). To definitely exclude any effect of poly(I:C)
injection on our results, we waited 2–4 mo before analyzing the
animals after the induced TCR switch.
We found significant numbers of tetramer+ CD4+ and CD8+ T
cells as a result of this switch experiment (Figure 4B–E).
‘‘Unloaded’’ tetramers did not stain these cells, demonstrating
that they were not reactive against CD1d itself (Figure S2B). The
TCR-switched tetramer+ T cells were predominantly enriched in
cells expressing Vb-chains that are associated with high avidity
auto-antigen binding: Vb2, Vb8.1/8.2, and Vb7 (Figure 4D,E)
[3,4,42]. The exceptions were CD8+ TCR-switched tetramer+ T
cells, in which Vb7-expressing cells were not enriched. The bias
toward tetramer+ CD8+ T cells (Figure 4C) is most likely due to
more efficient Mx-Cre-mediated recombination in these cells [40].
Sterile Inflammation in Mice Containing TCR-Switched T
Cells
Animals containing TCR-switched tetramer+ T cells, but not
controls, displayed splenomegaly (Figure 5A,B), characterized by
increased numbers of macrophages/monocytes, neutrophils, and
Ter119+ erythroid progenitor cells, suggesting an inflammatory
state (Figure 5C–E). In line with these findings, we could detect
Figure 4. TCR switch on mature conventional T cells. (A) Genetic set-up of the TCR switch experiment. In Mx-Cre CaF/Va14iStopF mice, the
endogenous TCRa-chains (Va(x)Ja(y)) are exclusively expressed from the CaF allele. Cre-mediated recombination leads to termination of expression
from the CaF allele, and simultaneous start of expression of the Va14i-TCRa-chain from the Va14iStopF allele. (B) T-cell-deficient mice were
reconstituted with NKT cell-depleted splenocytes of the indicated genotypes. After 2 wk, the TCR switch was induced by poly(I:C) injection. Eight
weeks later, percentages of tetramer+ and tetramer2 T cells (TCRb+) were analyzed in spleen and liver. Black numbers indicate percentages of total
lymphocytes, red numbers absolute cell number calculated from 9–17 animals. (C) Bars indicate means and SD (error bars) of CD4+, CD8+, or DN
(CD42 CD82) cells among tetramer2 and tetramer+ T cells, calculated from at least nine mice per genotype. (D, E) The Vb repertoires of the
depicted splenic CD4+ (D) or CD8+ (E) T cell subsets isolated from T-cell-deficient animals that received NKT cell-depleted Mx-Cre CaF/Va14iStopF
splenocytes. Some of these mice were injected with poly(I:C) 2 wk later to induce the TCR switch. Eight weeks after poly(I:C) injection, the Vb
repertoires were analyzed. Data represent means and SD (error bars) of two independent experiments with a total of three mice (tetramer2 without
poly(I:C) injection) or eight mice (poly(I:C) injected) per T cell population. Vbs typical for glycolipid selection of NKT cells are highlighted in red.
doi:10.1371/journal.pbio.1001589.g004
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elevated serum TNF in more than half of these mice (Figure 5F).
Elevated levels of other cytokines, such as IL-2, IL-4, IL-5, IL-6,
IL-10, IL-17, and IFN-c, were not found in the sera of these mice
(unpublished data). Interestingly, we found that 6 (highlighted in
red throughout the figure) of 17 spleens containing TCR-switched
T cells were almost completely devoid of B cells (Figure 5G) as well
as dendritic cells (DCs, Figure 5H), which present lipid antigens to
NKT cells via CD1d [1]. Furthermore, tetramer- ‘‘conventional’’
T cells were also strongly reduced in these animals (unpublished
data). Together, these results suggest that induced expression of
the Va14i-TCR on conventional naı¨ve T cells causes sterile
inflammation, possibly due to autoimmune activation.
Va14i-TCR Signaling Induces Cellular Activation, But Not
NKT Cell Differentiation of TCR-Switched Tetramer+ T
Cells
The appearance of tetramer+ cells displaying a Vb bias similar
to antigen-selected NKT cells, together with signs of inflammation
upon TCR switch and the absence of CD1d-expressing B cell and
DCs in some cases, suggested auto-antigen-mediated activation of
TCR-switched cells. To verify that the newly assembled Va14i-
TCR on conventional T cells is functional, we injected recipients
of Mx-Cre CaF/Va14iStopF and control cells with a-GalCer or PBS
2 mo after switch induction. Ninety minutes after a-GalCer, but
not PBS, injection, CD4+ and CD8+ tetramer+ T cells produced
IFN-c and TNF (Figure 6A), demonstrating the functionality of
the newly assembled Va14i-TCR. In comparison to NKT cells
from wild-type or CD4-Cre Va14iStopF/wt animals, a smaller
proportion of tetramer+ T cells produced cytokines (Figures 6A
and S2C). Tetramer+ TCR-switched T cells could also be
activated in vitro through a-GalCer-pulsed A20 cells overexpress-
ing CD1d (unpublished data) [43].
To study the consequences of Va14i-TCR expression on
tetramer+ TCR-switched T cells in more detail, we analyzed their
surface phenotype and transcription factor expression. Absence of
NK cell markers (Figures 6B and S2D) and PLZF expression
(Figure 6C) indicated that the Va14i-TCR signals are not sufficient
to induce NKT cell differentiation of mature conventional T cells.
However, the TCR-switched tetramer+ T cells expressed signifi-
Figure 5. Signs of sterile inflammation in mice harboring TCR-switched T cells. T-cell-deficient mice were reconstituted with NKT-cell-
depleted splenocytes of the indicated genotypes. Spleen weight (A), absolute splenic cell numbers (B–E, G, H), and serum TNF levels (F) of 3–28 mice
per genotype were determined 8 wk after poly(I:C) administration where indicated. Bars indicate medians. Red points show six animals with near
absence of B cells and dendritic cells. (B) Total splenocytes; (C) Macrophages/monocytes (Mac1+ Gr1int SiglecF2); (D) Neutrophils (Mac1+ Gr1high
SiglecF2); (E) Erythroblasts (Ter119+); (G) B cells (B220+ TCRb2); (H) Dendritic cells (CD11c+). *** p,0.001; ** p,0.01; * p,0.05, one-way ANOVA.
doi:10.1371/journal.pbio.1001589.g005
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cantly higher levels of Egr2 in comparison to tetramer2 T cells in
the same animals (Figure 6D), suggesting that the switched cells
receive stronger TCR signals [13]. TCR-switched T cells showed
further signs of cellular activation, as they expressed elevated levels
of CD69 (Figure 6E). Interestingly, these T cells displayed also
significantly increased surface levels of PD-1, LAG-3, and less
frequently, BTLA and TIM-3, which is typical of exhausted/
anergic cells (Figure 6F–H and unpublished data) [44,45].
To test whether exhaustion/anergy of tetramer+ TCR-switched
T cells prevented a more dramatic form of autoimmune
inflammation, we injected mice with PD-L1 and PD-L2 blocking
or control antibodies twice a week for 4 consecutive weeks, starting
2 d before switch induction. The administration of these blocking
antibodies has previously been shown to efficiently prevent anergy
induction of conventional T as well as NKT cells, and to partially
reverse the exhaustion of CD8+ T cells [44,45]. However, we did
Figure 6. TCR-switched tetramer+ T cells display an activated/exhausted phenotype, but no signs of NKT cell differentiation. T-cell-
deficient mice were reconstituted with NKT-cell-depleted splenocytes of the indicated genotypes. The TCR switch was induced by poly(I:C)
administration. Eight weeks later, the animals were analyzed. (A) Expression of intracellular IFN-c or TNF ex vivo 90 min after aGalCer injection of the
indicated mice. Data are representative of two independent experiments with two animals each. (B) Representative histograms of flow cytometric
analyses. Surface expression of NKG2D and NK1.1 on T cells (TCRb+) of the indicated surface phenotypes in comparison to NK cells (NKG2D+ TCRb2
CD52 or NK1.1+ TCRb2 CD52) are shown. Histograms are representative for at least three independent experiments with at least one mouse each.
(C–H) Representative histograms of flow cytometric analyses. T cells (TCRb+) of the indicated surface phenotypes, and of wild-type splenic CD4+ NKT
cells, are shown. Numbers in representative histograms indicate means of the median fluorescence intensities (MFIs), normalized to CD4+ tetramer2
T cells of animals that received NKT-cell-depleted Mx-Cre CaF/wt splenocytes, 8 wk after poly(I:C) injection. Means were calculated from 6–25 mice.
Scatter plots display normalized MFI. Bars indicate medians. Dotted lines indicate medians of the median fluorescence intensities of control CD4+
wild-type NKT cells calculated from 2–6 mice. (C, D) Intracellular PLZF (C) and Egr2 (D) expression. (E–H) Extracellular expression of CD69 (E), PD-1 (F),
LAG-3 (G), BTLA (H); *** p,0.001; ** p,0.01; * p,0.05; ns, not significant; one-way ANOVA.
doi:10.1371/journal.pbio.1001589.g006
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not observe any dramatic differences in spleen weight or
cellularity, or signs of increased inflammation, between animals
receiving PD-L blocking or control antibodies (unpublished data).
In response to PD-1 blockade, other inhibitory receptors such as
LAG-3, BTLA, or TIM-3 might control the TCR-switched T
cells.
Taken together, our results showed that expression of the
Va14i-TCR on mature conventional T cells is not sufficient to
induce a NKT cell differentiation program. Still, it is likely that
Va14i-TCR signals induce auto-antigen-mediated activation,
possibly to the point of exhaustion. We therefore present strong
evidence that the Va14i-TCR can constitutively recognize self-
lipids in the naı¨ve steady state situation in vivo.
Maintenance of Mature NKT Cells Is TCR-Independent
The evidence for autoreactivity of the Va14i-TCR on mature
peripheral T cells raised the old but still not completely resolved
question whether and to what extent interactions with self-lipid-
presenting APCs are required for NKT cell maintenance, cellular
identity, and function. In order to evaluate the importance of
constitutive TCR expression and signaling for NKT cells directly
in vivo and for long periods of time, we ablated the TCR on
mature T cells using poly(I:C) injection of Mx-Cre CaF/F mice [40].
Two weeks after induced Cre-mediated recombination, around
30% of CD4 and 65% of CD8 T cells had lost functional TCR
expression in these mice (Figure 7A and [40]). To unambiguously
identify TCR-deficient NKT cells, we developed a robust staining
strategy based on CD4, NK1.1, CD5, and CD62L expression
(Figure S3A). This limited us to CD4+ NKT cells, but our staining
identified over 50% of the total NKT cell populations in thymus
and spleen (Figure S3B). Around 65% of the thus identified NKT
cells had lost TCR surface expression 2 wk after Cre induction
(Figure 7A,B).
Due to complete Cre-mediated recombination in lymphoid
progenitors, T cell development is blocked at the double positive
stage in Mx-Cre CaF/F mice after induction of Cre [40]. This
allowed us to study the T cell decay in the absence of cellular efflux
from the thymus. In agreement with previous studies [40,46], we
found that loss of the TCR leads to decay of naı¨ve CD4+ CD44low
and memory/effector-like CD4+ CD44high T cells with a half-life
of 40 d and 297 d, respectively (Figure 7C,D). Interestingly, we
observed essentially no decay of receptor-less NKT cells, with a
calculated half-life of 322 d (Figure 7E), and could find significant
numbers of TCR-deficient NKT cells even 45 wk after TCR
deletion (unpublished data). To evaluate the role of TCR signals
during in situ homeostatic proliferation, we administered BrdU for
4 wk via the drinking water, starting 2 wk after induced TCR
ablation. Naı¨ve CD4+ CD44low as well as CD4+ CD44high
memory/effector-like T cells showed significantly decreased BrdU
incorporation in TCR-deficient compared to TCR-expressing
cells (Figure 7F,G). In contrast, TCR ablation did not affect NKT
cell proliferation (Figure 7F,G). Interestingly, the BrdU incorpo-
ration was identical in TCR-deficient CD4+ CD44high T and
NKT cells, indicating that in the absence of TCR signals the
cytokine-driven expansion of CD4+ CD44high memory/effector-
like T and NKT cells is similar (Figure 7F,G). Our results therefore
indicate that long-term in situ NKT cell homeostasis is completely
independent of TCR-induced signals.
The TCR Is Dispensable for the Identity and Cytokine-
Secretion Ability of Mature NKT Cells
In absence of de novo T cell generation, we found elevated Egr2
expression in mature thymic, but not splenic, NKT cells compared
to DP thymocytes and CD4+ T cells, respectively (Figure 8A). This
indicates that NKT cells receive stronger TCR signals in the
thymus, which is supported by the decreased Egr2 expression of
mature thymic TCR-deficient NKT cells (Figure 8A). Surprisingly,
in mature NKT cells in thymus and spleen, expression of the
TCR-signal-induced key transcription factor PLZF is completely
unaffected by TCR ablation (Figure 8B).
In order to more generally evaluate to what extent NKT cell
TCR-expression is required for the maintenance of characteristic
lineage-specific gene expression (resembling recently activated T
cells), we extensively analyzed the cell-surface phenotype of NKT
cells 6 wk after TCR ablation. Of all the analyzed markers, the
only significant changes that we observed on splenic NKT cells
upon TCR ablation were downregulation of NK1.1, CD4, CD5,
and ICOS (Figures 8C,D and S3C–E). NK1.1 expression was also
reduced in thymic TCR-deficient NKT cells, in addition to
CXCR6 expression (unpublished data). CD5 and ICOS expres-
sion were also reduced in TCR-deficient splenic naı¨ve as well as
CD62Llow CD4+ T cells (Figure S3C,D). CD4 was upregulated on
TCR-deficient CD4+ naı¨ve, but downregulated on NKT and
CD4+ CD44high T cells (Figure S3E). Strikingly, all other cell
surface markers characteristic for the NKT cell lineage, among
them the transcription factors PLZF, GATA-3, T-bet, and Th-
POK, as well as many cell surface markers whose expression is also
induced upon TCR engagement, remained largely unaffected by
loss of the NKT cell TCR (Figure 8D).
Treatment of mice with LPS, a cell wall component of gram-
negative bacteria, leads to release of IFN-c by NKT cells via
stimulation with IL-12 and IL-18 produced by innate immune
cells. This does not require acute TCR engagement [21].
However, it has been proposed that the ability of NKT cells to
rapidly release IFN-c in this context critically requires continuous
weak TCR activation in the steady state [25]. We therefore
analyzed IFN-c release of TCR+ and TCR- NKT cells after in
vivo injection of LPS, a-GalCer, and PBS (Figure 9A,B). As
expected, Egr2 expression could only be detected in NKT cells
that were activated through their TCR (Figure 9A). Accordingly,
90 min after a-GalCer injection, the majority of TCR+ NKT
cells, but virtually none of the TCR- NKT cells or the CD4+
conventional T cells, produced IFN-c protein (Figure 9B).
Interestingly, NKT cell activation through LPS injection in vivo
was able to induce similar IFN-c production by TCR- NKT cells
in comparison to their TCR+ counterparts (Figure 9B). Our results
thus clearly demonstrate that homeostasis and key features
defining the nature of NKT cells, namely the unique activated
cell-surface phenotype and the innate capacity for instant
production of IFN-c, do not require continuous auto-antigen
recognition in the mouse.
Discussion
The elucidation of NKT cell function and their intriguing
semi-invariant TCR benefited enormously from Va14i-TCR
transgenic mouse models [11,32,47,48]. Over the last years, it
became increasingly clear that premature expression of trans-
genic TCRa chains, including Va14i [11,32], leads to various
unwanted side-effects such as impaired b-selection and the
generation of large numbers of DN T cells both in the periphery
and in the thymus [26,27]. This drawback affects even TCR
alleles generated through nuclear transfer of mature NKT cells
[33]. For that reason, Baldwin et al. developed a system in which
a transgenic CAGGS-promoter-driven TCRa-chain is expressed
upon CD4-Cre-mediated excision of a loxP-flanked STOP
cassette, mimicking the physiologic expression time point [26].
Likewise, Griewank and colleagues expressed the Va14i-TCR
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under direct control of CD4 promoter and enhancer sequences
[11]. These are clear improvements, but carry the inbuilt caveats
of the respective heterologous expression construct. For example,
it has been shown that a large proportion of activated mature T
cells loses expression from such transgenic CD4 promoter
enhancer constructs [49].
Here, we present a novel approach, in which the expression
of the transgenic Va14i-TCRa-chain, and in the future any
other TCRa-chain of interest, can be initiated via CD4-Cre at
the DP stage in the thymus, and is under endogenous control
of the Tcra locus throughout the lifespan of the cell. In these
mice, large numbers of bona fide CD4+ and DN NKT cells
were generated. The reduced proportions of fully mature stage
3 NKT cells (NK1.1+, CD69high, T-bet+), as well as the
reduced numbers of NK cells, are most likely a consequence of
limiting amounts of common differentiation and maintenance
factors, such as IL-15 [14,37,50]. In addition, attenuated
TCR-signaling due to increased competition for self-antigen/
CD1d-complexes might delay the full maturation of NKT cells
in the transgenic animals. TCR signals have been proposed to
Figure 7. TCR signaling is not required for the steady state homeostasis of mature NKT cells. (A) Percentages of TCRb2 cells of the
depicted T cell subsets 2 wk after poly(I:C) injection into Mx-Cre CaF/F mice. Bars show means and SD (error bars) of 3–5 mice. (B) Surface TCRb
expression of splenic CD4+ NKT cells (NK1.1+ CD5+ CD62Llow) 2 wk after poly(I:C) injection. Numbers indicate means 6 SD of three independent
experiments with altogether five mice per genotype. (C, D) Total cell counts of splenic naı¨ve conventional CD4+ T cells (CD5+ CD44low NK1.12; C) or
of memory/effector-like CD4+ T cells (CD5+ CD44high NK1.12; D) from 26 control CaF/F (CTR, TCR+) animals as well as from 24 Mx-Cre CaF/F animals, all
after poly(I:C) injection (TCR+, TCR2). (E) Splenic CD4+ NKT cell numbers from in total 32 control CaF/F animals (CTR, TCR+) as well as TCRb+ and
TCRb2 CD4+ NKT cell numbers from in total 27 Mx-Cre CaF/F animals, at the indicated time after poly(I:C) injection. (C–E) Half-lives were calculated
with GraphPad Prism software using nonlinear regression, one-phase decay analysis. (F) BrdU was administered for 4 wk via the drinking water,
starting 2 wk after poly(I:C) injection. Directly afterwards, animals were sacrificed and BrdU incorporation was measured by flow cytometry.
Representative blots of 2 CaF/F and 4 Mx-Cre CaF/F mice are shown. (G) Bar chart showing proportion of cells that incorporated BrdU of the indicated T
cell subtypes. Bars show means calculated from 2 CaF/F and means and SD (error bars) 4 Mx-Cre CaF/F mice. *** p,0.001; * p,0.05; ns, not significant;
one-way ANOVA.
doi:10.1371/journal.pbio.1001589.g007
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play a role in the initiation of CD69 expression on NKT cells,
as well as in the induction of IL-2Rb, the b-chain of the IL-2
and IL-15 receptors [13].
Moreover, we observed the generation of tetramer+ CD8+ T
cells. CD8+ NKT cells are found in the human, but not in wild-
type mice. CD8 expression on Va14i NKT cells does not interfere
Figure 8. The maintenance of NKT lineage identity does not depend on TCR-signals. CaF/F and Mx-Cre CaF/F mice were injected with
poly(I:C) and analyzed 6 wk later. (A, B) Intracellular expression of Egr2 (A) and PLZF (B) in T cells from the depicted mice. Plots are representative for
at least three independent experiments. (C) Flow cytometric analysis of NK1.1 expression on splenic naı¨ve (CD62Lhigh CD5+), memory/effector-like
(CD62Llow CD5+) CD4+ T cells, and CD4+ NKT cells (NK1.1+ CD5+ CD62Llow), with or without TCR expression. Median fluorescence intensity,
normalized to NK1.1 expression of NK cells (NK1.1+ TCRb2 CD52). Bars indicate medians. *** p,0.001; ** p,0.01; * p,0.05; ns, not significant; one-
way ANOVA. (D) Flow cytometric expression analysis of extra- and intracellular markers of splenic T cells. Median fluorescence intensities of at least
four mice per analyzed protein were normalized to the expression on/in conventional CD4+ T cells (tetramer2 TCRb+) to account for
interexperimental variations. Expression of NK1.1, CD122, FasL, and T-bet were normalized to NK cells (NK1.1+ TCRb2 CD52) and then set to 1 for
naı¨ve T cells. Data are shown as heatmap, calculated by Perseus software. Blue letters, significantly reduced on splenic TCR2 CD4+ NKT cells in
comparison to TCR+ CD4+ NKT cells from CaF/F and Mx-Cre CaF/F mice; analyzed by one-way ANOVA.
doi:10.1371/journal.pbio.1001589.g008
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with negative selection, avidity for antigen presented by CD1d, or
NKT cell function [28]. Instead, it was proposed that the absence
of CD8+ NKT cells in the mouse is due to the constitutive
expression of the transcription factor Th-Pok in all CD4+ as well
as DN NKT cells [28]. Th-Pok has been shown to be crucial for
the maturation and function of NKT cells, and directly represses
CD8 expression [28]. This scenario fits well with the fact that the
CD8+ tetramer+ T cells in the CD4-Cre Va14iStopF/wt (as well as in
the Va11p-Va14itg animals) did not express Th-Pok. These cells
also lack many other characteristic features of NKT cells,
including PLZF expression. Therefore, we refer to them as
tetramer+ CD8+ T cells.
Given the faithful recapitulation of endogenous TCRa-chain
expression timing and strength in our knock-in mice, combined
with the extremely high homologous recombination efficiency, we
believe that our strategy should prove useful for the generation of
further novel TCR-transgenic mouse models. By replacing RAG-
mediated Va14 to Ja18 recombination with Cre-mediated
activation of Va14i expression in CD4-Cre Va14iStopF/wt mice,
we can directly couple conditional gain or loss of gene function
with Va14i-TCR expression in NKT cells. NKT cell-specific gene
targeting in mice with physiological NKT cell numbers could be
achieved through the generation of mixed bone marrow chimeras
with Ja182/2 bone marrow, which cannot give rise to Va14i-
NKT cells.
Our studies were designed to elucidate whether or to what
extent the expression of the autoreactive semi-invariant TCR
would activate a peripheral mature naı¨ve conventional T cell,
convert it into an NKT cell, or induce gene expression typical of
NKT cells. We took advantage of the conditional nature of the
Va14i-TCR knock-in transgene for a TCR switch experiment on
conventional peripheral T cells. Naı¨ve CD4+ T cells inherit a high
plasticity [51]. Depending on TCR signaling strength and cytokine
environment, they can differentiate in various subsets in periphery.
This differentiation includes the induction of specific transcription
factors, namely T-bet (Th1), GATA-3 (Th2), ROR-ct (Th17), and
FoxP3 (peripherally derived regulatory T cells). For NKT cells, it is
believed that strong TCR signaling, together with homotypic
interactions involving the SLAM family (SLAMf) receptors 1 and
6, ultimately leads to PLZF induction during thymic development
[11,13]. DP thymocytes, presenting auto-antigen via CD1d and
also expressing SLAMf members, are crucial for thymic NKT cell
selection [11]. These SLAMf receptors are expressed on periph-
eral lymphocytes in comparable levels to double positive
Figure 9. TCR-signals are not required for the innate activation of NKT cells. (A) Intracellular Egr2 expression of the depicted splenic T cells,
90 min after PBS or aGalCer injection, or 6 h after LPS injection. Plots are representative for at least three independent experiments. (B) Intracellular
IFN-c expression of the depicted cells stained directly ex vivo without addition of brefeldin or monensin. Splenic cells were isolated 90 min after PBS
or aGalCer injection, or 6 h after LPS injection. Plots are representative for at least three independent experiments.
doi:10.1371/journal.pbio.1001589.g009
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thymocytes (www.immgen.org). Therefore, lymphocytes, especial-
ly marginal zone B cells, which express CD1d to a similar level as
DP thymocytes, should be able to present antigen and SLAMf-
mediated co-stimulation, to naı¨ve conventional T cells with a
newly expressed Va14i-TCR on their surface. The elevated levels
of the TCR-induced transcription factor Egr2 in switched
tetramer+ T cells suggest that they receive an (auto-)antigenic
signal. This finding is in principle in agreement with our finding
that tetramer+ TCR-switched T cells are enriched in cells that
express Vb2- and Vb8.1-/8.2-containing Va14i-TCRs. These
TCRs were shown to have the highest avidity for NKT cell
antigens [3]. Furthermore, Vb7-containing Va14i-TCRs were
shown to be favored when endogenous ligand concentration are
suboptimal in CD1d+/2 mice [42]. In fact, in CD4+ tetramer+
TCR-switched T cells the relative enrichment for Vb7-expressing
cells was slightly higher than for Vb2- and Vb8.1-/8.2-expressing
cells (unpublished data). However, the interpretation that this
advantage is due to antigenic selection is at odds with the fact that
Vb7-expressing cells are not enriched in tetramer+ TCR-switched
CD8+ T cells. We currently have no satisfactory explanation for
this discrepancy. Both CD4+ and CD8+ Va14i-TCR-expressing
conventional T cells show features of activation and exhaustion/
anergy, but do not develop into NKT cells, judged by absent
PLZF and NK cell marker expression. This indicates that either
mature T cells have lost the ability to enter the NKT cell lineage,
the peripheral Va14i-TCR signal is not strong enough, or as yet
unidentified components of the thymic microenvironment are
required to induce an NKT cell fate. Indeed, the high Egr2
expression of mature NKT cells that matured in the periphery and
migrated back to the thymus (Figure 8A) suggests that stronger
self-antigens are presented at this location. Interestingly, unlike
TCR-switched tetramer+ T cells, Egr2 expression in mature
splenic NKT cells was similar to that of conventional mature
CD4+ T cells. Our data therefore suggest that in the periphery,
the Va14i-TCR can recognize self-lipids, but maturing NKT cells
undergo a developmental program that prevents an auto-reactive
inflammatory response. At this point, we cannot exclude the
possibility that the observed cellular activation was antigen-
independent. The fact that the internal control cells, the co-
transferred tetramer2 T cells, show no or significantly less signs of
activation strongly argues for an involvement of antigen
recognition or tonic signaling by the Va14i-TCR. It also remains
possible that the transient immune activation caused by the
poly(I:C) administration contributes to the observed phenotypes.
In all likelihood, this contribution is small, as we never observed
any significant immune activation, not to mention loss of CD1d-
expressing antigen-presenting B cells and dendritic cells, in Mx-Cre
CaF/wt control mice that received poly(I:C). Despite these caveats,
our results clearly show that under our experimental conditions,
Va14i-TCR expression on conventional naı¨ve T cells leads to their
activation and general immune deregulation.
These findings seemed to support notions that NKT cell
maintenance [52], their activated surface phenotype, and espe-
cially their rapid cytokine expression abilities might depend on
constant antigen recognition [25]. However, by ablating the TCR
on mature NKT cells in situ, we unequivocally demonstrated that
long-term mouse NKT cell homeostasis and gene expression are
nearly completely independent of TCR signals. In this regard, they
are similar to memory T and B cells, which can maintain their
numbers, identity, and functional capabilities in the absence of
antigen [53,54]. Our results are hard to reconcile with a recent
report suggesting that NKT cell maintenance requires lipid
presentation by B cells [52]. While there might be some differences
between mouse and man, a more likely scenario is that the
observations of Bosma et al. reflect rather acute local activation
than true homeostatic requirements. Most of the known functions
of NKT cells critically depend on their ability to rapidly secrete
large amounts of many different immune-modulatory cytokines
shortly after their activation. Still, it is not fully understood how
NKT cell activation is triggered in different disease settings, and
especially to what extent signaling in response to TCR-mediated
recognition of antigens versus activation by proinflammatory
cytokines contributes to this. Various studies reported that CD1d-
dependent signals were required for full NKT activation in vitro
[19,20,55], although most of them contained the caveat of
potentially incomplete blockade of CD1d function by blocking
antibodies. Our experiments, in line with a recent report [21],
show that even in the complete absence of TCR signaling for
4 wk, NKT cells can be robustly activated in vivo to produce IFN-
c upon LPS injection in similar amounts as their TCR+
counterparts. Thus, we demonstrate that in mouse NKT cells
continuous steady-state TCR-signaling is not required to maintain
the Ifng locus in a transcriptionally active state, as recently
proposed for human NKT cells [25]. Therefore, our results clearly
demonstrate that cellular identity and critical functional abilities of
mature NKT cells, such as steady-state proliferation and innate
cytokine secretion ability, although initially instructed by strong
TCR signals, do not require further antigen recognition through
their TCR.
Collectively, our data strongly support the view that Va14i-
TCR expression on developing NKT cells triggers a program that
makes them unresponsive to peripheral self-antigens, which can
continuously be recognized by their auto-reactive TCR. NKT
cells are extremely potent immune-modulatory cells that upon
activation can instantly secrete a large array of cytokines. Although
they are selected by high affinity to auto-antigens, similar to
regulatory T cells, they are not mainly suppressive cells. Therefore,
it seems plausible that NKT cells are rendered ‘‘blind’’ to
peripheral auto-antigens, rather than depend on continuous
stimulation by self-lipids to maintain their cellular identity and
innate functions. By keeping their activated state independent of
self-antigen recognition, NKT cells can stay poised to secrete
immune-activating cytokines while minimizing the risk of causing
damage to self during normal physiology. On the other hand, the
presence of the auto-reactive Va14i-TCR serves to detect
pathogenic states when a stronger signal is generated by the
enhanced presentation of potentially more potent self-antigens or
foreign lipids.
Materials and Methods
Genetically Modified Mice
To generate Va14iStopF mice, B6 ES cells (Artemis) were
transfected, cultured, and selected as previously described for
Bruce 4 ES cells [56]. Mx-Cre [39], CaF [40], CD4-Cre [57], Nestin-
Cre [31], Va11p-Va14i-tg [32], and Va14iStopF mice were kept on a
C57BL/6 genetic background. As we did not observe any
differences between CD4-Cre and Va14iStopF/wt mice in NKT cell
biology, they were sometimes grouped together as controls. Mice
were housed in the specific pathogen-free animal facility of the
MPIB. All animal procedures were approved by the Regierung of
Oberbayern.
Cre Induction in Mx-Cre Animals
At the age of 6–8 wk (or 2 wk after cell transfer for the TCR
switch experiment), animals were given a single i.p. injection
(400 mg) of poly(I:C) (Amersham). All mice were analyzed 6–8 wk
after injection, unless otherwise indicated.
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Flow Cytometry and Heat Map Generation
Single-cell suspensions were prepared and stained with mono-
clonal antibodies: B220 (clone RA3-6B2), BTLA (8F4), CD11c
(N418), CD122 (TM-b1), CD127 (A7R34), CD160 (eBioCNX46-
3), CD25 (PC61.5), CD28 (37.51), CD38 (90), CD39 (24DMS1),
CD4 (RM4-5), CD44 (IM7), CD45RB (C363.16A), CD5 (53-7.3),
CD62L (MEL-14), CD69 (H1.2-F3), CD8a (53-6.7), CD8b (H35-
17.2), CD95 (15A7), DX5 (DX5), Egr2 (erongr2), GATA-3
(TWAJ), Gr1 (RB6-8C5), ICOS (7E.17G9), IL-4 (11B11), IL-13
(eBio13A), IL-17A (eBio17B7), IFN-c (XMG1.2), LAG-3
(eBioC9B7W), LFA-1 (M17/4), Ly49A/D (eBio12A8), Ly49C/I
(14B11), Ly49G2 (eBio4D11), Mac1 (M1/70), NKG2A (16A11),
NKG2D (CX5), NK1.1 (PK136), PD-1 (J43), ROR-ct (AFKJS-9),
T-bet (eBio4B10), TCRb (H57-597), Ter119 (TER-119), Th-POK
(2POK), and TNF (MP6-XT22) (all from eBioscience). SiglecF
(E50-2440) was from BD. TCRb chains were stained with the
mouse Vb TCR screening panel (BD). PLZF antibody and the
CXCL16-Fc fusion were generous gifts from Derek Sant’Angelo
and Mehrdad Matloubian, respectively. mCD1d-tetramers were
provided by the NIH tetramer core facility. For intracellular
transcription factor stainings, cells were fixed and permeabilized
with the FoxP3 staining kit (eBioscience). For intracellular cytokine
stainings, mice were injected i.v. in the tail vein with 40 mg of LPS
(Sigma) or 2 mg aGalCer (Funakoshi) in a total volume of 200 ml
PBS. Afterwards, cells were treated according to manufacturer’s
instructions with the Cytofix/Cytoperm kit (BD). For multiplex
measurement of cytokines in the serum, we used the mouse Th1/
Th2 10plex Cytomix kit according to manufacturer’s instructions
(eBioscience). Samples were acquired on a FACSCanto2 (BD)
machine, and analyzed with FlowJo software (Treestar). The heat
map was generated using perseus (part of the MaxQuant software
[58]).
BrdU Incorporation
Mice were fed with 0.5 mg/ml BrdU (Sigma) in the drinking
water for 4 consecutive weeks. Directly afterwards, BrdU
incorporation was analyzed with a BrdU Flow Kit (BD).
ELISA
Serum TNF levels were determined by ELISA as recommended
by the manufacturer (BD).
Quantitative RT-PCR
RNA was isolated (QIAGEN RNeasy Micro Kit) and reverse
transcribed (Promega) for quantitative real-time polymerase chain
reaction (PCR) using probes and primers from the Universal
Probe Library (Roche Diagnostics) according to the manufactur-
er’s instructions.
Statistics
Statistical analysis of the results was performed by one-way
ANOVA followed by Tukey’s test, or by student t test, in Prism
software (GraphPad). The p values are presented in figure legends
where a statistically significant difference was found.
Supporting Information
Figure S1 Southern blot screening strategy for the Va14iStopF
knock-in allele and NKT cell characterization in Va14i–
transgenic mice. (A) DNA of targeted neomycin-resistant embry-
onic stem cells was digested with BamHI. The Southern Blot
probe contains the untranslated exon 4 of Ca and recognizes a
12.5 kb fragment for the knock-in in comparison to 8.9 kb for the
wild-type allele. Representative Southern blot for 325 clones, six of
eight showing homologous integration of the knock-in allele. (B)
Absolute cell numbers in thymus and spleen of 7–13 mice of the
indicated genotypes of CD8+ tetramer+ T cells. Bars indicate
medians. *** p,0.001; ns, not significant, one-way ANOVA. (C)
CD8a/CD8b expression of splenic CD8a+ NKT cells from CD4-
Cre Va14iStopF/wt animals. Numbers indicate mean percentages 6
SD of three mice. (D) Serum cytokine levels, measured by
FlowCytomix, of three CTR mice and each five CD4-Cre
Va14iStopF/wt and Va11p-Va14itg mice. (E, F) CD69 and
intracellular T-bet expression of NK1.1+/NK1.12 NKT cells
from CTR and CD4-Cre Va14iStopF/wt mice. Numbers in
representative histogram indicate percentage of CD69high or T-
bet+ cells among the indicated NKT cells calculated from eight
animals per genotype (CD69) or three animals per genotype (T-
bet). Histograms are representative of three or more independent
experiments with each at least seven mice in total. (G) CD69
expression of CD4+ conventional T cells (filled grey) and NKT
cells (black) from Va11p-Va14itg mice. Number in representative
histogram indicates percentage of CD69high cells among the NKT
cells, calculated from seven animals. Throughout the figure, NKT
cells were gated as tetramer+ TCRb+, conventional (conv) T cells
as tetramer2 TCRb+; CTR, CD4-Cre or Va14iStopF/wt.
(TIF)
Figure S2 NKT-cell-depletion before cell transfer and additional
analysis of the animals in the TCR-switch experiment. (A) Splenocytes
of the indicated genotypes were stained before and after depletion of
NKT cells by MACS. Numbers indicate percentages of tetramer+ and
tetramer2 T cells (TCRb+). Plots are representative for over 15
independent experiments. (B) Staining with ‘‘unloaded’’ mCD1d-
tetramer in comparison to PBS57-loaded mCD1d-tetramer of
splenocytes from the same animal. Plots are representative for three
independent experiments with five mice in total. (C) Expression of
intracellular IFN-c or TNF ex vivo 90 min after aGalCer injection.
Data are representative of two independent experiments with two
animals each. (D) Representative histograms of flow cytometric analysis
of T cells in animals 8 wk after switch induction: CD4+ tetramer–,
CD4+ tetramer+, CD8+ tetramer–, and CD8+ tetramer+ T cells
(TCRb+). Surface expression of the depicted markers in comparison to
NK cells (gated as marker+, TCRb2). Representative plots for at least
three independent experiments with at least one mouse each.
(TIF)
Figure S3 Gating strategy for the TCR-ablation experiments.
(A) Gating strategy to identify TCR2 NKT cells. (B) Yield of the
applied gating strategy. (C–E) Extracellular expression of the
depicted proteins on CD4+ naı¨ve (CD62Lhigh CD5+), CD4+
memory/effector-like (CD62Llow CD5+) T cells, and CD4+ NKT
cells (NK1.1+ CD5+ CD62Llow). MFIs were normalized to the
expression of CD4+ naı¨ve T cells.
(TIF)
Table S1 Comparison of different Va14i-transgenic mice.
(DOCX)
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Table S1: Comparison of different Vα14i-transgenic mice. 
 
 control 
 
(n = 13) 
CD4-Cre 
Vα14iStopF/wt 
(n = 7) 
Cre-deleter 
Vα14iStopF/wt 
(n = 7) 
Vα11p-
Vα14itg 
(n = 11) 
CD4p- 
Vα14itg 
(Yue et al.) 
rec- 
Vα14itg 
(Thapa et al.) 
Nuc. transfer- 
Vα14itg 
(Wakao et al.) 
thymus        
total cells (x 106) 132 ± 39 54 ± 13 15 ± 3 15 ± 4 - - 16 ± 10 
% NKT cells 0.4 15.2 10.4 14.8 9.0 1.1 16 
total NKT cells (x 106) 0.3 7.9 1.7 2.1 4.0 - 2.5* 
NKT: % CD4+/DN/CD8+ 68/32/- 67/24/8 44/53/3 36/61/4 - - - 
CD+/DN/CD8+ NKT cells (x 106) 0.2/0.1/- 4.6/1.7/0.6 0.7/0.9/0.1 0.7/1.2/0.1 - - - 
NKT: % of CD69high 84 61 - 54 - - 28 
CD69high NKT cells (x 106) 0.3 4.8 - 1.1 - - 0.7* 
NKT: % of NK1.1+ 87 15 27 24 10** 66 23 
NK1.1+ NKT cells (x 106) 0.3 1.2 0.5 0.5 0.4*/** - 0.6* 
DN tetramer- T cells (x 106) 0.1 0.1 0.5 1.0 - - - 
spleen        
total cells (x 106) 74 ± 19 70 ± 14 57 ± 19 47 ± 7 - - 60 ± 12 
% NKT cells 0.6 19.1 13.5 8.3 4.5 3.8 12.0 
total NKT cells (x 106) 0.3 12.1 6.1 3.7 5.7 - 7.2* 
NKT: % CD4+/DNCD8+ 80/20/- 72/19/9 46/49/5 25/66/9 - - - 
CD+/DN/CD8+ NKT cells (x 106) 0.2/0.1/- 8.7/2.2/1.0 2.7/2.9/0.3 1.0/2.4/0.3 - - - 
NKT: % of CD69high 57 17 - 33 - - - 
CD69high NKT cells (x 106) 0.2 2.1 - 1.2 - - - 
NKT: % of NK1.1+ 72 20 31 44 - - - 
NK1.1+ NKT cells (x 106) 0.2 2.5 1.9 1.7 - - - 
DN tetramer- T cells (x 106) 0.3 0.2 1.3 0.9 - - - 
 
Shown are average total cell counts and percentages (+/- SD) in thymus and spleen of the indicated mice. Grey results 
were not measured by us, but instead taken from the respective publications. *, calculated by multiplying the 
representative percentage with the average cell number. **, probably higher due to dim NK1.1 staining. 
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ABSTRACT 
Regulatory T (Treg) cells are of critical importance to prevent the development 
of autoimmune responses. During their development in the thymus, T cells 
expressing T cell receptors (TCRs) with increased reactivity towards self are 
selected to become Treg cells. Several observations suggest that mature 
Treg cells continuously receive autoreactive TCR signals in the periphery, but 
the importance of this inherent autoreactivity is still unclear. To address this 
question, we ablated the TCR of mature Treg cells in vivo and followed their 
fate over several weeks. Our experiments demonstrate that the homeostasis, 
cell-type-specific gene expression and suppressive function of Treg cells 
depend on continuous triggering of their TCR. 
 
INTRODUCTION 
The generation of a peripheral T cell pool with a broad variety of T cell 
receptors (TCRs) is critical for a functional immune system. The random 
nature of somatic TCR gene assembly ensures that a large number of foreign 
antigens can be recognized, but self-reactive TCRs are also generated. 
Various cellular and molecular checkpoints exist to delete autoreactive T cells 
or render them ineffective. These checkpoints can be subdivided into central 
and peripheral tolerance mechanisms (Xing and Hogquist, 2012). During 
thymic T cell development, most T cells with a strong self-reactivity to peptide-
MHC complexes are deleted.  
Some cells displaying intermediate self-reactivity are instructed to develop 
into regulatory T (Treg) cells, a process known as agonist selection 
(Josefowicz et al., 2012; Stritesky et al., 2012; Xing and Hogquist, 2012). 
Regulatory T cells are critical to control aberrant autoimmune activation in the 
periphery, since their absence or dysfunction leads to severe T cell-mediated 
pathologies in man and mouse (Josefowicz et al., 2012; Sakaguchi et al., 
2008). Regulatory T cells act mostly by suppressing the expansion and 
function of effector T cells, through various direct and indirect mechanisms. 
The key lineage-defining transcription factor Forkhead Box P3 (FoxP3) 
controls the expression of gene programs necessary to induce and maintain 
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Treg cell identity and function. While the number genes whose expression is 
influenced by FoxP3 alone is limited, much larger and diverse sets of genes 
are regulated by FoxP3 in conjunction with other transcriptional regulators, 
depending on the type of the immune response and the tissue where this 
response takes place. Recently, it was shown that establishment of a Treg cell-
specific hypomethylation pattern constitutes an additional independent 
requirement (Ohkura et al., 2012). Hypomethylation might also hard-wire a 
transcriptionally poised state in a set of Treg cell core genes, rendering their 
expression less dependent on the flexible composition of activated 
transcription factors. Peripheral Treg cell identity depends on continued FoxP3 
expression, which is remarkably stable in the mouse. Furthermore, the 
majority of Treg cells express high levels of CD25, the α-chain of the high 
affinity IL-2 receptor, and their survival and full FoxP3 expression depends on 
IL-2 (Fontenot et al., 2005a).  
Similar to conventional T cells, the peripheral Treg cell pool contains naïve 
and effector/tissue-homing subsets (Campbell and Koch, 2011; Fisson et al., 
2003). Naïve Treg cells are quiescent and express the adhesion/homing 
receptor CD62L and the chemokine receptor CCR7, allowing them to enter 
secondary lymphoid organs (Campbell and Koch, 2011). In contrast, effector 
Treg cells are cycling, predominantly found in the CD25low subset and show 
increased expression of CD5, CD38, CD44, Ox40, GITR, CD69, and ICAM-1 
in comparison to naïve Treg cells (Campbell and Koch, 2011; Feuerer et al., 
2009; Fisson et al., 2003; Fontenot et al., 2005b; Huehn et al., 2004; 
Stephens et al., 2007). It was proposed that the effector Treg cell subset is 
comprised of short-lived cells that were recently activated upon (self-)antigen 
recognition (Campbell and Koch, 2011; Fisson et al., 2003). 
Importantly, both lineage-defining characteristics of Treg cells, namely 
FoxP3 expression and the specific hypomethylated state, are induced by 
strong, and in the latter case long lasting, TCR signals in developing Treg cells. 
TCR-mediated activation of NF-κB, NF-AT and Nr4a family transcription 
factors is essential for Treg cell development, at least in part through induction 
of FoxP3 expression (Isomura et al., 2009; Medoff et al., 2009; Schmidt-
Supprian et al., 2003; 2004; Sekiya et al., 2013). Furthermore, a mutation in 
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LAT abolishing its ability to bind to PLCγ1 severely interfered with Treg cell, but 
not conventional T cell development (Koonpaew et al., 2006). Interruption of 
TCR signaling in developing thymic Treg cells by ablation of Lck via Ox40-Cre 
led to reduced splenic, although increased lymph node FoxP3+ Treg cell 
numbers. Lck-deficient Treg cells displayed a striking deficiency in Treg cell 
signature genes (Kim et al., 2009).  
The importance of TCR-generated signals for the maintenance of mature 
Treg cell pool size and lineage identity in the immunological periphery is less 
well understood. A reporter mouse for TCR signal strength suggested that 
Treg cells continuously receive stronger TCR signals in comparison to 
conventional T cells not only during thymic development, but also in the 
periphery (Moran et al., 2011). Mice expressing MHCII only on cortical thymic 
epithelial cells showed normal proportions of in vitro suppressive CD4+ 
CD25+ T cells in peripheral lymph nodes (Bensinger et al., 2001), which 
would suggest that peripheral homeostasis of Treg cells is to a large degree 
MHCII independent. Fittingly, Treg cell-specific deletion of IKK2, a kinase that 
links TCR activation to the transcription factor NF-κB pathway and that is 
crucial during thymic Treg cell development (Schmidt-Supprian et al., 2004), 
did not lead to changes in peripheral Treg cell numbers (Chang et al., 2012). 
Furthermore, graded interference of TCR signaling by ZAP mutations of 
varying severity led to reduced Treg cell numbers in the thymus, but not in the 
spleen (Siggs et al., 2007). Altogether, these observations indicated that the 
homeostasis of mature Treg cells is independent of TCR signals.  On the other 
hand, ablation of MHCII expression specifically on CD11chigh dendritic cells 
(DCs) significantly reduced proportions and absolute cell numbers of Treg cells 
in lymph nodes and spleen (Darrasse-Jèze et al., 2009). These results are in 
line with the fact that the homeostatic proliferation of adoptively transferred in 
vitro suppressive CD4+ CD25+ T cells requires MHCII expression (Gavin et 
al., 2002). 
To directly address the importance of tonic TCR signaling for peripheral 
Treg cell homeostasis and lineage identity, we monitored the effects of induced 
TCR ablation on mature Treg cells over time. Our results show that TCR-less 
Treg cells quickly lose their activated phenotype and further show impaired 
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homeostasis and function. Therefore, we propose that TCR-derived signals 
are not only critical during thymic development, but also for the maintenance 
and function of peripheral regulatory T cells. 
 
RESULTS 
Inducible TCR ablation on regulatory T cells 
In order to study the importance of constitutive TCR signaling for regulatory 
T cells, we conditionally ablated the TCRα-chain by using the previously 
described Mx-Cre CαF/F system (Polic et al., 2001). Regulatory T cells, as well 
as conventional T cells, develop normally in these mice. Cre expression is 
controlled by the Mx1-promoter, which can be induced by injection of type-I-
interferons or double-stranded RNA (poly(I:C)) in vivo (Polic et al., 2001). It 
was previously shown that upon Cre-dependent Cα-ablation, the surface 
expression of the TCRβ-chain and CD3 was noticeable down-regulated 5 d 
after poly(I:C) treatment, and both molecules were absent from the surface 
after 10 d (Polic et al., 2001). Intracellular FoxP3 staining of CD4+ CD25high 
splenocytes showed that 2 wk after poly(I:C) treatment, around ¼ of the 
FoxP3+ Treg cells had lost TCR surface expression (Fig. 1A). Importantly, 
TCR-deficient Treg cells still expressed high FoxP3 levels (Fig. 1A), indeed we 
did not observe at any time point FoxP3 downregulation in TCR-deficient 
Treg cells. For further studies, the mice were bred to the FoxP3-eGFP reporter 
strain to facilitate the identification of TCR+ and TCR- Treg cells (Bettelli et al., 
2006).  
Together, these experiments demonstrate that continuous TCR-generated 
signals are not obligate for the maintenance of FoxP3 expression of mature 
Treg cells. For the following experiments, we analyzed Treg cells 6 wk after 
induced TCR ablation unless otherwise indicated, so that they did not receive 
TCR signals for at least 1 month. At this time-point the effects of cellular 
activation by  poly(I:C) injection should also have completely subsided.  
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Peripheral homeostasis of regulatory T cells is strongly impaired upon 
TCR deletion 
The continued FoxP3 expression allowed us to unambiguously identify TCR-
deficient Treg cells. Upon poly(I:C) treatment, Cre-mediated recombination of 
conditional TCRα alleles is complete in lymphoid progenitors of Mx-Cre mice 
(Polic et al., 2001). Accordingly, 6 wk after poly(I:C) treatment, the thymi of 
Mx-Cre CαF/F mice were almost devoid of mature TCRβ+ T cells as well as of 
TCRint CD69high cells that are undergoing positive selection (Fig. 1B). Many of 
the remaining TCRint CD69high cells are recirculating NKT cells (Vahl et al., 
2013). Furthermore, Treg cells were almost absent from the thymi of the 
poly(I:C)-treated Mx-Cre CαF/F mice, in line with the previously described fast 
emigration of Treg cells upon selection (Toker et al., 2013) (Fig. 1B). 
Therefore, we could employ these mice to study the homeostasis of 
peripheral Treg cells in the absence of cellular influx from the thymus.  
Interestingly, the half-life of Treg cells was significantly reduced in 
comparison to their TCR+ counterparts in the absence of TCR signals, down 
to around 46 days (Fig. 1C). Their half-life was comparable to that of TCR-
deficient naïve CD4+ cells (40 - 46 days, (Polic et al., 2001; Vahl et al., 2013). 
On the other hand, TCR-deficient NKT cells and CD4+ CD44high 
memory/effector T cells, whose homeostasis depends on cytokines and not 
on TCR signals (Polic et al., 2001; Vahl et al., 2013), have a dramatically 
longer half-life at around 300 d. However, the total number of peripheral 
Treg cells was not changed 6 and 15 wk after poly(I:C) injection in Mx-Cre 
CαF/F mice, which was in contrast to the total numbers of naïve CD4+ as well 
as CD8+ T cells (Supplementary Fig. 1). Thus, the peripheral Treg cell pool 
size is kept stable in the absence of thymic output (Fig. 1C & Supplementary 
Fig. 1).  
Previously, it has been demonstrated that cytokines, most importantly IL-2 
and IL-7, influence the homeostasis of Treg cells (Burchill et al., 2007; 
Setoguchi et al., 2005). Interestingly, when we analyzed expression of CD25, 
the α-chain of the high affinity IL-2 receptor, we observed that all TCR-
deficient Treg cells expressed high levels of CD25 (Fig. 1D). In contrast, the 
expression of CD122, the β-chain of the receptors for IL-2 and IL-15, and 
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CD127, a component of the IL-7 receptor, were not significantly altered upon 
TCR deletion, whereas the expression of the IL-15 receptor α-chain was only 
partially reduced (Fig. 1D). Therefore, the homeostatic defects of TCR-
deficient Treg cells are mostly likely not due to defective cytokine signaling. 
The decrease of peripheral TCR-deficient Treg cells (Fig. 1C) could be a 
consequence of impaired survival or proliferation, or both. To answer this 
question, we first addressed Treg cell proliferation. Previously, it has been 
shown that peripheral Treg cells, especially the CD25low subset, vigorously 
cycle in the steady-state in comparison to conventional T cells (Fisson et al., 
2003; Fontenot et al., 2005b). Interestingly, both the proliferation marker Ki-67 
as well as CD71, a marker for dividing T cells (Bayer et al., 1998), were not 
expressed by TCR-deficient Treg cells (Fig. 1E). In order to study the 
proliferation of Treg cells in the absence of TCR signals over a longer period of 
time, we fed mice containing TCR-deficient and –proficient Treg cells with 
BrdU via drinking water for 4 weeks and analyzed BrdU incorporation directly 
afterwards. As expected, the vast majority of CD25low Treg cells, as well as a 
significant proportion of TCR+ CD25high Treg cells, had incorporated BrdU 
(Fig. 1F). However, in line with the absent Ki-67 and CD71 expression, BrdU-
incorporation of TCR-deficient Treg cells was significantly reduced in 
comparison to their TCR-sufficient counterparts, indicating that their 
proliferation requires tonic TCR signals (Fig. 1F). 
To study whether TCR-deficiency directly impairs the survival of Treg cells, 
we extracted splenic lymphocytes and stained them for 1 h for presence of 
activated caspases, a marker for apoptotic cells. Interestingly, a significantly 
higher percentage of TCR-deficient Treg cells contained activated caspases 
after this incubation time (Fig. 1G), indicating that at least under these culture 
conditions, TCR-deficient Treg cells have an increased tendency to enter into 
apoptosis. 
Together, these results demonstrate that the absence of TCR signals 
abrogates Treg cell homeostasis, due to impaired proliferation and probably 
increased apoptosis. 
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TCR-deficient Treg cells lose their activated phenotype 
A direct comparison of the CD25high/CD25low Treg cell subsets revealed that 
the CD25low subset is enriched for cells expressing effector/tissue-homing 
markers (Fontenot et al., 2005b). Therefore, as the TCR-deficient Treg cells 
were exclusively CD25high (Fig. 1D), we compared the gene expression of 
these cells to TCR-expressing CD25high Treg cells unless noted otherwise. 
Treg cells leaving the thymus express high levels of the chemokine 
receptor CCR7 as well as of CD62L, similar to conventional naïve T cells, 
which allow them to recirculate between secondary lymphoid organs 
(Campbell and Koch, 2011). TCR ablation did not did not reduce the 
proportions of Treg cells expressing CCR7 and CD62L, suggesting that TCR-
deficient Treg cells can recirculate efficiently (Fig. 2A). In contrast, we 
observed that activation/effector markers such as 4-1BB, CD49b, CD69, 
CD103 and KLRG-1 were almost not expressed on TCR-deficient Treg cells 
(Fig. 2B). In addition, we could not detect PD-1 expression on TCR- Treg cells, 
a marker for the recently discovered follicular Treg cell subset that is important 
for the control of follicular helper T cells and germinal center B cells 
(Linterman et al., 2011; Sage et al., 2012).  
To further elucidate the impact of TCR ablation on Treg cell identity, we 
monitored the expression of several well-described Treg cell markers on TCR-
deficient Treg cells in comparison to naïve conventional CD4+ T cells, CD25high 
or CD25low TCR+ Treg cells. Interestingly, our analysis revealed that CD44, 
highly expressed on effector Treg cells and intermediately expressed on naïve 
Treg cells (Campbell and Koch, 2011), was further downregulated on TCR-
deficient Treg cells to the level observed on naïve conventional T cells (Fig. 
2C). Furthermore, surface expression of the costimulatory molecules CD28, 
ICOS and Ox40, as well as of CD5, CD38, and ICAM-1, was significantly 
decreased (Fig. 2C). Additional analysis of intracellular transcription factor 
expression showed that c-Rel and Egr2, both of which have been linked to 
TCR activation, were downregulated (Fig. 2D). Furthermore, Treg cells 
expressing increased levels of T-bet were not found among the TCR-deficient 
cells (Supplementary Fig. 2). A comprehensive overview on the marker 
proteins analyzed by flow cytometry is shown in Supplementary Fig. 2. 
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Together, these findings demonstrate that Treg cells revert to a naïve 
phenotype in absence of TCR-derived signals. 
 
Dramatic changes in gene expression upon TCR ablation 
To analyze the consequences of loss of TCR signals for Treg cell phenotype 
and homeostasis in an unbiased and global fashion, we analyzed gene 
expression changes caused by the absence of TCR signals through 
Affymetrix microarrays. We FACS-purified TCR+/TCR- FoxP3-eGFP+ 
CD25high Treg cells to exclude effector/tissue-homing CD25low Treg cells that 
were not present among the TCR-deficient Treg cells as mentioned above. In 
total, we found 915 genes to be at least 3-fold differentially expressed 
between TCR+ and TCR- Treg cells. The vast majority of these genes (802 = 
88%) were significantly downregulated and included as expected the 
TCRα-chain and molecules induced by TCR-signaling such as Egr2 and Egr3. 
We confirmed the downregulation of surface molecules such as 4-1BB 
(encoded by Tnfrsf9), CD38, ICOS and PD-1 (encoded by Pdc1) that we 
already observed by flow cytometry.  
Next, we analyzed the expression of a set of Treg cell signature genes, as 
described by Hill and colleagues (Hill et al., 2007), and could detect 559 of 
603 of these genes in our microarrays. Interestingly, 76 (14 %) of the Treg cell 
signature genes were at least 3-fold differently expressed when compared to 
control Treg cells (Fig. 3B), and 325 (58 %) Treg cell signature genes were at 
least 2-fold differentially expressed (data not shown), indicating that a 
substantial proportion of the characteristic Treg cell gene expression pattern 
relies on TCR-derived signals. 
The transcription factor FoxP3, central in Treg cell biology, has been shown 
to regulate Treg cell gene expression through forming complexes and 
interacting with various other transcription factors, including Aiolos, Eos, 
Foxo1, IRF4, NFAT, Ror-γt, Runx1, T-bet and various others (Fu et al., 2012; 
Rudra et al., 2012). Recently, a genome-wide list of FoxP3 target genes has 
been established (Zheng et al., 2007). Although FoxP3 expression itself was 
unaltered (Fig. 1A, B), the expression of several genes specifically repressed 
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or upregulated by FoxP3 (33 of 99 genes = 30 %) was significantly changed, 
with all of them being downregulated (Fig. 3C). Among these significantly 
downregulated genes were the four transcription factor-encoding genes Crem, 
Ikzf2, Irf6 and Prdm1 (data not shown), whose expression is directly initiated 
by FoxP3 in wild-type Treg cells and which were suggested to play an 
important role in the FoxP3-induced developmental and functional 
reprogramming of Treg cells (Zheng et al., 2007). In addition, we discovered 
downregulation of further important transcription factors including Aiolos, 
Eomes, Eos, IRF4 and T-bet (Fig. 3A, B and data not shown).  
Together, the results from the gene expression analysis confirm and 
extend our findings from the flow cytometric analysis, showing that TCR 
ablation causes dramatic changes for Treg cells. Importantly, the 
overwhelming majority of differentially expressed mRNAs were downregulated 
in TCR-deficient Treg cells, indicating that a large part of the Treg cell specific 
gene expression pattern is induced through their autoreactivity TCR. 
Furthermore, although FoxP3 is still present in TCR-deficient Treg cells, its 
functionality is probably impaired due to the decreased expression or even 
absence of several of its important co-factors. 
 
The lineage-specific epigenetic pattern is not affected by TCR ablation 
Recently, it was proposed that besides FoxP3 expression, the establishment 
of a specific hypomethylation pattern (nTreg-Me) is of critical importance 
during thymic Treg cell development (Ohkura et al., 2012). These 
hypomethylated regions were consistently found in the gene loci of FoxP3, 
GITR, CTLA4 and Eos, and partially in Helios (Ohkura et al., 2012). Long-
lasting TCR stimulation of developing thymocytes was shown to induce 
nTreg-Me, whereas FoxP3 expression was a consequence of strong TCR 
activation (Ohkura et al., 2012). This demethylation is performed 
independently of cell-division through members of the family of Tet 
dioxygenases (Toker et al., 2013). Interestingly, we observed that the 
expression of two of these Tet family members, Tet1 and Tet2, was 
significantly reduced upon TCR deletion in Treg cells (Fig. 3B and data not 
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shown). This suggested that continuous TCR activation might play a role in 
maintaining the lineage-specific hypomethylation pattern of peripheral 
Treg cells. To test this possibility, we FACS-purified TCR-deficient and 
proficient Treg cells from multiple animals, similar as for the Affymetrix gene 
array, 6 and 15 weeks after TCR ablation by poly(I:C) injection, and 
performed bisulfite sequencing. Against our expectations, we found no 
changes in the nTreg-Me 6 weeks and also 15 weeks after induced TCR 
deletion (Fig. 4A). These results indicate that while establishment of the 
Treg cell-specific methylation pattern is induced through TCR signals, its 
maintenance is independent of continuous TCR signals. In line with these 
results, the expression levels of the proteins that contain hypomethylated 
regulatory regions were, albeit reduced, still significantly higher in TCR-
deficient Treg cells than in naïve conventional T cells (Fig. 1A & 4B). These 
results suggest that in absence of TCR signals, some genes in Treg cells 
remain highly expressed due to the stable nTreg-Me. 
 
TCR-deficient Tregs lose at least half of their suppressive protein arsenal 
Various mechanisms are implicated in the suppressive ability of Treg cells 
(Fontenot et al., 2005a; Josefowicz et al., 2012; Sakaguchi et al., 2008; 
Shevach, 2009). First, it was suggested that Treg cells are able to consume 
large amounts of the cytokine IL-2, which is important for the survival and 
proliferation of activated T cells. Furthermore, Treg cells directly act on 
activated T cells through release of suppressive cytokines (IL-10 and IL-35), 
granzymes, perforin and Galectin-1. Moreover, Treg cell-expression of 
molecules including CTLA-4, CD39, CD73, LAG-3, LFA-1 and Neuropilin-1 
(Nrp1) was shown to be important in the modulation of the costimulatory 
abilities of antigen-presenting cells. 
Interestingly, we found that for 8 of 18 (44 %) tested putative suppressor 
genes, TCR-deficient Treg cells expressed significantly reduced transcript 
levels. This was the case for CD73, CTLA-4, IL-10, Ebi3, Fgl-2, LFA-1, Nrp1 
and PD-1L2 (Fig. 3B and data not shown). Perforin was the only significantly 
upregulated suppressor gene (Fig. 3A). To test whether this could be 
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confirmed on the protein level, we analyzed the expression of putative 
suppressor molecules by flow cytometry. Our results confirmed the 
downregulation of CTLA-4 (Fig. 4B), CD73, LFA-1 and Nrp1 that was already 
seen on the mRNA level (Fig. 5A). Furthermore, we found significant 
reduction of surface expression of GITR (Fig. 4B), but not of CD39 (Fig. 5A). 
LAG-3 was significantly reduced in comparison to TCR+ CD25high Treg cells 
from the same animals, but not in comparison to control animals.  
To study the ability of Treg cells to release IL-10 upon activation, we 
stimulated them in vitro with PMA/ionomycin and assessed IL-10 production 
by flow cytometry. A significantly smaller percentage of TCR-deficient 
Treg cells produced IL-10 in comparison to their TCR-expressing counterparts 
(Fig. 5B). In total, we demonstrated that half of the proteins implicated in 
Treg cell-mediated suppression  (9 of 18) were significantly downregulated 
after TCR ablation. We therefore conclude that the suppressive function of 
Treg cells depends on constant TCR generated signals to a large extent. 
 
DISCUSSION 
Treg cells are mostly generated in the thymus and are crucial to control 
autoimmune responses in the periphery. Upon egress from the thymus, 
control of peripheral Treg cell homeostasis has been mostly attributed to 
cytokine signaling (Burchill et al., 2007; Setoguchi et al., 2005). Conversely, 
we found that despite the fact that TCR-deficient Treg cells expressed high 
levels of cytokine receptors for IL-2 and IL-7 and should be able to properly 
compete for these cytokines with conventional T cells, their half-life was 
strongly reduced. The expression of the IL-15 receptor was slightly reduced, 
but this is unlikely to account for the reduced half-life, as peripheral Treg cell 
homeostasis was not affected in IL-15-deficient animals (Burchill et al., 2007). 
Furthermore, we showed that the impaired homeostasis of these cells is a due 
to a proliferative block and potentially also to decreased survival. Therefore, 
our study demonstrates that the inherent Treg cell autoreactivity is of crucial 
importance for Treg cell homeostasis. Interestingly, the size of the peripheral 
Treg cell pool was not affected when the thymic T cell production was blocked, 
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in line with the previously reported finding that Treg cells are under 
homeostatic control and quickly fill empty niches (Benoist and Mathis, 2012). 
Regulatory T cells can be broadly separated into two different subsets in 
vivo (Campbell and Koch, 2011; Fisson et al., 2003; Huehn et al., 2004). The 
majority of Treg cell displays a naïve phenotype, is slowly cycling and held in a 
resting state. In contrast, the smaller subset is composed of highly 
proliferative cells with a effector phenotype that express homing receptors 
allowing them to migrate to non-lymphoid sites in the body (Campbell and 
Koch, 2011). It was speculated that the effector subsets consists of cells that 
were recently activated upon auto-antigen recognition (Campbell and Koch, 
2011; Fisson et al., 2003). Further strengthening this hypothesis, we failed to 
detect TCR-deficient Treg cells expressing the characteristic activated/effector 
T cell markers 4-1BB, CD49b, CD69, CD103 and KLRG1, as well as the 
newly described PD-1-expressing follicular Treg cell subset, 6 weeks after TCR 
deletion. Moreover, we did not detect actively cycling cells among the TCR-
deficient Treg cells. Interestingly, we also found significant changes in the gene 
expression of the naïve Treg cell subset, including downregulation of CTLA-4, 
CD38, CD44, ICAM, ICOS and Ox40, and upregulation of CD45RB. This 
indicates that also the naïve Treg cell subset is composed of autoreactive cells 
that are consistently activated, and this activation is fundamental for their 
gene expression.  
Various molecules are implicated in the Treg cell suppressor function 
(Josefowicz et al., 2012; Shevach, 2009). However, there is probably no 
single mechanism that is active in each scenario. This is notion is supported 
by the fact that no knockout has been described to date that causes a similar 
dramatic phenotype as FoxP3-deficiency. Thus, probably depending on the 
type of immune response regulated and the location in the body, one or 
several different suppression mechanisms are important. In this regard, 
subsets of Treg cells expressing transcription factors typical for helper T cells, 
such as Bcl-6 (Linterman et al., 2011) IRF4 (Zheng et al., 2009), STAT-3 
(Chaudhry et al., 2009) and T-bet (Koch et al., 2009), are each important in 
different disease settings. Still, it is not well understood how Treg cell TCR 
engagement is involved in suppression of their target cells. It was recently 
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shown that at least in vitro, directly ex vivo isolated Treg cells are able to 
suppress without previous activation (Szymczak-Workman et al., 2009). It has 
been speculated that auto-antigen recognition is key to maintain polyclonal 
Treg cells in an activated state allowing them to control various different 
immune responses independently of TCR specificity (Shevach, 2009). We did 
not only find that Treg cells expressing helper T cell transcription factors such 
as IRF4 and T-bet were absent from the TCR-deficient population, but also 
that the TCR-deficient Treg cell subset lost expression of many proteins 
implicated in their suppressive function, including CTLA-4, GITR, LFA-1 and 
IL-10. These results strongly suggest that constant TCR-generated signals 
are crucial to maintain the suppressive abilities of these cells. The loss of 
suppressive function and shortened half-live of TCR-deficient Treg cells did 
not lead to manifestation of an autoimmune phenotype. However, our system 
just allowed partial TCR deletion in Treg cells, and the size of the TCR-
expressing Treg cell pool was kept stable despite the block of thymic Treg cell 
development and the decay of TCR-deficient Treg cells. For that reason, it is 
likely that the TCR-expressing Treg cell subset is able protect these mice from 
autoimmunity in most of the cases. 
TCR signaling is essential for Treg cell development through induction of 
FoxP3 expression and the establishment of hypomethylated regions. 
Recently, it was shown that upon TCR stimulation, c-Rel directly binds the 
FoxP3 promoter and also a highly conserved noncoding sequence, CNS3, in 
the Foxp3 locus (Long et al., 2009). This regulatory CNS3 element was 
shown to play a role in the maintenance of FoxP3 expression after its 
induction. Surprisingly, we found that in the absence of TCR expression, 
causing a significant downregulation of c-Rel, FoxP3 expression of Treg cells 
was remarkably stable. Therefore, continuous TCR signals are clearly 
dispensable for the maintenance of FoxP3 expression in mature Treg cells, 
which instead is probably stabilized by the Treg cell-specific demethylation of 
regulatory regions of the Foxp3 locus. However, despite the presence of 
FoxP3, the expression of a large proportion of its target genes was 
significantly downregulated in response to TCR ablation. These findings 
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indicate that a crucial role of FoxP3 is to repress TCR activation-induced 
genes and thereby to desensitize Treg cells from their autoreactive TCR. 
In summary, our study demonstrates that Treg cells continuously receive 
signals through their autoreactive TCR, and that these signals are essential 
for Treg cell survival, activation status and suppressive function. Despite this 
ongoing activation, only few Treg cells acquire an effector phenotype, whereas 
the majority of Treg cells are still “naïve”. Most likely, this is due to differential 
activation strength, depending on receptor affinity, costimulation and also the 
cytokine environment. Only upon proper activation, naïve Treg cells acquire an 
effector phenotype, migrate to the specific location of an immune response, 
and quickly decay after its end.   
 
MATERIALS AND METHODS 
Genetically modified mice 
Mx-Cre (Kuhn et al., 1995), CαF (Polic et al., 2001), and FoxP3-eGFP (Bettelli 
et al., 2006) mice were kept on a C57BL/6 genetic background. At the age of 
6-8 wk, the animals were given a single dose (400 µg) of poly(I:C) 
(Amersham). All mice were analyzed 6 wk after injection, unless otherwise 
indicated. Mice were housed in the specific pathogen–free animal facility of 
the MPIB. All animal procedures were approved by the Regierung of 
Oberbayern. 
Flow Cytometry & Heat Map Generation 
Single-cell suspensions were prepared and stained with monoclonal 
antibodies: 4-1BB (17B5), Aiolos (8B2), CCR7 (4B12), CD103 (2E7), CD122 
(TM-b1), CD126 (D7715A7), CD127 (A7R34), CD25 (PC61.5), CD28 (37.51), 
CD200 (OX90), CD38 (90), CD39 (24DMS1), CD4 (RM4-5), CD44 (IM7), 
CD45RB (C363.16A), CD5 (53-7.3), CD62L (MEL-14), CD69 (H1.2-F3), CD71 
(R17217), CD73 (eBioTY/11.8), CD8α (53-6.7), CD83 (Michel-17), c-Rel 
(1RELAH5), CTLA-4 (UC10-4B9), Egr2 (erongr2), Eomes (Dan11mag), Eos 
(ESB7C2), Fas (15A7), FasL (MFL3), FolR4 (eBio12A5), FoxP3 (FJK-16s), 
GARP (YGIC86), GATA-3 (TWAJ), GITR (DTA-1), Helios (22F6), ICAM-1 
(YN1/1.7.4), IL-10 (JES3-16E3), IL-15Rα (DNT15Ra), IRF4 (3E4), ITGAL 
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(M17/4), ICOS (7E.17G9), Ki-67 (SolA15), KLRG-1 (2F1), LAG-3 
(eBioC9B7W), Ly6C (HK1.4), Nur77 (12.14), Ox40 (Ox86), PD-1 (J43), Runx1 
(RXDMC), T-bet (eBio4B10) and TCRβ (H57-597) (all from eBioscience). 
CD49b (HMa2) and Nrp1 (AF566) were purchased from BioLegend or R&D 
Systems, respectively. For intracellular transcription factor stainings, cells 
were fixed and permeabilized with the FoxP3 staining kit (eBioscience). For 
intracellular cytokine stainings, cells were activated for 5 h with phorbol-12-
myristat-13-acetat (PMA) and ionomycin (both from Sigma), and monensin 
(eBioscience) was added for the last 3 h of culture. Afterwards, cells were 
fixed and permeabilized with the Cytofix/Cytoperm kit (BD). To detect active 
caspases, cells were stained for 1 h with the CaspGLOW Red Active Caspase 
Kit (BioVision) as recommended by the manufacturer. Samples were acquired 
on a FACSCanto2 (BD) machine, and analyzed with FlowJo software 
(Treestar). To evaluate the relative expression of regulatory T cell marker 
genes, the median fluorescence intensities (MFI) of at least five mice per 
genotypes were calculated with FlowJo, and the MFI for the CD4+ naïve 
conventional (CD44low FoxP3- TCRβ+) T cells of CαF/F control mice was set to 
1 for each set. 
 
BrdU incorporation 
Mice were fed with 0.5 mg/ml BrdU (Sigma) in the drinking water for 
4 consecutive weeks. Directly afterwards, BrdU incorporation was measured 
with the BrdU Flow Kit (BD). 
 
Cell sorting & gene expression analysis 
TCR+ (FoxP3+ CD4+ CD25high cells from CαF/F FoxP3-eGFP control animals) 
and TCR- (FoxP3+ TCR- CD4+ CD25high cells from Mx-Cre CαF/F 
FoxP3-eGFP animals) Treg cells were sorted 6 weeks after poly(I:C) injection 
with a FACSAria (BD). To reduce variability, cells from several mice were 
pooled for sorting, and 4 replicates for the control animals as well as 
5 replicates for the Mx-Cre animals were generated. mRNA from 3-5 x 105 
cells was purified with a RNeasy Micro kit (Qiagen), amplified, labeled and 
hybridized to Affymetrix M430 V2 microarrays.  
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CpG methylation analysis by bisulfite sequencing 
TCR+ and TCR- Treg cells cells were sorted 6 wk and 15 wk after poly(I:C) 
injection similar as for the gene expression analysis. The CpG methylation 
status was analyzed as previously described (Ohkura et al., 2012). 
 
Statistics  
Statistical analysis of the results was performed by one-way ANOVA followed 
by Tukey’s test or by student t test. P values are presented in figure legends 
where a statistically significant difference was found. 
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FIGURE LEGENDS 
Figure 1. Regulatory T cells homeostasis is impaired upon TCR deletion 
(A) Surface TCRβ and intracellular FoxP3 expression of splenic CD4+ 
CD25high Treg cells from the indicated animals 2 wk after poly(I:C) injection. 
Plots are representative for 5 independent experiments.  
(B) Expression of CD69 and FoxP3 in comparison to TCRβ of total 
thymocytes, 6 wk after poly(I:C) injection. Plots are representative for 
5 independent experiments. 
(C) Splenic regulatory T cell numbers from in total 24 control (CTR) CαF/F 
animals as well as TCRβ+ and TCRβ- Treg cell numbers from in total 
23 Mx-Cre CαF/F animals, at the indicated time after poly(I:C) injection. Half-
lifes were calculated with GraphPad Prism software using non-linear 
regression, one-phase decay analysis. The lines for the TCR+ Treg cell 
subsets lie directly on top of each other. 
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(D) Extracellular expression of the respective cytokine receptor subunits on 
splenic FoxP3-eGFP+ Treg cells of the depicted animals, 6 wk after poly(I:C) 
injection. Numbers indicate mean percentage ± SD of at least 6 mice per 
genotype. 
(E) Extracellular expression of CD71, and intracellular expression of Ki-67, 
on/in splenic FoxP3-eGFP+ Treg cells of the depicted animals, 6 wk after 
poly(I:C) injection. Plots are representative for at least 3 independent 
experiments. 
(F) BrdU was administered for 4 wk via the drinking water, starting 2 wk after 
poly(I:C) injection. Directly afterwards, mice were sacrificed, and BrdU 
incorporation in CD25low/CD25high FoxP3-eGFP+ Treg cells of the depicted 
animals was measured by flow cytometry. Bar chart depicts means and SD 
(error bars) of one experiment with 2 CαF/F as well as 4 Mx-Cre CαF/F animals. 
(G) Splenic FoxP3-eGFP+ Treg cells of the depicted animals were stained in 
vitro for 1 h for the presence of active caspases. Numbers indicate mean 
percentage ± SD of 2 CαF/F animals or 4	  Mx-Cre CαF/F animals. Scatter plot 
shows the percentage of active caspase-stained FoxP3-eGFP+ Treg cells from 
control 2 CαF/F or from 4	  Mx-Cre CαF/F animals. Bars indicate means. 
 
Figure 2. Regulatory T cells lose their activated phenotype upon TCR 
deletion 
(A) Extracellular expression of CCR7 or CD62L on splenic FoxP3-eGFP+ 
CD25high Treg  cells from the depicted animals, 6 wk after poly(I:C) injection. 
Black numbers in representative plots indicate mean percentage ± SD of at 
least 6 mice per genotype. Red numbers indicate percentage among TCR+ or 
TCR- Treg cells, respectively. 
(B) Extracellular expression of the depicted markers on splenic FoxP3-eGFP+ 
CD25high Treg cells from the depicted animals, 6 wk after poly(I:C) injection. 
Black numbers in representative plots indicate mean percentage ± SD of at 
least 6 mice per marker per genotype.  
(C, D) Extracellular (C) or intracellular (D) expression of the depicted markers 
of the indicated splenic T cell subsets, all from Mx-Cre CαF/F animals 6 wk 
after poly(I:C) injection. Numbers in representative histograms indicate means 
of the median fluorescence intensities (MFIs), normalized to CD4+ CD44low 
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naïve conventional T cells of CαF/F animals. Means were calculated from at 
least 5 mice per genotype. 
 
Figure 3. Regulatory T cell mRNA expression is severely changed upon TCR 
deletion 
The mRNA expression of splenic TCR+ CD25high Treg cells from 4 CαF/F 
control animals and TCR- CD25high Treg cells from 5 Mx-Cre CαF/F animals, 
6 wk after poly(I:C) injection, was compared by Affymetrix microarray. 
(A) Volcano plot representation (fold change vs. t test p value) of all analyzed 
genes. For better visibility, significantly changed genes discussed in the text 
are marked in red. 
(B) Heatmap showing the expression of 76 at least 3-fold differentially 
expressed genes of the Treg cell signature. The values of the 4 control animals 
were averaged, and are displayed together with the values of the 5 individual 
Mx-Cre CαF/F animals. 
(C) FoxP3 specifically up- or downregulates the expression of a set of target 
genes in the periphery only or in the thymus and the periphery. Bar chart 
shows the expression of these FoxP3 target genes after TCR deletion. 
 
Figure 4. Treg cell-specific methylation pattern is unaltered upon TCR deletion 
(A) CpG methylation status of splenic CD25high TCR+/TCR- Treg cells of the 
depicted animals, 6 wk or 15 wk after poly(I:C) injection. 
(B) Extracellular (GITR) or intracellular (CTLA-4; Eos; Helios) expression of 
the depicted markers of the indicated splenic T cell subsets, all from Mx-Cre 
CαF/F animals 6 wk after poly(I:C) injection. Numbers in representative 
histograms indicate means of the median fluorescence intensities (MFIs), 
normalized to CD4+ CD44low naïve conventional T cells of CαF/F animals. 
Means were calculated from at least 5 mice per genotype. 
 
Figure 5. Regulatory T cells show reduced expression of several suppressor 
markers and reduced IL-10 production upon TCR deletion 
(A) Extracellular expression of the depicted markers of the indicated splenic 
T cell subsets, all from Mx-Cre CαF/F animals 6 wk after poly(I:C) injection. 
Numbers in representative histograms indicate means of the median 
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fluorescence intensities (MFIs), normalized to CD4+ CD44low naïve 
conventional T cells of CαF/F animals. Means were calculated from at least 
5 mice per genotype. 
(B) Intracellular IL-2 and IL-10 expression of splenic FoxP3-eGFP+ Treg cells, 
activated in vitro with PMA/Ionomycin for 5 h. Cells were extracted from mice 
and activated 6 wk after poly(I:C) injection. Numbers indicate mean 
percentages of TCR+ or TCR- Treg cells expressing the respective cytokine. 
Data are representative for 4 animals per genotype. 
 
Supplementary Figure 1. Total splenic cell counts of CD4+ and CD8+, naïve 
(CD44low) and memory/effector (CD44high), as well as Treg cells, of the 
depicted animals, 6 wk or 15 wk after poly(I:C) injection. Data represents 
means and SD (error bars) of three independent experiments with at least 6 
mice per genotype and time point. 
 
Supplementary Figure 2. Flow cytometric expression analysis of extra- and 
intracellular markers of splenic T cells, 6 wk after poly(I:C) injection. Median 
fluorescence intensities of at least 5 mice per analyzed protein were 
normalized to the expression on/in conventional CD4+ T cells to account for 
interexperimental variations. Data are shown as heatmap, calculated by 
Perseus software. Blue letters, significantly reduced on/in TCR- Treg cells in 
comparison to TCR+ CD25high Treg cells from both CαF/F control as well as Mx-
Cre CαF/F animals. Red letter, significantly increased; analyzed by one-way 
ANOVA. 
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Figure 1. Regulatory T cells homeostasis is impaired upon TCR deletion.
(A) Surface TCRβ and intracellular FoxP3 expression of splenic CD4+ CD25high Treg cells from the indicated animals 
2 wk after poly(I:C) injection. Plots are representative for 5 independent experiments. 
(B) Expression of CD69 and FoxP3 in comparison to TCRβ of total thymocytes, 6 wk after poly(I:C) injection. Plots are 
representative for 5 independent experiments.
(C) Splenic regulatory T cell numbers from in total 24 control (CTR) CαF/F animals as well as TCRβ+ and TCRβ- Treg 
cell numbers from in total 23 Mx-Cre CαF/F animals, at the indicated time after poly(I:C) injection. Half-lifes were 
calculated with GraphPad Prism software using non-linear regression, one-phase decay analysis. The lines for the 
TCR+ Treg cell subsets lie directly on top of each other.
(D) Extracellular expression of the respective cytokine receptor subunits on splenic FoxP3-eGFP+ Treg cells of the 
depicted animals, 6 wk after poly(I:C) injection. Numbers indicate mean percentage ± SD of at least 6 mice per 
genotype.
(E) Extracellular expression of CD71, and intracellular expression of Ki-67, on/in splenic FoxP3 eGFP+ Treg cells 
of the depicted animals, 6 wk after poly(I:C) injection. Plots are representative for at least 3 independent experiments.
(F) BrdU was administered for 4 wk via the drinking water, starting 2 wk after poly(I:C) injection. Directly afterwards, 
mice were sacrificed, and BrdU incorporation in CD25low/CD25high FoxP3-eGFP+ Treg cells of the depicted animals 
was measured by flow cytometry. Bar chart depicts means and SD (error bars) of one experiment with 2 CαF/F as well 
as 4 Mx-Cre CαF/F animals.
(G) Splenic FoxP3-eGFP+ Treg cells of the depicted animals were stained in vitro for 1 h for the presence of active 
caspases. Numbers indicate mean percentage ± SD of 2 CαF/F animals or 4 Mx-Cre CαF/F animals. Scatter plot 
shows the percentage of active caspase-stained FoxP3-eGFP+ Treg cells from control 2 CαF/F or from 
4 Mx-Cre CαF/F animals. Bars indicate means.
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Figure 2. Regulatory T cells lose their activated phenotype upon TCR deletion.
(A) Extracellular expression of CCR7 or CD62L on splenic FoxP3-eGFP+ CD25high Treg  cells from the depicted 
animals, 6 wk after poly(I:C) injection. Black numbers in representative plots indicate mean percentage ± SD of at 
least 6 mice per genotype. Red numbers indicate percentage among TCR+ or TCR- Treg cells, respectively.
(B) Extracellular expression of the depicted markers on splenic FoxP3-eGFP+ CD25high Treg cells from the depicted 
animals, 6 wk after poly(I:C) injection. Black numbers in representative plots indicate mean percentage ± SD of at 
least 6 mice per marker per genotype. 
(C, D) Extracellular (C) or intracellular (D) expression of the depicted markers of the indicated splenic T cell subsets, 
all from Mx-Cre CαF/F animals 6 wk after poly(I:C) injection. Numbers in representative histograms indicate means 
of the median fluorescence intensities (MFIs), normalized to CD4+ CD44low naïve conventional T cells of CαF/F 
animals. Means were calculated from at least 5 mice per genotype.
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Figure 3. Regulatory T cell mRNA expression is severely changed upon TCR deletion
The mRNA expression of splenic TCR+ CD25high Treg cells from 4 CαF/F control animals and TCR- CD25high 
Treg cells from 5 Mx-Cre CαF/F animals, 6 wk after poly(I:C) injection, was compared by Affymetrix microarray.
(A) Volcano plot representation (fold change vs. t test p value) of all analyzed genes. For better visibility, significantly 
changed genes discussed in the text are marked in red.
(B) Heatmap showing the expression of 76 at least 3 fold differentially expressed genes of the Treg cell signature. 
The values of the 4 control animals were averaged, and are displayed together with the values of the 5 individual 
Mx-Cre CαF/F animals.
(C) FoxP3 specifically up- or downregulates the expression of a set of target genes in the periphery only or in the 
thymus and the periphery. Bar chart shows the expression of these FoxP3 target genes after TCR deletion.
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The ubiquitin-editing enzyme A20/TN-
FAIP3 is essential for controlling signals
inducing the activation of nuclear fac-
tor-B transcription factors. Polymor-
phisms and mutations in the TNFAIP3
gene are linked to various human autoim-
mune conditions, and inactivation of A20
is a frequent event in human B-cell lym-
phomas characterized by constitutive
nuclear factor-B activity. Through B cell-
specific ablation in the mouse, we show
here that A20 is required for the normal
differentiation of the marginal zone B and
B1 cell subsets. However, loss of A20 in
B cells lowers their activation threshold
and enhances proliferation and survival
in a gene-dose–dependent fashion.
Through the expression of proinflamma-
tory cytokines, most notably interleu-
kin-6, A20-deficient B cells trigger a pro-
gressive inflammatory reaction in naive
mice characterized by the expansion of
myeloid cells, effector-type T cells, and
regulatory T cells. This culminates in old
mice in an autoimmune syndrome charac-
terized by splenomegaly, plasma cell hy-
perplasia, and the presence of class-
switched, tissue-specific autoantibodies.
(Blood. 2011;117(7):2227-2236)
Introduction
B cells play essential roles during protective immune responses to
invading pathogens. On encounter of foreign antigen and with
cognate T-cell help, B lymphocytes proliferate and form distinct
histologic structures, termed germinal center (GC). In the GC, they
undergo somatic hypermutation and class-switch recombination.
During somatic hypermutation, they introduce random mutations
into their immunoglobulin variable regions while they exchange
the heavy chain constant region during class-switch recombination
to allow for different effector functions. After a selection process
by antigen, B cells differentiate into memory B cells and plasma
cells (PCs), which secrete antibodies.1 The deregulation of this
process is heavily implicated in human disease. Production of
class-switched antibodies against self-antigens causes or contrib-
utes to various autoimmune syndromes and unrestrained B-cell
proliferation and survival can result in lymphomas.1,2 It is thought
that the majority of human lymphomas derive from the GC,
probably because the DNA damage inherent to the GC reaction
facilitates mutations and chromosomal translocations.1,3
Recently, the ubiquitin-editing enzyme A20, encoded by the
tumor necrosis factor--inducible gene 3 (TNFAIP3), has been
associated with both autoimmunity and lymphomagenesis. Polymor-
phisms and mutations in or near the TNFAIP3 genomic locus have
been linked with various human autoimmune syndromes with a
strong humoral component, such as systemic lupus erythematosus
(SLE),4,5 rheumatoid arthritis,6,7 and celiac disease.8 Loss of A20
function through mutations, chromosomal deletions, and/or pro-
moter methylation is a frequent event in several human lympho-
mas,9-12 all of which are characterized by constitutive activation of
nuclear factor-B (NF-B).13 These factors regulate a plethora of
genes encoding for proinflammatory mediators, antiapoptotic pro-
teins, cell adhesion molecules and, for negative feedback control,
inhibitory proteins, such as p100, IB, and A20.14,15
During the transmission of NF-B activating signals from
cell-surface receptors such as the B-cell receptor (BCR), CD40, or
Toll-like receptors (TLRs), signal transduction occurs via the
attachment of polyubiquitin chains to key proteins, including
MALT1 or TRAF6. Polyubiquitin chains, linked via K63 or linear
assembly, serve to recruit different kinase complexes. In the case of
canonical NF-B, induced proximity allows the upstream kinase
TAK1 to phosphorylate its target IKK2, which then effects NF-B
activation. A20, whose transcription is induced by NF-B, damp-
ens signaling through 2 main activities. First, as deubiquitinase
A20 removes K63-linked polyubiquitin chains from essential
signaling intermediates, such as TRAF6. Second, A20 induces, in
concert with other proteins, degradation of some of its molecular
targets, through addition of K48-linked ubiquitin chains.14,16 Degra-
dation of RIP1 limits TNF-induced signaling,14 whereas degrada-
tion of the K63-chain-specific E2 ligases Ubc13/UbcH5c generally
affects the assembly of K63-linked polyubiquitin chains.17
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To date, the main molecular action of A20 is to prevent
prolonged NF-B activation in response to stimulation of TNF-R,
TLR-, or NOD-like receptors and the TCR.14,16 Signal con-
tainment by A20 is crucial for immune homeostasis because
A20-deficient mice die early on due to an uncontrolled inflamma-
tory disease. The inflammation is triggered via MyD88-dependent
TLRs by the commensal intestinal flora.18 To study the cell-type-
specific and cell-intrinsic roles of A20 in the mouse, we recently
generated a conditional Tnfaip3 allele (A20F).19 Given the implica-
tion of A20/TNFAIP3 in B-cell lymphomas and autoimmune
diseases, we used B lineage-specific ablation of A20 to study its
role in B-cell development, function, and disease.
Methods
Genetically modified mice
All mice described in this study are published and were originally generated
using C57BL/6 ES cells, or backcrossed to C57BL/6 at least 6 times. Mice
were housed in the specific pathogen-free animal facility of the Max Planck
Institute. All animal procedures were approved by the Regierung of
Oberbayern.
Flow cytometry
Single-cell suspensions were prepared20 and stained with monoclonal
antibodies: AA4.1(AA4.1), B220(RA3-6B2), CD1d(1B1), CD19(eBio1D3),
CD22(2D6), CD23(B3B4), CD25(PC61.5), CD3(17A2), CD38(90)
CD4(RM4-5), CD44(IM7), CD5(53-7.3), CD62L(MEL-14), CD69(H1.2F3),
CD8(53-6.7), FoxP3(FJK-16s), GR-1(RB6-8C5), IgD(11-26), IgM(II/41),
IL-10(JES5-16E3), IL-17A(eBio17B7), IL-4(11B11), IL-6(MP5-20F3),
INF-(XMG1.2), Mac-1(M1/70), TCR-(H57-597), TNF-(MP6-XT22),
CD95(15A7), CD21(7G6), CD86(GL-1), CD80(16-10A1), c-kit(2B8)
(eBioscience), Ly-6G(1A8), Siglec-F(E50-2440), CD138(281-2) (BD Bio-
sciences), and PNA (Vector Laboratories).
For intranuclear FoxP3 stainings (eBioscience) according to the manu-
facturer’s instructions, dead cells were excluded with ethidium monoazide
bromide. Samples were acquired on FACSCalibur and FACSCantoII (BD Bio-
sciences) machines and analyzed with FlowJo software (TreeStar). For intracellu-
lar cytokine stainings, cells were stimulated for 5 hours at 37°C with 10nM
phorbol myristate acetate (Calbiochem), 1mM ionomycin (Calbiochem), and
10nM brefeldin-A (Applichem). Cells were treated with Fc-block (eBioscience),
and washed and surface-stained before fixation with 2% paraformaldehyde and
permeabilization with 0.5% saponin. For in vitro culture, cells were purified by
MACS (Miltenyi Biotec; 85%-90% pure). Final concentrations of the activat-
ing stimuli: 2.5g/mL CD40 (HM40–3, eBioscience), 10g/mL IgM
(Jackson ImmunoResearch Laboratories), 0.1M CpG (InvivoGen), 20g/mL
lipopolysaccharide (LPS; Sigma-Aldrich), and 4 ng/mL IL-4 (R&D Systems).
Enzyme-linked immunosorbent assays were conducted using antibody pairs to
IL-6 (BD Biosciences) and TNF (BD Biosciences). Cell-cycle analyses by pro-
pidium iodide (PI) and carboxyfluorescin diacetate succimidyl ester (CFDASE)
were conducted as described.20
Real-time PCR
RNA was isolated (QIAGEN RNeasy Mini Kit) and reverse transcribed
(Promega) for quantitative real-time polymerase chain reaction (PCR)
using probes and primers from the Universal Probe Library (Roche
Diagnostics) according to the manufacturer’s instructions.
Biochemistry
B-cell whole-cell, cytoplasmic, and nuclear lysates were essentially pre-
pared as published.20 PVDF membranes were blotted with the following
antibodies: p-IB, p-ERK, ERK, p-JNK, JNK, p-Akt, Akt, p-p38, p38,
p100/p52 (Cell Signaling); IB, PLC2, RelB, RelA, c-Rel, Lamin
B (Santa Cruz Biotechnology); tubulin (Upstate Biotechnology); p105/50
(Abcam); and A20.19
Immunofluorescence and immunohistochemistry
For immunofluorescence stainings, frozen 10-m sections were thawed,
air-dried, methanol-fixed, and stained for 1 hour at room temperature in a
humidified chamber with B220-fluorescein isothiocyanate (eBioscience),
biotinylated rat anti-CD3 (BD Biosciences), biotinylated rat anti-CD138
(BD Biosciences), and rabbit anti–laminin (gift from Michael Sixt)
followed by Cy3-streptavidin and Cy5-conjugated anti–rabbit antibodies
(Jackson ImmunoResearch). Immunohistochemically, MZB cells were
identified by anti-CD1d (eBioscience) and metallophilic macrophages
by anti-MOMA1 (Serotec). Detection of IgG immune complexes in
paraformaldehyde-fixed kidney sections was performed using peroxidase-
labeled anti–mouse IgG antibodies and 3-amino-9-ethylcarbazole staining
(Vector Laboratories). For the detection of tissue-specific autoantibodies,
frozen sections from organs of Rag2/ mice were incubated with sera of
aged and control mice and an anti–mouse IgG-Cy3 conjugate (Jackson
ImmunoResearch Laboratories).
Images were acquired on a Zeiss Axiophot microscope (10/0.3 or
20/0.75 objectives; Carl Zeiss) using a Zeiss AxioCamMRm camera (Carl
Zeiss) for monochromatic pictures and a Zeiss AxioCamMRC5 for RGB
pictures. The following software programs were employed: Axiovision release
4.8 (Carl Zeiss), Photoshop CS4 and Illustrator CS4 (Adobe Systems).
Immunizations, ELISA
Mice were immunized intraperitoneally with 10 g NP-Ficoll (Biosearch
Technologies) and bled by the tail vein. Serum immunoglobulin concentra-
tions and NP-specific antibodies were determined by ELISA.21 The
detection of antinuclear and anticardiolipin autoantibodies was performed
using ELISA kits (Varelisa). Rheumatoid factor: ELISA plates were coated
with rabbit IgG (Jackson ImmunoResearch Laboratories).
Results
Loss of A20 leads to defects in the generation and/or
localization of mature B-cell subsets
To inactivate A20 specifically in B lineage cells at different
developmental time points and to distinguish the specific effects of
A20 ablation from potential artifacts inherent to individual cre-
transgenic strains,22 we initially investigated the consequences of
CD19cre- and Mb1cre-mediated ablation of A20 in parallel (supple-
mental Figure 1A, available on the Blood Web site; see the
Supplemental Materials link at the top of the online article).
Because we did not observe any significant differences between
CD19cre/A20F/F and Mb1cre/A20F/F mice in our experiments, we
refer to them collectively as BA20/ mice (BA20	/ for heterozy-
gous deletion). Most of the experiments presented here were
conducted using CD19cre. Efficient loss of the NF-B–inducible
A20 protein in B cells of these mice was confirmed by Western
blot in both resting conditions and after treatment with LPS
(Figure 1A).
Loss of A20 does not affect early B-cell development in the
bone marrow, except for a minor increase in immature B cells. In
contrast, the number of mature recirculating B cells is significantly
reduced (supplemental Figure 1C-E). BA20/ mice have enlarged
spleens, coinciding with a minor increase in total B-cell numbers
(supplemental Figure 1B; Figure 1B), suggesting that other cell
types are also expanded. Mature follicular B-cell numbers are
unaffected by A20 deficiency, but immature transitional B cells
accumulate (Figure 1C-D) without any apparent block within the
transitional compartment (supplemental Figure 2A). The numbers
of marginal zone B (MZB) cells, defined by CD1d and CD21
expression (Figure 1C), are elevated because of an expansion of
CD23	 MZB precursor cells (Figure 1E; supplemental Figure 2B).
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Inspection of the splenic follicular organization by immunofluores-
cence revealed normal B- and T-cell compartments in BA20/
spleens (Figure 1F). However, in BA20/ spleen sections, CD1d-
expressing MZB cells are mostly located inside the follicle, whose
border is defined by MOMA-1-expressing metallophilic macro-
phages located adjacent to the marginal sinus. In contrast, on
BA20	/ and control spleen sections, CD1d-expressing cells are
properly located in the marginal zone (Figure 1F). Immunofluores-
cent detection of laminin and B cells indicates that the BA20/
splenic marginal zone is essentially devoid of B cells (supplemental
Figure 2B), further demonstrating that A20-deficient MZB cells are
not at their proper location. To test MZB cell function, we treated
splenocyte cultures with LPS for 3 days and monitored the
differentiation of short-lived plasma cells. At early times after
activation of splenic B cells by LPS MZB cells, and to much lesser
extent follicular B cells, differentiate into short-lived plasma
cells.23 As opposed to control B cells, A20-deficient splenic B cells
show a profound defect in their ability to differentiate into
Blimp1-expressing plasmablasts after LPS stimulation in vitro
(Figure 1G-H), indicating the absence or paucity of functional
MZB cells. Further underscoring this notion, BA20/ mice display
a significant reduction in the production of class-switched, antigen-
specific IgG3 after immunizations with the TI-II antigen NP-Ficoll
(Figure 1I), a response exquisitely dependent on the presence of
MZB cells.24 These results are in line with a significant reduction of
total IgG3 serum levels in naive BA20/ mice. IgG1 levels are also
lower in these mice, whereas IgG2c and IgG2b levels are un-
changed and IgM and IgA serum levels are strongly elevated (Figure
2A; supplemental Table 1). Supporting a role for A20 in B-cell
differentiation and/or proper localization, peritoneal B1, especially B1a
cells, are reduced in BA20/ mice (Figure 2B; supplemental Figure 2E).
In addition, thymic B cells are reduced in BA20/ mice, although they
appear elevated in BA20	/ mice (supplemental Figure 2D). Together,
our results uncover several surprising deficiencies in the gen-
eration, differentiation, and/or maintenance of mature B-cell subsets in
absence of A20. The affected subsets include MZB and B1 cells, which
are thought to mediate the innate functions of the B lineage.25
A20-deficiency enhances GC B-cell formation in gut-associated
lymphoid tissues
Given A20’s role as negative regulator of NF-B signaling, we
expected A20-deficient B cells to be hyper-reactive to stimulation.
We did not observe significant spontaneous GC formation in the
spleens of the mice analyzed, indicating that spontaneous B-cell
activation, if present in these mice, is not strong enough to induce
GCs. In naive mice, gut-associated lymphoid tissue (GALT) is the
place where B cells are constantly triggered by bacterial antigens to
enter the GC.26 The percentages and, to a lesser extent, absolute cell
numbers of GC B cells in mesenteric lymph nodes and Peyer
patches are increased in BA20/ and BA20	/ mice (Figure 2C; and
data not shown). This shows that, during B-cell activation by
bacterial antigens in the GALT, strong hemizygous effects of
A20 deficiency become apparent.
B cell–specific lack of A20 induces the spontaneous expansion
of regulatory T, effector-type T, and myeloid cells
The increase in transitional and MZB precursor cell numbers is not
sufficient to explain the higher splenocyte numbers in young
BA20/ mice (Figure 1B). Further detailed analyses showed that
Figure 1. Conditional knockout of A20 in B cells
induces severe defects in B-cell development and
differentiation. (A) A20 protein expression in CD43-
depleted B cells after 4-hour culture with or without
10 g/mL LPS. (B-E) Absolute cell numbers were calcu-
lated from 5 to 7 age-matched mice per genotype.
Data are mean 
 SD. (B) Absolute splenocyte and B-cell
numbers of the indicated genotypes. (C) Absolute cell num-
bers of splenic mature (B220	AA4.1), marginal zone/
marginal zone precursor (MZ; MZ-P: B220	CD1dhighCD21high),
follicular (B220	AA4.1CD1dCD23	), and transitional
(B220	AA4.1	) B cells. (D) Representative proportions
of transitional (Trans: B220	AA4.1	) and mature
(B220	AA4.1) B cells of total lymphocytes (top panels)
and of follicular (FO: CD1dintCD21int) and marginal
zone/marginal zone precursor (MZ: CD1dhighCD21high)
B cells of CD19	 B cells (bottom panels) in the spleen.
(E) CD23 expression on B220	CD1dhiCD21hi B cells
(left panel). Absolute cell numbers of marginal zone
(B220	CD1dhiCD21hiCD23lo) and marginal zone precursor
(B220	CD1dhiCD21hiCD23hi) B cells (right panel). (F) Top
panels: Immunofluorescence of spleen sections: green
represents B220, B cells; red, CD3, T cells; and blue,
laminin. Bottom panels: Immunohistochemistry of spleen
sections: blue represents MOMA-1, metallophilic macro-
phages; and brown, CD1d-expressing cells. Bar repre-
sents 100 m. (G) Proportions of B220loCD138hi plasma
blasts in splenic B cells 3 days after LPS treatment.
(H) Blimp1 mRNA expression relative to porphobilinogen
deaminase was determined by real-time PCR in splenic
B cells 3 days after LPS treatment. (I) Antigen-specific IgM
and IgG3 serum titers in response to T-independent im-
munizations with 10 g NP-Ficoll determined by ELISA.
Lines represent geometric means for 5 mice per experimen-
tal group. *P  .05 (1-way analysis of variance). **P  .001
(1-way analysis of variance).
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homozygous and heterozygous ablation of A20 in B cells
induces elevated numbers of T and myeloid cells. The sizes of
many splenic T-cell compartments are increased in BA20/
mice, especially the regulatory (Figure 3A-B), memory-type and
effector-type CD4 (Figure 3B), and effector-type CD8 T cells
(Figure 3C). Similar effects on T cells were observed in the
lymph nodes (data not shown). The analysis of ex vivo T-cell
cytokine production by intracellular staining revealed compa-
rable proportions of IL-17–, interferon-– and TNF-producing
cells between BA20/ and control mice (Figure 3E). We were
unable to detect any IL-4-producing cells (not shown). These
analyses suggest the absence of detectable T-cell differentiation
into specific T-helper lineages. The cell numbers of all splenic
myeloid subsets analyzed were higher in BA20/ compared
with control mice, with significant increases in dendritic cells
and eosinophils (Figure 3D). Importantly, heterozygous loss of
A20 in B cells induces an intermediate phenotype (Figures
3A-D) in most aspects of this immune deregulation. BA20	/
mice contain even higher proportions of splenic regulatory and
effector T cells than BA20/ mice (Figure 3A). However, the
higher absolute cell numbers of total CD4 T cells in BA20/
mice leads to the greatest absolute cell numbers also in these
subsets (Figure 3B). BA20/ and BA20	/ mice contain elevated
proportions of IL-10–producing B cells (supplemental Figure
2C), excluding the possibility that absence of this immune-
regulatory B-cell subset27 causes the perturbation in immune
homeostasis. To validate that CD19cre mediates inactivation
of A20 alleles only in B cells, we performed PCR on DNA
purified from splenic cell subsets of BA20/ mice. The purified
T cells, dendritic cells, macrophages, and granulocytes contain
less than 0.2% A20-knockout cells, which could be contami-
nating B cells (supplemental Figure 3). Our findings therefore
indicate that the absence or gene-dose reduction of A20, spe-
cifically in B cells, induces an immune deregulation reminiscent
of sterile inflammation, possibly held in check by regulatory
lymphocyte subsets.
Figure 2. A20-deficiency impairs B1 cell generation
but enhances GC formation in the GALT. (A) Titers of
immunoglobulin isotypes were determined by ELISA;
n  6 to 12 per genotype. (B) Absolute cell numbers of
B-cell subsets in the peritoneal cavity: B2 (CD19	B220	),
B1 (CD19highB220low), B1a (CD19highB220lowCD5	), and
B1b (CD19highB220lowCD5) cell numbers were calcu-
lated from 5 to 7 age-matched mice per genotype. Data
are mean 
 SD. (C) Left panel: Proportions of GC
(CD19	PNAhiFashiCD38lo) of total B cells in Peyer patches.
Data are mean
 SD of 8 mice per genotype. Right panel:
Proportions of GC B cells depicted as individual data
points (left chart), absolute cell numbers for naive B cells
(mantle zone B cells: CD19	PNA FasCD38hi; middle
chart), and GC B cells (right chart). Bars represent medi-
ans of 8 mice per group (same as in the left panel).
*P  .05 (1-way analysis of variance). **P  .001 (1-way
analysis of variance).
Figure 3. Ablation of A20 in the B-lineage has
B cell-extrinsic effects on immune homeostasis.
(A) Dot-plots showing percentages of CD4	Foxp3	 regula-
tory T cells and CD4	CD25 T cells (naïve indicates
CD44intCD62Lhi; memory, CD44hiCD62Lhi; and effector,
CD44hiCD62Llo) in the spleen. Numbers indicate the mean
of 4 to 6 mice for each genotype. (B-D) Absolute cell
numbers of CD4 T (B), CD8 T (C), and myeloid cell
(D) subsets in BA20/, BA20	/, and CD19cre mice (n  6
per group; 8-12 weeks old). Data are mean 
 SD. Treg
indicates Foxp3	; naive, CD44intCD62Lhi; memory,
CD44hiCD62Lhi; effector/memory, CD44hiCD62Llo; DC, den-
dritic cell (CD11c	); Eos, eosinophils (Gr1intSiglecF	); Mac,
macrophages (Mac1	Gr1lo); and Neu, neutrophils
(Gr1hiLy6G	). (E) Intracellular cytokine staining of ex vivo
isolated splenocytes (gated on T cells). Numbers represent
mean plus or minus SD of 3 mice per genotype. *P  .05
(1-way analysis of variance). **P  .001 (1-way analysis of
variance).
2230 CHU et al BLOOD, 17 FEBRUARY 2011  VOLUME 117, NUMBER 7
 For personal use only. at HINARI on February 17, 2011. www.bloodjournal.orgFrom 
A20 regulates B-cell responses in vitro in a
gene-dose–dependent fashion
Our observations of enhanced GC B-cell formation in the GALT in
BA20/ and BA20	/ mice suggested the possibility that their
B cells are more easily activated in this context. To analyze this in
more detail, we first quantified the relative A20 mRNA expression
at different time points after activation with IgM, CD40, LPS,
CpG DNA, and TNF. All these stimuli induced a strong increase in
A20 mRNA, peaking at approximately 1 hour (supplemental
Figure 4A), prompting us to test the in vitro responses of purified
A20-deficient and A20	/ B cells to these mitogens. B cells
up-regulate certain cell surface molecules (activation markers)
upon activation, among them B7.1/CD80, B7.2/CD86, MHC II,
CD25, and Fas. The expression of these markers was already
slightly higher in unstimulated B cells purified from BA20/ and
BA20	/ mice compared with control B cells (Figure 4A; supplemen-
tal 4B). This is probably because of the latent immune activation
we observed in these mice. Upon activation with the indicated
mitogens, A20-deficient B cells produced higher surface levels of
many activation markers (Figure 4A; supplemental Figure 3B).
B cells carrying one functional A20 allele showed an intermediate
phenotype regarding expression of these activation markers (Figure
4A). We then monitored IgM-, CD40-, LPS-, and CpG DNA-
induced proliferation by 3 assays: Both [3H]thymidine incorpora-
tion (Figure 4B) and cell cycle analysis (Figure 4C) showed increased
proliferative activity in the A20-deficient B-cell cultures in response to
all stimuli, and quantification of live cells revealed increased survival
after all stimuli, except for CpG DNA (Figure 4C). By CFSE dilution
assay (Figure 4D), we determined that the absence of A20 increased the
proportion of B cells that initially start to divide (% divided) in response
to CD40 and LPS. Only CpG DNA and BCR crosslinking
enhanced the proliferation of dividing A20-deficient B cells
(Proliferation Index; Figure 4D). Combination of stimuli, such as
LPS and IgM, or the addition of IL-4, did not yield additive
effects (supplemental Figure 4C). In all stimulations, the magni-
tude of the A20	/ B-cell response was in between A20/ and
control B cells (Figure 4B-D). Taken together, our studies show
that reduction of A20 function magnifies B-cell responses through
3 mechanisms, depending on the activating stimulus: lowering the
threshold for initial activation (CD40, LPS), protecting activated
B cells against apoptosis (IgM, CD40, LPS), and enhancing the
proliferation of cells that were activated to divide (IgM, CpG).
Figure 4. A20-deficiency amplifies B-cell responses.
(A) Expression levels of the respective B-cell activation
marker after overnight stimulation with LPS or CD40. The
dot-plots are representative of 3 to 6 independent experi-
ments. (B) [3H]Thymidine incorporation during a 10-hour
pulse 48 hours after stimulation of B-cell cultures with
IgM, CD40, LPS, or CpG. Data are mean 
 SD of
triplicate measurements. The experiment was repeated
with similar results. (C) Cell cycle profile analysis by
propidium iodide staining of B cells 2 days after stimulation
with the indicated mitogens. Percentages of dead (sub G0)
and live cells are indicated at the top of each histogram.
The distribution within the cell cycle was calculated with
the FlowJo software Version 8.7.3 using the Watson model
(values do not add up to 100%). Data are means of
2 independent experiments. (D) Assessment of prolifera-
tion by the carboxyfluorescein succinimidyl ester dilution
assay: histograms represent carboxyfluorescein succinimi-
dyl ester intensities 3 days after stimulation. The tables
under each histogram show the proliferation index (Prol.
Index: average number of divisions of the proliferating
cells), the percentage of dividing cells (% Divided: the
proportion of cells that initially started to divide), and the
division index (Div. Index: average number of divisions of
all cells); values were calculated with the FlowJo software.
Data represent the means of 5 independent experiments,
and bold values are significantly different (P  .05) from
wild-type according to 1-way analysis of variance analysis.
(E) Evaluation of IL-6 production in overnight activated B
cells by ELISA (top panels), intracellular FACS (middle
panels), and real-time PCR (bottom panels). For intracellu-
lar FACS, B cells were stimulated for 3 days. cDNA was
quantified relative to porphobilinogen deaminase. Data
are mean
 SD of 3 independent experiments. (F) Quanti-
fication of TNF production by overnight-stimulated B cells
via ELISA. Data are mean 
 SD of 3 independent
experiments.
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A20-deficient B cells exhibit spontaneous IL-6 secretion and
highly elevated IL-6 secretion on activation
In light of the T effector and myeloid cell expansion, we wondered
whether the higher excitability of A20-deficient B cells leads to
secretion of proinflammatory cytokines, which in turn affect the
differentiation and expansion of immune cells. IL-6 is a pleiotropic
cytokine with inflammatory activity, and its levels are up-regulated
in various autoimmune diseases, such as rheumatoid arthritis and
SLE.28 Activated A20-deficient B cells produced dramatically more
IL-6 mRNA and protein than control B cells in response to all
mitogens (Figure 4E). We could again detect an intermediate
phenotype in A20	/ B cells (supplemental Figure 4D). Indeed,
A20-deficient B cells spontaneously produced and released IL-6
into the cell culture medium in the absence of stimulation in
comparable amounts to the IL-6 secretion in IgM-stimulated
control B cells (Figure 4E). A20-deficient B cells also produced
slightly more TNF in response to all stimuli (Figure 4F). In accord
with these findings, we detected more IL-6 and TNF-producing
cells in ex vivo isolated A20-deficient compared with control
B cells (supplemental Figure 4E). The evaluation of IL-6 produc-
tion in immune cell subsets of 3- to 4-month-old BA20/ mice by
intracellular flow cytometry and real-time PCR revealed that, in
addition to B cells, dendritic cells and, to a lesser extent,
macrophages also produce IL-6 (supplemental Figure 5). This
suggests that secondary activation of myeloid cells by A20-
deficient B cells exacerbates the immune deregulation in
BA20/ mice.
A20 negatively regulates canonical NF-B, but not MAPK or
AKT activation, in response to engagement of the
BCR, CD40, and TLRs
We established that A20 is a gene-dose–dependent negative
regulator of B-cell activation in response to triggering of the BCR,
CD40, and TLRs. A20 was reported to limit the activation of
canonical NF-B in response to various stimuli in other cell
types.14,16 Therefore, we wanted to confirm that the hyper-reactivity
of A20-deficient B cells also correlates with enhanced canonical
NF-B activity in response to the stimuli used in our study. Indeed,
the absence of A20 selectively enhances the activation of the
canonical NF-B pathway, evidenced by prolonged increased
IB phosphorylation and degradation (Figure 5A-C). The activa-
tion of MAPK pathways or AKT phosphorylation was unaltered in
response to IgM, LPS, and CD40 (Figure 5A-C). The increased
IB phosphorylation correlated well with an increase in nuclear
translocation of p50 and RelA 2 and 4 hours after activation with
CD40 (Figure 5D). We detected elevated expression of p100 and
RelB, substrates of the alternative NF-B pathway and transcrip-
tional targets of canonical NF-B in whole cell extracts of
A20-deficient B cells (data not shown) in accord with the higher
canonical NF-B activity in these cells. Taken together, although
we do not rule out that A20 has additional functions, we demon-
strate that deficiency for A20 in B cells strongly enhances
activation of the canonical NF-B pathway in response to BCR
cross-linking (antigen), T-cell costimulation (CD40), and micro-
bial components (TLRs).
Figure 5. A20 controls canonical NF-B activation in
response to B-cell mitogens. (A-C) Western blot of whole
cell lysates stimulated for the indicated time points with
(A) 10 g/mL IgM, (B) 20 g/mL LPS, and (C) 10 g/mL
CD40. (D) Western blots on cytoplasmic and nuclear
extracts after stimulation with CD40. Results are represen-
tative of 2 or 3 independent experiments.
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Loss of A20 in B cells leads to autoimmune pathology in
old mice
To assess the impact of the chronic proinflammatory state induced
by B cell-specific loss of A20 in old age, we aged a cohort of
BA20/ and control mice. Histologic analysis of organs from
20-week-old BA20/ mice did not yield any signs of inflammation
(not shown). BA20/ mice, more than one year old, on the contrary,
were characterized by splenomegaly (Figure 6A; supplemental
Figure 6A-B). Although total B-cell numbers were not significantly
elevated in old BA20/ compared with control mice, all A20/
B cells appeared activated, as judged by the larger cell size and
elevated levels of the activation marker CD69 (Figure 6B). In
addition, we observed a marked expansion of PCs in the spleen
(Figure 6C; supplemental Figure 6C), but not in the bone marrow
(data not shown). Immunofluorescence analysis of the enlarged
spleens revealed a diffuse pattern of PCs surrounding altered and
disrupted B-cell follicles (Figure 6D). Analysis of the serum
isotype titers in aged BA20/ mice revealed higher IgM titers
compared with controls, as seen in young mice. However, in
contrast to the latter, in old BA20/ mice the levels of the
pathogenic IgG2b isotype29 are elevated (Figure 6E; supplemental
Table 2). The increase of effector and regulatory T cells, already
apparent in young BA20/ mice, has further expanded in old mice,
at the expense of the respective naive compartments (Figure 6F-G).
In addition, the expansion of myeloid cell subsets was much more
pronounced (Figure 6H). The progressive nature of the inflamma-
tion in the BA20/ mice is also reflected in elevated levels of serum
IL-6 in aged BA20/ mice (Figure 6I), which could not be detected
in the 20-week-old BA20/ mice (not shown). Histologic analysis
of organs from aged mice revealed inflammatory infiltrates in the
liver and kidney of most of the old BA20/ mice (supplemental
Figure 6D). Examinations of the renal pathology revealed no
extensive glomerular damage but clear IgG immune complex
depositions in aged BA20/ mice (Figure 6J).
Given this finding, we tested the sera of all old BA20/ and
control mice for indicators of self-recognition. Class-switched
antibodies against nuclear self-antigens (ANAs) are the most
common autoantibodies observed in autoimmune conditions in
mice and humans.30 Sera from BA20/ mice did not contain
significantly higher ANA levels than sera from the controls, and we
also did not detect enhanced reactivity to endogenous red blood
cells (Figure 7A). In addition, we observed increased levels of
rheumatoid factor of the IgM isotype in some BA20/ mice, but not
of the IgG isotype (Figure 7A). However, we detected significantly
elevated amounts of anticardiolipin IgG antibodies in aged BA20/
mice (Figure 7A), demonstrating systemic class-switched autoim-
mune reactivity. To evaluate whether antiphospholipid antibodies
are already detectable in younger mice, we screened the sera of
3-month-old mice. We detected elevated anticardiolipin IgG anti-
bodies in sera from BA20/ mice (and BA20	/ mice) compared
with control sera, but the differences were not statistically signifi-
cant (Figure 7C).
To screen for further autoreactivity against potentially tissue-
specific self-antigens, we incubated organ sections of Rag2/
mice with the sera of the aged mice. We detected autoreactive
class-switched IgG antibodies in the sera of BA20/, but not of
Figure 6. Splenomegaly and plasma cell hyperplasia in old
BA20/ mice. Cohort description: age range, 60 to 85 weeks;
mean age of experimental group, 68 weeks; mean age of control
group, 66 weeks. (A) Absolute cell numbers of splenocytes
(n(BA20/)  10, n(control)  9). (B) Left panel: Absolute cell
numbers of B cells (CD19	; n(BA20/)  12, n(control)  11).
Right panel: Representative size and CD69 expression of splenic
B220	 B cells. (C) Absolute cell numbers of splenic plasma cells
(B220loCD138hi; n(BA20/)  10, n(control)  9). (D) Representa-
tive immunofluorescence analysis of plasma cells in the spleen,
plasma cells (red represents CD138), B cells (green represents
B220). Bar represents 100 m. (E) Titers of immunoglobulin
isotypes in aged mice were determined by ELISA; n(BA20/)
 12, n(control) 11. (F-H) Absolute splenic cell numbers for the
following cellular subsets: CD4 T cells. (F) Treg (CD4	CD25	); CD4	
naive (CD25CD44intCD62Lhi), memory-type (CD25CD44hiCD62Lhi),
and effector T (CD4	CD44hiCD62Llo); CD8-T cells. (G) Naive
(CD44intCD62Lhi), memory-type (CD44hiCD62Lhi), and effector
T (CD44hiCD62Llo); myeloid cells (H): DC indicates dendritic cell
(CD11c	); Eos, eosinophils (Gr1intSiglecF	); Mac, macrophages
(Mac1	Gr1lo); and Neu, neutrophils (Gr1hiLy6G	). n(BA20/) 5,
n(control) 5. (I) Serum IL-6 (pg/mL) in aged mice was measured by
ELISA; n(BA20/) 12, n(control) 11. (J) Representative stainings
of IgG immune complexes in kidneys of BA20/ and control mice.
Original magnification 20. *P .05 (1-way analysis of variance).
**P .001 (1-way analysis of variance).
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control mice, directed predominantly against kidney, harderian
gland, stomach, thyroid gland, eye, liver, and lung (Figure 7B;
supplemental Figure 6E). Pancreas, salivary, lacrimal, and adrenal
glands were also recognized by sera from few BA20/ mice but
with a lower penetrance compared with the organs mentioned
earlier (Figure 7B). Notably, the kidney was recognized by
autoantibodies in the sera of the majority of BA20/ mice.
Therefore, we conclude that A20-deficient B cells induce chronic
progressive inflammation, which results in significant autoimmune
manifestations and pathologic alterations in old mice.
Discussion
The prevalent inactivation of the ubiquitin-editing enzyme A20 in
human B-cell lymphoma and the linkage of polymorphisms in the
A20/TNFAIP3 gene to human autoimmune diseases raise the
question of its function in the B-lineage, especially during B-cell
activation.
The major molecular function of A20 uncovered to date is the
negative regulation of canonical NF-B activation.14 We confirm
that, also in B cells, A20 limits activation of this signaling pathway
by all relevant physiologic inducers. Constitutive activation of
canonical NF-B in B cells induces B-cell hyperplasia, especially
pronounced in MZB cells.20 In contrast, we uncovered that
A20 activity is required for the correct localization of MZB cells
and for MZB cell function. Therefore, we conclude that proper
differentiation of A20-deficient MZB cells does not take place. In
addition, A20 is needed for the generation or cellular maintenance
of peritoneal B1, bone marrow recirculating and thymic B cells,
either directly or by mediating their correct localization. Reduced
cellular maintenance could be caused by lower sensitivity to
survival signals available in naive mice, but also by increased
terminal differentiation because of their hyperactivatable state. The
elevated IgA serum levels could be a consequence of the enhanced
GC reactivity in the GALT of BA20/ mice. Another possible
explanation is that the lower levels of B1a cells could, at least in
part, be caused by their enhanced differentiation to IgA-producing
plasma cells in response to inducing signals, such as IL-15,31 a
cytokine known to induce NF-B activation. This phenomenon
could also contribute to the elevated IgM levels. Because B1 cells
are thought to be the main source of naturally occurring autoanti-
bodies in naive mice,32 this could signify that also natural
autoantibody IgM titers, which are not pathogenic but rather play a
protective role, are enhanced in the BA20/ mice. The accumula-
tion of A20-deficient precursor populations (transitional B cells and
MZB cell precursors) points to blocks in development, although we
cannot exclude a role for impaired negative selection.
Taken together, our data on B-cell development and in vitro
activation studies suggest the following: A20 activity is required to
limit acute B-cell activation induced by stimuli connected to
invasion by pathogens. Its absence reduces the activation threshold
and enhances survival and proliferation in response to such stimuli.
On the other side, the absence of A20 does not render B cells more
responsive to maintenance signals required for mature resting cells.
Increased B cell–mediated IL-6 secretion resulting from spo-
radic local activation and, at least in the case of A20 deficiency,
spontaneous production and release of IL-6 is a probable underly-
ing cause of the effector T-cell differentiation and myeloid cell
hyperplasia that we observed in BA20/ and BA20	/ mice.
Subsequent cytokine secretion by activated myeloid cells most
probably amplifies this response. Indeed, Tsantikos et al recently
showed that effector T-cell activation, myeloid cell expansion, and
the development of autoimmune disease in Lyn-deficient mice,
which strikingly resemble BA20/ and BA20	/ mice in this regard,
are entirely dependent on the secretion of IL-6.33 Interestingly, the
authors also observed expansion of CD4	CD25	 T cells but did
not investigate whether they represent activated or regulatory
Figure 7. Autoimmune manifestations in old BA20/ mice.
(A) Analysis of autoantibodies in aged mice. ANA indicates
that antinuclear IgG antibodies were detected by ELISA,
n(BA20/)  12, n(control)  21; RBC-IgM, antierythrocyte
IgM was detected by FACS and represented as mean
fluorescence intensity, n(BA20/)  8, n(control)  4. IgG
and IgM rheumatoid factor (RF) was measured by ELISA;
n(BA20/)  12, n(control)  11. -Cardiolipin IgG antibod-
ies were detected by ELISA; n(BA20/)  12, n(control)  11.
*P  .05 (2-tailed unpaired Student t test). **P  .001
(2-tailed unpaired Student t test). (B) Table depicting the
self-reactivity of sera from individual BA20/ mice against the
indicated organs from Rag2/ mice. 	, 		, and 			
indicate the severity of autoreactivity; and n.s., not screened.
(C) Levels of -cardiolipin IgG autoantibodies in 3-month-old
mice (left panel; n  8 per genotype) and in 11-month-old
mice (right panel; n  5 per genotype) were detected by
ELISA. *P  .05 (1-tailed unpaired Student t test).
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T cells.33 The enhanced numbers of Tregs we observe in the
BA20/ and BA20	/ mice appear paradoxical in the context of
elevated IL-6 levels.34 We suggest that they expand and/or are
induced in reaction to the IL-6-driven inflammation. However, the
presence of IL-6 increases the resistance of effector T cells to
suppression by regulatory T cells,35 both systemically and locally.
Expansion of Tregs has also been observed in the BWF1 mouse
model for human SLE.36 Whether, and to what extent, an expanded
Treg population serves to keep the sterile inflammation in check is
an intriguing question to be tested in future studies.
While this manuscript was in preparation, a study by Tavares et
al on the same topic was published.37 The authors also found a
convincing gene-dose–dependent effect of A20 ablation on B-cell
activation. They detected elevated levels of antibodies in the serum
of CD19cre/A20F/F mice that recognize self-antigens on a protein
array. However, in their approach, anti–mouse Ig was used to detect
autoantibodies, which also recognizes IgM. Indeed, both studies
find highly elevated titers of IgM in naive BA20/ mice (in our
case, a 10-fold difference in the geometric mean). Naturally
occurring autoantibodies are mostly of the IgM isotype.38,39
Therefore, the increased recognition of self observed by Tavares et
al37 could reflect, at least to some degree, this increase in natural
autoantibodies. This possibility is substantiated by the fact that
only IgM	 dsDNA-recognizing plasma cells were detected and that
IgM immune complex deposits were revealed in naive 6-month-old
mice, in the absence of any sign of pathology.37 Given that the role
of IgM autoantibodies is also discussed as being protective,38,39 it is
unclear whether the autoreactivity observed in younger mice
contributes to the development of, or helps to prevent, disease.
We observed significant autoreactivity of class-switched antibod-
ies only in old mice, together with autoimmune pathology
and inflammation. The chronic inflammation induced by the
A20-deficient B cells perhaps contributes to a progressive break in
B-cell tolerance resulting in the production of class-switched,
autoreactive antibodies. The immune senescence of old age might
also contribute to this break in tolerance.32 The inflammatory
microenvironment in the spleen, and potentially in other affected
organs, together with the elevated presence of the pleiotropic
cytokine IL-6, may serve as a niche for the (autoreactive) plasma
cells. However, we do not detect significant levels of IgG ANAs,
the hallmark of SLE.30 Instead, we observe general IgG autoreactiv-
ity to cardiolipin, a common autoantigen in autoimmune dis-
ease30,40 in old BA20/ mice. The presence of tissue-specific
class-switched autoantibodies strongly underscores the loss of
tolerance. Some pathologic features of the old BA20/ mice are
reminiscent of human Castleman disease, namely, massive infiltra-
tions of plasma cells and the elevated presence of IL-6.28,41 It is
indeed possible that the disturbed B-cell development, including
the elevated levels of naturally occurring auto-IgM, are preventing
a more severe syndrome. Heterozygous BA20	/ mice display
inflammation and B-cell hyper-reactivity, but no developmental
defects. Therefore, they might represent a good tool for modeling
the reduced expression or function of A20 that should underlie the
link between mutations and polymorphisms in A20/TNFAIP3 and
human autoimmune disease. Indeed, initial analyses revealed
elevated class-switched antibodies against cardiolipin in a cohort of
11-month-old BA20	/ mice (Figure 7C).
We demonstrate here that selective loss of A20 in B cells is
sufficient to cause an inflammatory syndrome with autoimmune
manifestations in old mice. This condition is characterized by a
progressive chronic inflammation, elevated levels of IL-6, dramatic
plasma cell expansion, and the presence of class-switched systemic
and tissue-specifc autoantibodies. The exquisite dose effects of
monoallelic loss of A20 make it a prime target for deregulation by
proinflammatory miRNAs and oncomirs in disease contexts. Our
results demonstrate that B-cell hyper-reactivity caused by reduced
A20 function can contribute to the observed link between inherited
genetic mutations or polymorphisms in A20/TNFAIP3 and various
human autoimmune diseases.
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Cell purification and flow cytometry 
The purification of lymphocyte and leukocyte subsets was achieved by a two step 
procedure. Splenic cell suspensions were first separated into CD43-expressing and 
CD43-negative fractions by MACS (Miltenyi). The CD43-negative fraction was stained 
with antibodies against B220 (eBioscience) and CD19 (eBioscience) and B220+CD19+ 
B cells were purified using a FACSAria (BD). The CD43-positive fraction was stained 
with antibodies against B220, TCRȕ, CD11c, Gr-1 and Mac1 (all eBioscience). The 
following subsets were purified by FACS: T cells (B220íTCRȕ+), dendritic cells 
(B220íTCRȕíCD11c+), granulocytes (B220íTCRȕíCD11cíGr1+Mac1lo) and 
macrophages (B220íTCRȕíCD11cíGr1loMac1hi). All cell populations were over 99% 
pure. 
 
For intracellular ex vivo IL-6 stainings of lymphocytes and leukocyte subsets, cells were 
stimulated for 5 h at 37°C with 10 nM brefeldin-A (Applichem). 
 
PCR to identify A20 knock-out cells 
PCR was performed using the primers a (CATTTAACCCTTCTGAGTTTCCA), b 
(CCGGGCTTTAACCACTCTC), c (CCACCCCTATTACTACGTGACC) and the following 
touchdown program: (1) 95°C 3min, (2) 95°C 30s, (3) 65°C 45s, (4) 72°C 60s, while 
steps (2)–(4) are repeated 10 times, the annealing temperature is decreased by 
1°C/cycle, until 55°C is reached; (5) 95°C 30s, (6) 55°C 45s, (7) 72°C 60s, (5)–(7) are 
repeated 20 times; (8) 72°C 5min, (9) 4°C 15min. The PCR was conducted with either 
all three primers or only two (b, c) to specifically amplify the A20-knockout allele. PCR 
was performed on DNA isolated from the purified cell subsets. To estimate the 
sensitivity of the PCR for the knockout allele, we diluted DNA from CD19cre/A20F/F B 
cells at different ratios in DNA from A20F/F macrophages. 
 
Immunohistochemistry 
Spleen, kidney, liver were fixed in 4% PFA, processed, and embedded in paraffin. 2-ȝm 
sections for PAS stainings were prepared according to routine protocols. For the 
detection of tissue-specific autoantibodies, frozen sections from organs of Rag2í⁄í mice 
were incubated with sera of aged and control mice and an anti–mouse IgG–Cy3 
conjugate (Jackson ImmunoResearch). 
 
Table S1. Immunoglobulin titers in young mice 
 
IgM IgG1 IgG2c IgG2b IgG3 IgA 
KO Het WT KO Het WT KO Het WT KO Het WT KO Het WT KO Het WT 
841 150 31 66 81 178 56 71 59 3493 1178 981 2959 10141 9547 480439 1923 3237 
131 70 71 33 72 80 32 47 46 1588 4593 3269 1177 9541 9553 285393 6048 8266 
4220 121 81 97 82 66 42 41 46 2886 4480 2141 5473 10099 8299 124031 1923 5450 
581 71 41 96 94 198 39 49 37 2815 3059 1301 2389 9961 6361 137648 327 3593 
581 50 21 70 61 194 45 45 41 2123 4868 965 3235 2287 9421 351497 753 1733 
201 90 90 53 122 115 52 44 25 544 1874 896 7495 9829 9787 3237 194 2628 
63 75 14 6 66 31    482 479 467       
73 79 12 6 30 60    446 470 469       
172 63 8 10 63 25    483 478 449       
85 49 20 7 28 29    485 455 464       
70 52 54 10 49 54    455 485 414       
6

9 116 10 8 71 32    494 488 442       
216 77 28 22 63 68 44 49 41 957 1187 796 3214 7762 8734 117737 1012 36
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Table S2. Immunoglobulin titers in old mice 
 
IgM IgG1 IgG2c IgG2b IgG3 IgA 
KO WT KO WT KO WT KO WT KO WT KO WT
95 36 16 56 17 10 1085 346 7912 9512 26417 24875 
97 40 36 43 10 18 991 552 5752 23912 21417 8208 
116 37 64 73 14 17 956 239 38552 5192 4750 18625 
59 59 69 58 14 7 615 385 2952 16472 24750 16958 
80 28 50 56 9 7 249 506 5432 20952 23083 10708 
57 70 37 41 8 7 403 266 1752 2312 23917 10292 
124 38 48 41 19 19 828 737 312 4632 23917 19875 
122 60 6 46 11 17 920 917 7512 9832 18917 3208 
104 87 16 43 6 16 544 616 4232 19752 28917 26542 
107 53 33 42 6 11 781 196 10472 20232 23917 8208 
82 49 10 39 13 13 928 648 6552 10712 16417  
9

5  37  9 4 598 54 5192  8083  
92 48 28 48 10 11 689 371 4861 10568 18419 12573 
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Figure S1. Loss of A20 B-lineage cells leads to decreased numbers of 
recirculating B cells in the bone marrow 
(A) Scheme of B cell development and developmental time-frame (depicted as arrow), 
during which Mb1cre and CD19cre mouse strains express the cre recombinase. 
CD19cre induces partial recombination in preB and immature B cells: dotted line. (B) 
Representative spleen sizes of 8–12-week-old age-matched mice. (C) Representative 
dotplots showing proportions of pre/pro (B220+IgMí), immature (B220loIgM+) and 
mature/recirculating (B220hiIgM+) B cells of lymphocytes (upper panels) and pro (proB: 
CD25íc-Kit+) and pre (preB: CD25+c-Kití) B cells of B220+IgMí cells (lower panels) in 
the bone marrow. (D) Absolute cell numbers of lymphocyte subsets in the bone marrow: 
total bone marrow cells, B cells (B220+), proB, preB, immature B and recirculating B 
cells (defined as in C). Values represent means and s.d. calculated from 5–6 mice per 
genotype. (E) Effects of Mb1cre-mediated ablation of A20 on B-lineage cells in the bone 
marrow: upper two sets of panels as in (C), lower panels: percentages of large 
(B220hiIgM+CD25+c-KitíFSChi) preB of total preB cells. * = p < 0.05; ** = p < 0.001; one-
way anova 
 
Figure S2. Loss of A20 B-lineage cells leads to an accumulation of transitional B 
cells in the spleen 
(A) Representative dotplots showing proportions (left) and bar charts with absolute cell 
numbers (right) of B220+AA4.1+ transitional B cell subsets in the spleen: IgMhiCD23í T1, 
IgMhiCD23+ T2 and IgMloCD23+ T3 (anergic). Values represent means and s.d. 
calculated from 5–6 mice per genotype. (B) Upper panels: representative dotplots 
showing proportions of CD19+CD21hiCD1dhi B cells in the spleen: CD23lo MZ and 
CD23hi MZ precursor B cells. Values represent means and s.d. calculated from 5–6 
mice per genotype. Lower panels: immunofluorescence of spleen sections 
demonstrating the marginal sinus (depicted as dotted yellow line) as border between the 
marginal and follicular zone: green = ĮB220, B cells; red = ĮCD3, T cells; blue = 
laminin. Magnification: 20×. (C) Representative dotplots showing proportions of IL-10 
producing B cells (B220+IL10+) after 5h stimulation with PMA/ionomycin/BFA/LPS. 
Values represent means and s.d. of 3 mice per genotype. (D) Representative dotplots 
showing proportions of B cells in the thymus (B220+TCRȕí). Values represent means 
and s.d. of 3 mice per genotype. (E) Representative dotplots showing proportions of B 
cell subsets in the peritoneal cavity (absolute cell numbers are shown in Fig. 2B): 
B220hiCD19+ B2 and B220loCD19hi B1 cells of total lymphocytes (upper panels) and 
CD43loCD5í B1b and CD43+CD5+ B1a cells of B1 cells (lower panels). * = p < 0.05; ** = 
p < 0.001; one-way anova 
 
Figure S3. Fidelity of CD19cre for specific recombination of conditional A20 
alleles only in B cells 
(A) Scheme of the conditional A20 allele before (upper panel) and after (lower panel) 
cre-mediated recombination. The location of the primers (a–c) employed for the 
genotyping PCR are shown and the length of the respective PCR amplification 
products. Squares indicate exons (E3–E7) and triangles loxP sites. (B) Upper panels: 
representative PCR results for two PCR reactions on DNA from purified splenic cell 
subsets: the three primer PCR (a, b, c) amplifies A20 loxP-flanked and knockout alleles, 
whereas the two primer PCR (a, c) amplifies only DNA from A20-knockout alleles. 
Splenic cell subsets (T cells = B220íTCRȕ+, dendritic cells/DC = B220íTCRȕíCD11c+, 
macrophages/Mac = B220íTCRȕíCD11cíGr1loMac1hi and granulocytes/Gr = 
B220íTCRȕíCD11cíGr1+Mac1lo) were MACS purified followed by cell sorting and were 
over 99% pure. Identical results were obtained for all the cellular subsets sorted from 
three individual CD19cre/A20F/F mice. Lower panels: evaluation of the sensitivity of the 
two PCRs. A20-knockout cells were diluted at different ratios with A20F/F cells. The 
PCRs are able to amplify the knockout allele at a dilution of 1 to 500. The amplification 
product for the knockout allele that could be observed with the DNA from purified T 
cells, DCs, macrophages and granulocyte was weaker than the amplification product 
from the 1:500 A20-knockout to A20F/F dilution in all cases. This band therefore 
represents most likely the presence of less than 0.2% contaminating B cells in the 
respective purified cell-type. However, this analysis does not allow us to rule out the 
presence of less than 0.2% A20-knockout cells within each cell-type. 
 
Figure S4. A20 regulates B cell activation in a dose-dependent fashion 
(A) Realtime PCR quantifying the amount of A20 mRNA relative to PBGD mRNA in 
wild-type B cells stimulated with the indicated mitogens for 1, 4 and 12 h. Means and 
s.d. of triplicate measurements are shown. (B) Expression levels of the B cell activation 
marker after o/n stimulation with ĮIgM, LPS, CpG or ĮCD40. The dotplots are 
representative of 3 independent experiments. (C) Assessment of proliferation by the 
CFSE dilution assay: histograms show CFSE intensities 3 days after stimulation with 
the indicated mitogens. The table depicts the proliferation index (Proliferation index: 
average number of divisions of the proliferating cells), the percentage of dividing cells 
(% Divided: the proportion of cells that initially started to divide) and the division index 
(Div. Index: average number of divisions of all cells). Numbers represent the means of 3 
to 4 (ĮCD40/IL-4) independent experiments. (D) IL-6 levels were measured in the 
supernatant after o/n stimulation with ĮIgM, LPS, CpG or ĮCD40. (E) Representative 
dotplots showing proportions of TNFĮ- or IL-6–producing B cells (B220+ TNFĮ+ or 
220+ IL-6+) after 5h stimulation with PMA/ionomycin/BFA. Values represent means 
nd s.d. of 3 mice per genotype. 
B
a

Figure S5. IL-6 producing cell-types in CD19cre/A20F/F mice 
(A) Realtime PCR analysis of IL-6 expression in FACS-purified splenic cell subsets of 
CD19cre/A20F/F and CD19cre control mice. Splenic cell subsets (T cells = B220íTCRȕ+, 
dendritic cells/DC = B220íTCRȕíCD11c+, macrophages/Mac = 
B220íTCRȕíCD11cíGr1loMac1hi and granulocytes/Gr = 
B220íTCRȕíCD11cíGr1+Mac1lo) were MACS purified followed by cell sorting and were 
over 99% pure. IL6 cDNA was quantified relative to PBGD. Values represent means 
and s.d. of 3 independent experiments. (B) Proportions of IL-6 expressing cells of 
individual immune cell subsets in the spleen of CD19cre/A20F/F and CD19cre control 
mice identified by intracellular FACS. Values represent means and s.d. of 3 
independent experiments. 
 
Figure S6. Chronic inflammation and autoreactivity in aged BA20í⁄í mice 
(A) Representative spleen size of old CD19cre/A20F/F and age-matched CD19cre 
control mice. (B) Spleen weight (n(BA20í⁄í) = 10, n(control) = 9). (C) Representative 
dotplot showing proportions of plasma cells (B220loCD138hi), mean and s.d. for n = 9 
mice per genotype are shown. (D) Representative PAS stainings of liver and kidney 
sections from aged mice. Magnification: 10×. (E) Representative immunofluorescence 
staining of tissue-specific IgG autoantibodies directed against kidney, harderian gland, 
stomach and lacrimal gland. Staining was performed by incubating sera from aged mice 
on sections of tissues isolated from Rag2í⁄í mice. Magnification: 20×. 
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